[
  {
    "text": "Metagenomic Next-Generation Sequencing Unravels Talaromyces Marneffei-Induced",
    "entities": [
      {
        "text": "Next-Generation Sequencing Unravels Talaromyces Marneffei-Induced",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bone Destruction in an HIV-Negative Woman: A Case Report with Fatal Outcome.",
    "entities": [
      {
        "text": "HIV-Negative Woman",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Department of Spinal Orthopedics, The Second Affiliated Hospital of Guangxi",
    "entities": [
      {
        "text": "Spinal Orthopedics",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical University, Nanning, Guangxi, People's Republic of China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Nanning",
        "label": "GPE"
      },
      {
        "text": "Guangxi",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "INTRODUCTION: Talaromycosis is an opportunistic fungal disease caused by",
    "entities": []
  },
  {
    "text": "Talaromyces marneffei (TM), a significant pathogen predominantly affecting",
    "entities": [
      {
        "text": "TM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immunocompromised individuals, especially those with HIV infection. Although",
    "entities": []
  },
  {
    "text": "traditionally regarded as an HIV-associated infection, increasing cases have",
    "entities": []
  },
  {
    "text": "been reported among HIV-negative patients.",
    "entities": []
  },
  {
    "text": "CASE PRESENTATION: This report details a case of a 36-year-old HIV-negative",
    "entities": [
      {
        "text": "36-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "woman infected with Talaromyces marneffei. The patient presented with bone",
    "entities": [
      {
        "text": "Talaromyces marneffei",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "destruction and was diagnosed through metagenomic next-generation sequencing",
    "entities": []
  },
  {
    "text": "(mNGS). Despite receiving antifungal, anti-inflammatory, and symptomatic",
    "entities": []
  },
  {
    "text": "treatment, the infection remained uncontrolled, ultimately progressing to",
    "entities": []
  },
  {
    "text": "multi-organ failure and resulting in death.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Bone damage due to Talaromyces marneffei infection is very uncommon",
    "entities": [
      {
        "text": "Talaromyces marneffei",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in HIV-negative patients. Thus, healthcare providers should be alert for",
    "entities": []
  },
  {
    "text": "possible skeletal lesions linked to this infection. Early diagnosis and",
    "entities": []
  },
  {
    "text": "appropriate antimicrobial treatment are vital for the patient's prognosis.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no competing",
    "entities": []
  },
  {
    "text": "interests in this work.",
    "entities": []
  },
  {
    "text": "Retention in HIV Pre-Exposure Prophylaxis Among Men Who Have Sex with Men in",
    "entities": []
  },
  {
    "text": "(1)Department of Behavioural Sciences, Muhimbili University of Health and Allied",
    "entities": [
      {
        "text": "Behavioural Sciences",
        "label": "ORG"
      },
      {
        "text": "Muhimbili University of Health",
        "label": "ORG"
      },
      {
        "text": "Allied",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Community Medicine and Global Health, University of Oslo, Oslo,",
    "entities": [
      {
        "text": "Community Medicine and Global Health, University of Oslo, Oslo",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Educational Psychology and Curriculum Studies, University of",
    "entities": [
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Mbeya College of Health and Allied Sciences, University of Dar Es Salaam,",
    "entities": [
      {
        "text": "4)Mbeya College of Health",
        "label": "ORG"
      },
      {
        "text": "Allied Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Dar Es Salaam",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: Men who have sex with men are at high risk of Human immunodeficiency",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "virus (HIV) infection and bear the highest burden of the disease in Tanzania.",
    "entities": [
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Although pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in the",
    "entities": []
  },
  {
    "text": "prevention of HIV infection in clinical trials, challenges with retention",
    "entities": []
  },
  {
    "text": "threaten its effectiveness. Therefore, we assessed the extent and predictors of",
    "entities": []
  },
  {
    "text": "retention in PrEP care among men who have sex with men in Tanga, Tanzania.",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      },
      {
        "text": "Tanga",
        "label": "GPE"
      },
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: This study included 369 men who have sex with men who were recruited",
    "entities": [
      {
        "text": "369",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "using respondent-driven sampling. Baseline data were collected using structured",
    "entities": []
  },
  {
    "text": "questionnaires that captured socio-demographic and behavioral characteristics.",
    "entities": []
  },
  {
    "text": "The primary outcome was one-month retention in PrEP care. A statistical analysis",
    "entities": [
      {
        "text": "one-month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "using modified Poisson regression was conducted to identify independent factors",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "associated with 1-month retention.",
    "entities": [
      {
        "text": "1-month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 369 men (mean age, 24.7 (\u00b1 5.5 years)) participated in the",
    "entities": [
      {
        "text": "369",
        "label": "CARDINAL"
      },
      {
        "text": "24.7",
        "label": "CARDINAL"
      },
      {
        "text": "5.5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "study. After one month, 87 participants (23.6%) were retained in PrEP care.",
    "entities": [
      {
        "text": "one month",
        "label": "DATE"
      },
      {
        "text": "87",
        "label": "CARDINAL"
      },
      {
        "text": "23.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Independent factors associated with retention included assuming a receptive",
    "entities": []
  },
  {
    "text": "position in anal sex (aPR 1.6, 95 CI: 1.0-2.6, p = 0.030), having initiated",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.0-2.6",
        "label": "CARDINAL"
      },
      {
        "text": "0.030",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sexual activity with anal, oral, or thigh sex (aPR 2.1, 95% CI: 1.2-3.8, p =",
    "entities": [
      {
        "text": "2.1",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.2-3.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.011), and having adequate social support (aPR: 1.6, 95% CI: 1.0-2.6, p =",
    "entities": [
      {
        "text": "0.011",
        "label": "CARDINAL"
      },
      {
        "text": "1.6, 95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.0-2.6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Tailored interventions that improve social support and address the",
    "entities": []
  },
  {
    "text": "varying needs of men who have sex with men with diverse sexual behavior patterns",
    "entities": []
  },
  {
    "text": "are essential for improving retention and maximizing the effectiveness of PrEP",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in HIV prevention. Practically, this highlights the need to strengthen",
    "entities": []
  },
  {
    "text": "supportive environments within communities and healthcare systems to enhance",
    "entities": []
  },
  {
    "text": "retention in PrEP, reduce HIV transmission, and advance progress toward ending",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HIV as a public health threat by 2030.",
    "entities": [
      {
        "text": "2030",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors report no conflicts of interest in",
    "entities": []
  },
  {
    "text": "this work.",
    "entities": []
  },
  {
    "text": "HIV Infection Among Pregnant Women in a Vietnamese Population: Prevalence and",
    "entities": [
      {
        "text": "Vietnamese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Associated Factors.",
    "entities": [
      {
        "text": "Associated Factors",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Vinh Long Department of Health, Vinh Long City, Vietnam.",
    "entities": [
      {
        "text": "Long Department of Health",
        "label": "ORG"
      },
      {
        "text": "Long City",
        "label": "GPE"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho",
    "entities": [
      {
        "text": "Can Tho\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "City, Vietnam.",
    "entities": [
      {
        "text": "City",
        "label": "GPE"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Physiology, Faculty of Medicine, Can Tho University of Medicine",
    "entities": [
      {
        "text": "Physiology, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Pharmacy, Can Tho City, Vietnam.",
    "entities": [
      {
        "text": "Tho City",
        "label": "GPE"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: In pregnant women, HIV infection warrants special attention due to",
    "entities": []
  },
  {
    "text": "the high risk of complications during pregnancy and the increased likelihood of",
    "entities": []
  },
  {
    "text": "fetal HIV exposure. Consequently, screening for HIV in pregnant women within the",
    "entities": []
  },
  {
    "text": "community and identifying associated risk factors are essential.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: The study aims to investigate the prevalence of HIV infection and the",
    "entities": []
  },
  {
    "text": "associated risk factors in pregnant women.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: This is a cross-sectional study that utilized convenience",
    "entities": []
  },
  {
    "text": "sampling and was conducted between 2018 and 2020 at 107 commune health stations,",
    "entities": [
      {
        "text": "between 2018 and 2020",
        "label": "DATE"
      },
      {
        "text": "107",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "8 district health centers, and the Obstetrics Department of Vinh Long Provincial",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "the Obstetrics Department of Vinh Long Provincial",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 18,034 pregnant women, with a median age of 28 years.",
    "entities": [
      {
        "text": "18,034",
        "label": "CARDINAL"
      },
      {
        "text": "age of 28 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Fifty-one cases (0.3%) tested positive for HIV. The risk factors associated with",
    "entities": [
      {
        "text": "Fifty-one",
        "label": "CARDINAL"
      },
      {
        "text": "0.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "an increased likelihood of HIV infection included having multiple sexual",
    "entities": []
  },
  {
    "text": "partners, drug addiction, smoking, and engaging in unprotected sex. In the",
    "entities": []
  },
  {
    "text": "multivariate model, only multiple sexual partners, drug addiction and alcohol",
    "entities": []
  },
  {
    "text": "consumption were independent factors that significantly increased the risk of",
    "entities": []
  },
  {
    "text": "HIV infection among pregnant women.",
    "entities": []
  },
  {
    "text": "CONCLUSION: The study among pregnant women indicated that the HIV exposure rate",
    "entities": []
  },
  {
    "text": "within the community is below 1.0%. Unsafe sexual behaviors with multiple",
    "entities": [
      {
        "text": "1.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "partners were identified as the most significant risk factor for HIV exposure",
    "entities": []
  },
  {
    "text": "4. Open Forum Infect Dis. 2025 Jul 2;12(7):ofaf369. doi: 10.1093/ofid/ofaf369.",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul.",
    "entities": [
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025 Jul.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Prevalence and Risk Factors of Liver Fibrosis Among People With HIV and",
    "entities": []
  },
  {
    "text": "Metabolic Dysfunction-Associated Steatotic Liver Disease.",
    "entities": [
      {
        "text": "Metabolic Dysfunction-Associated Steatotic Liver Disease",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Infection and Immunity, Shanghai Public Health Clinical Center,",
    "entities": [
      {
        "text": "Infection and Immunity",
        "label": "ORG"
      },
      {
        "text": "Shanghai Public Health Clinical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fudan University, Shanghai, China.",
    "entities": [
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: We aimed to investigate the prevalence of liver fibrosis and",
    "entities": []
  },
  {
    "text": "identify the associated risk factors among people with HIV (PWH) and metabolic",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dysfunction-associated steatotic liver disease (MASLD).",
    "entities": []
  },
  {
    "text": "METHODS: Abdominal ultrasonography and transient elastography were performed to",
    "entities": []
  },
  {
    "text": "assess liver fibrosis and steatosis. Lean MASLD was defined as MASLD occurring",
    "entities": []
  },
  {
    "text": "in PWH with a body mass index (BMI) < 24 kg/m2. A cutoff of liver stiffness",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      },
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "24 kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "measurement \u2265 7.1 kPa was set for significant liver fibrosis. The prevalence,",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "kPa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "correlation factors, and risk factors were evaluated.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 361 PWH, 250 (69.25%) had a BMI < 24 kg/m2, and 141 (39.06%) were",
    "entities": [
      {
        "text": "361",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "250",
        "label": "CARDINAL"
      },
      {
        "text": "69.25%",
        "label": "PERCENT"
      },
      {
        "text": "24 kg",
        "label": "QUANTITY"
      },
      {
        "text": "141",
        "label": "CARDINAL"
      },
      {
        "text": "39.06%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diagnosed with MASLD. The 141 PWH with MASLD were classified as 2 groups based",
    "entities": [
      {
        "text": "141",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "on BMI: 58 (41.13%) as lean MASLD and 83 (58.87%) as overweight MASLD.",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "41.13%",
        "label": "PERCENT"
      },
      {
        "text": "83",
        "label": "DATE"
      },
      {
        "text": "58.87%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Significant fibrosis was observed in 121 of the 361 PWH, including 75 of the 141",
    "entities": [
      {
        "text": "121",
        "label": "CARDINAL"
      },
      {
        "text": "361",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "141",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with MASLD, 28 of the 58 with lean MASLD, and 47 of the 83 with overweight",
    "entities": [
      {
        "text": "MASLD",
        "label": "ORG"
      },
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "MASLD. Among PWH with MASLD, independent risk factors for significant liver",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fibrosis included higher alanine aminotransferase levels and the presence of",
    "entities": []
  },
  {
    "text": "type 2 diabetes. Among PWH with lean MASLD, independent risk factors for",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant liver fibrosis included elevated aspartate aminotransferase levels",
    "entities": []
  },
  {
    "text": "and the administration of non-nucleoside reverse transcriptase inhibitors.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Significant liver fibrosis is highly prevalent among PWH and MASLD.",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Multiple risk factors are associated with significant liver fibrosis among PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "These findings underscore the importance of early identification and management",
    "entities": []
  },
  {
    "text": "of liver fibrosis in PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CLINICAL TRIALS REGISTRATION: NCT04215926.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infectious Diseases Society of America.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Potential conflicts of interest. All authors: No",
    "entities": []
  },
  {
    "text": "reported conflicts. All authors have submitted the ICMJE Form for Disclosure of",
    "entities": []
  },
  {
    "text": "Potential Conflicts of Interest.",
    "entities": [
      {
        "text": "Potential Conflicts of Interest",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Attomolar Detection of HIV-1 with Label-Free RCA-rCRISPR on Smartphone.",
    "entities": [
      {
        "text": "Smartphone",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Human Immunodeficiency Virus-1 (HIV) remains a major global public health",
    "entities": []
  },
  {
    "text": "challenge, having led to over 42.3 million deaths since its discovery in the",
    "entities": [
      {
        "text": "over 42.3 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "early 1980s. Despite progress in prevention and treatment, around 60% of people",
    "entities": [
      {
        "text": "early 1980s",
        "label": "DATE"
      },
      {
        "text": "around 60%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with HIV (PWH) remain undiagnosed in resource-limited regions,",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disproportionately affecting vulnerable populations and underserved communities",
    "entities": []
  },
  {
    "text": "across the world. This illustrates the critical need for accessible, accurate,",
    "entities": []
  },
  {
    "text": "and equipment-free diagnostic tools to enhance detection and thus provide",
    "entities": []
  },
  {
    "text": "opportunities to curb its spread. Here, we developed a low-cost, robust, and",
    "entities": []
  },
  {
    "text": "label-free rolling circle amplification (RCA)-rCRISPR diagnostic platform for",
    "entities": [
      {
        "text": "RCA)-rCRISPR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "detecting HIV viral load with minimal instrumentation. Our strategy, combining",
    "entities": []
  },
  {
    "text": "the integration of RNA-detecting RCA reaction with plasmid reporter-based",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "RCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ratiometric CRISPR (rCRISPR), enables sensitive detection of unprocessed RNA",
    "entities": [
      {
        "text": "CRISPR",
        "label": "PERSON"
      },
      {
        "text": "rCRISPR",
        "label": "PERSON"
      },
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "targets without the need for intensive sample pre-treatment. This label-free",
    "entities": []
  },
  {
    "text": "RCA-rCRISPR diagnostic platform detected HIV RNA down to single-digit aM",
    "entities": [
      {
        "text": "RCA-rCRISPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sensitivity (~3000 copies/mL) from PWH-derived HIV samples ex vivo . Unlike",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "typical RCA, which requires sample fragmentations to break long RNA target",
    "entities": [
      {
        "text": "RCA",
        "label": "ORG"
      },
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sequences, our design harnesses the triple functions of the phi29 DNA polymerase",
    "entities": []
  },
  {
    "text": "(namely exonuclease activity, polymerization, and strand displacement), enabling",
    "entities": []
  },
  {
    "text": "the detection of the entire HIV genome without pre-fragmentation. For",
    "entities": []
  },
  {
    "text": "point-of-care (POC) applications, we constructed an all-in-one smartphone-based",
    "entities": []
  },
  {
    "text": "testing, making it accessible to resource-limited communities. Additionally, the",
    "entities": []
  },
  {
    "text": "assay has demonstrated the ability for point mutation detection ( BRAF mutation",
    "entities": [
      {
        "text": "BRAF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in canine urothelial carcinoma), showcasing the robustness of our strategy for",
    "entities": []
  },
  {
    "text": "broad disease diagnostic applications.",
    "entities": []
  },
  {
    "text": "The soluble HIV-1 Vpu protein interacts with calmodulin in a Ca (2+) -dependent",
    "entities": [
      {
        "text": "HIV-1 Vpu protein interacts with calmodulin",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Ca",
        "label": "WORK_OF_ART"
      },
      {
        "text": "2+",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The HIV-1-encoded membrane protein Vpu plays key roles in virus lifecycle. Our",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "lab recently revealed a soluble form of Vpu, and we strived to determine its",
    "entities": []
  },
  {
    "text": "possible physiological function. Here, we provide solid experimental proof that",
    "entities": []
  },
  {
    "text": "soluble Vpu interacts with Ca 2+ -bound calmodulin (Ca 2+ -CaM). A putative",
    "entities": [
      {
        "text": "2+ -bound",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CaM-binding motif in Vpu was predicted, but there was no experimental evidence",
    "entities": []
  },
  {
    "text": "of the Vpu-CaM association. We applied double electron electron-resonance (DEER)",
    "entities": [
      {
        "text": "the Vpu-CaM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and protein spin labeling to detect the soluble Vpu-CaM complex. We found that",
    "entities": [
      {
        "text": "Vpu-CaM",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "soluble full-length and truncated C-terminal region of Vpu directly interact",
    "entities": []
  },
  {
    "text": "with Ca 2+ -CaM. DEER results from the spin-labeled double cysteine mutant",
    "entities": [
      {
        "text": "2+",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "S39C/A103C of CaM showed that upon association with Vpu Ca 2+ -CaM adopts a more",
    "entities": [
      {
        "text": "S39C/A103C",
        "label": "ORG"
      },
      {
        "text": "CaM",
        "label": "ORG"
      },
      {
        "text": "2+",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "closed conformation compared to those in the absence of Vpu. This restructuring",
    "entities": []
  },
  {
    "text": "is in agreement with previously observed Ca 2+ -CaM association with cellular",
    "entities": [
      {
        "text": "2+ -CaM",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and other HIV-1 proteins. Our results indicate that soluble Vpu and CaM form an",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      },
      {
        "text": "CaM",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "in Vpu C-terminal region suggest that Vpu's helices 2 and 3 move away from each",
    "entities": [
      {
        "text": "Vpu",
        "label": "PERSON"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "other to facilitated CaM binding. These observations tell that under",
    "entities": [
      {
        "text": "CaM",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "physiological conditions the soluble Vpu-CaM complex may provide Vpu with a",
    "entities": []
  },
  {
    "text": "trafficking pathway to membrane destination.",
    "entities": []
  },
  {
    "text": "Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      },
      {
        "text": "V2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "antibody mouse model after a single bolus immunization.",
    "entities": []
  },
  {
    "text": "Amereh K, Avillion G, Bottermann M, Liang B, Chaudhary N, Callaghan S, Dye J, Li",
    "entities": [
      {
        "text": "Amereh K",
        "label": "PERSON"
      },
      {
        "text": "Avillion G",
        "label": "PERSON"
      },
      {
        "text": "Bottermann M",
        "label": "PERSON"
      },
      {
        "text": "Liang B",
        "label": "PERSON"
      },
      {
        "text": "Chaudhary N",
        "label": "PERSON"
      },
      {
        "text": "Callaghan S",
        "label": "PERSON"
      },
      {
        "text": "Dye J",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "X, Ellis-Pugh JR, Chowdhury RR, James NE, Liu X, Maiorino L, Maldonado P,",
    "entities": [
      {
        "text": "Chowdhury RR",
        "label": "ORG"
      },
      {
        "text": "James NE",
        "label": "PERSON"
      },
      {
        "text": "Liu X",
        "label": "PERSON"
      },
      {
        "text": "Maiorino L",
        "label": "PERSON"
      },
      {
        "text": "Maldonado P",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BH, Burton DR, Shapiro L, Kwong PD, Irvine DJ, Andrabi R, Shaw GM, Batista FD.",
    "entities": [
      {
        "text": "BH",
        "label": "ORG"
      },
      {
        "text": "Burton DR",
        "label": "GPE"
      },
      {
        "text": "Shapiro L",
        "label": "NORP"
      },
      {
        "text": "Kwong PD",
        "label": "NORP"
      },
      {
        "text": "Irvine DJ",
        "label": "PERSON"
      },
      {
        "text": "Shaw GM",
        "label": "PERSON"
      },
      {
        "text": "Batista FD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Current vaccine strategies to elicit broadly neutralizing antibodies (bnAbs)",
    "entities": []
  },
  {
    "text": "against HIV-1 generally propose complex, multi-boost immunization regimens. In",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rhesus macaques, SHIV infection has been observed to rapidly drive the",
    "entities": []
  },
  {
    "text": "development of some classes of bnAbs that share structural similarities with",
    "entities": []
  },
  {
    "text": "those in humans. Here, we generated a knockin mouse model with B cells bearing",
    "entities": []
  },
  {
    "text": "the unmutated common ancestor (UCA) of the V2 apex-targeted bnAb lineage,",
    "entities": [
      {
        "text": "UCA",
        "label": "ORG"
      },
      {
        "text": "V2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "V033-a. A single immunization of mice with a germline-targeting native-like",
    "entities": [
      {
        "text": "V033-a.",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "trimer was sufficient to recapitulate the ontogeny of the mature rhesus bnAb in",
    "entities": [
      {
        "text": "rhesus bnAb",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "knockin mice-including rare, disfavored somatic mutations-leading to the",
    "entities": [
      {
        "text": "knockin mice-including",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "induction of antibodies that exhibited potent neutralization against both",
    "entities": []
  },
  {
    "text": "autologous and heterologous tier 2 viruses. A boost with Env escape mutant",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "trimers further improved breadth and potency, and cryo-EM structure revealed the",
    "entities": []
  },
  {
    "text": "structural basis for heterologous neutralization breadth. Non-human primate and",
    "entities": []
  },
  {
    "text": "mouse models can thus combine with structure to serve as a platform for",
    "entities": [
      {
        "text": "mouse",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "identifying and confirming immunogens that streamline HIV-vaccination regimens.",
    "entities": []
  },
  {
    "text": "Dolutegravir Developmental Toxicity is Mitigated by Magnesium and Folate in",
    "entities": [
      {
        "text": "Mitigated by Magnesium",
        "label": "ORG"
      },
      {
        "text": "Folate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Zebrafish Embryos.",
    "entities": [
      {
        "text": "Zebrafish Embryos",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Integrase-strand-transfer inhibitors have transformed HIV therapy, yet the",
    "entities": []
  },
  {
    "text": "widely prescribed drug dolutegravir (DTG) has been linked to developmental",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "toxicity and its teratogenic mechanism remains uncertain. Here we use zebrafish",
    "entities": []
  },
  {
    "text": "to dissect DTG toxicity during early vertebrate development. DTG exposure from",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2-4 h post-fertilization (hpf) to 24 hpf produced high mortality and abnormal",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "morphology; co-treatment with folic acid or 5-methyltetrahydrofolate partially",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "restored normal morphology, whereas calcium had no effect. Strikingly,",
    "entities": []
  },
  {
    "text": "supplementation with magnesium (Mg) rescued DTG-exposed embryos almost as",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effectively as folate, implicating magnesium availability in protection. In",
    "entities": []
  },
  {
    "text": "competitive binding assays, Mg increased binding of folate to purified folate",
    "entities": [
      {
        "text": "Mg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "receptor (FOLR1) by 30% in the presence of DTG. Maternal-zygotic zebrafish folr1",
    "entities": [
      {
        "text": "FOLR1",
        "label": "PERSON"
      },
      {
        "text": "30%",
        "label": "PERCENT"
      },
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "folr1\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "mutant embryos contained significantly less endogenous folate than wild-type",
    "entities": []
  },
  {
    "text": "embryos yet displayed marked hypersensitivity to DTG that could not be mitigated",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by folate supplementation. Together, these findings reveal a dual mechanism in",
    "entities": []
  },
  {
    "text": "which DTG antagonizes FOLR1 while concurrently sequestering Mg. Excess Mg",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "FOLR1",
        "label": "PERSON"
      },
      {
        "text": "Mg",
        "label": "PERSON"
      },
      {
        "text": "Excess Mg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "converts DTG into a Mg-bound DTG complex that can no longer antagonize FOLR1,",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "FOLR1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "thereby restoring normal development. Our work identifies magnesium status as a",
    "entities": []
  },
  {
    "text": "modifiable determinant of DTG teratogenicity and provides a proof-of-concept",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "zebrafish model that could be adapted for rapid in vivo screening of integrase",
    "entities": []
  },
  {
    "text": "inhibitors for developmental phenotypes.",
    "entities": []
  },
  {
    "text": "Virus glycoprotein nanodisc platform for vaccine design.",
    "entities": []
  },
  {
    "text": "Transmembrane glycoproteins of enveloped viruses are the targets of neutralizing",
    "entities": [
      {
        "text": "Transmembrane",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "antibodies and essential vaccine antigens. mRNA-LNP technology allows in situ",
    "entities": []
  },
  {
    "text": "production of transmembrane glycoproteins upon immunization, but biophysical",
    "entities": []
  },
  {
    "text": "characterization of transmembrane antigens and in vitro analysis of",
    "entities": []
  },
  {
    "text": "post-immunization antibody responses typically rely on soluble proteins. Here,",
    "entities": []
  },
  {
    "text": "we present a methodological platform for assembling transmembrane glycoprotein",
    "entities": [
      {
        "text": "transmembrane glycoprotein",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vaccine candidates into lipid nanodiscs. We demonstrate the utility of the",
    "entities": []
  },
  {
    "text": "development by binding assays using surface plasmon resonance (SPR), ex vivo B",
    "entities": [
      {
        "text": "SPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cell sorting with fluorescence-activated cell sorting (FACS), and by determining",
    "entities": [
      {
        "text": "FACS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the structure of a prototypical HIV MPER-targeting immunogen nanodisc in complex",
    "entities": []
  },
  {
    "text": "with three broadly neutralizing antibodies (bnAbs), including the MPER bnAb",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "MPER",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10E8, to 3.5 \u00c5 by cryogenic electron microscopy (cryo-EM), providing a template",
    "entities": [
      {
        "text": "10E8",
        "label": "DATE"
      },
      {
        "text": "3.5",
        "label": "CARDINAL"
      },
      {
        "text": "cryogenic",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for structure-based immunogen design for MPER. Overall, the platform offers a",
    "entities": []
  },
  {
    "text": "tool for accelerating the development of next-generation viral vaccines.",
    "entities": []
  },
  {
    "text": "10. Health Sci Rep. 2025 Jul 15;8(7):e71076. doi: 10.1002/hsr2.71076. eCollection",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HIV and Maternal-Fetal Immunity: Challenges and Strategies for Reducing Vertical",
    "entities": []
  },
  {
    "text": "Transmission-A Narrative Review.",
    "entities": [
      {
        "text": "Transmission-A Narrative Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Biomedical and Laboratory Science Africa University Mutare",
    "entities": [
      {
        "text": "Biomedical and Laboratory Science Africa University Mutare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND AND AIMS: Mother-to-child transmission (MTCT) of HIV remains a",
    "entities": [
      {
        "text": "MTCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant global health challenge, particularly in resource-limited settings.",
    "entities": []
  },
  {
    "text": "The virus disrupts maternal-fetal immunity through immune dysregulation,",
    "entities": []
  },
  {
    "text": "placental barrier impairment, and altered antibody transfer, thereby increasing",
    "entities": []
  },
  {
    "text": "the risk of vertical transmission.",
    "entities": []
  },
  {
    "text": "METHODS AND RESULTS: This narrative review synthesizes current evidence on the",
    "entities": []
  },
  {
    "text": "immunological and clinical factors influencing MTCT. It highlights how maternal",
    "entities": [
      {
        "text": "MTCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immune exhaustion, placental inflammation, and suboptimal ART timing contribute",
    "entities": []
  },
  {
    "text": "to transmission. While widespread use of ART has reduced MTCT rates, persistent",
    "entities": [
      {
        "text": "MTCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "challenges include late ART initiation, HIV drug resistance, co-infections, and",
    "entities": []
  },
  {
    "text": "transmission through breastfeeding. Emerging strategies-such as maternal immune",
    "entities": []
  },
  {
    "text": "modulation, monoclonal antibody therapies, and tailored ART regimens-show",
    "entities": []
  },
  {
    "text": "potential for further risk reduction.",
    "entities": []
  },
  {
    "text": "CONCLUSION: To effectively minimize MTCT, comprehensive prevention approaches",
    "entities": [
      {
        "text": "MTCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "are essential. These should combine medical interventions with maternal",
    "entities": []
  },
  {
    "text": "nutrition support, co-infection management, and safe breastfeeding practices",
    "entities": []
  },
  {
    "text": "under ART coverage. A multifaceted strategy is key to protecting both maternal",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and infant health.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The author declares no conflicts of interest.",
    "entities": []
  },
  {
    "text": "A paradigm shift in simulating affinity maturation to elicit broadly",
    "entities": []
  },
  {
    "text": "(1)Biomedical Engineering Graduate Program, University of Colorado Boulder,",
    "entities": [
      {
        "text": "Engineering Graduate Program",
        "label": "ORG"
      },
      {
        "text": "University of Colorado Boulder",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boulder, CO, United States.",
    "entities": [
      {
        "text": "Boulder, CO",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Chemical and Biological Engineering, University of Colorado",
    "entities": [
      {
        "text": "Chemical",
        "label": "ORG"
      },
      {
        "text": "Biological Engineering",
        "label": "ORG"
      },
      {
        "text": "University of Colorado",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boulder, Boulder, CO, United States.",
    "entities": [
      {
        "text": "Boulder",
        "label": "GPE"
      },
      {
        "text": "Boulder, CO",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Broadly neutralizing antibodies (bnAbs) offer a promising route to protect",
    "entities": []
  },
  {
    "text": "against rapidly evolving pathogens such as HIV, influenza, and SARS-CoV-2, yet",
    "entities": []
  },
  {
    "text": "eliciting them through vaccination remains a significant challenge. A key to",
    "entities": []
  },
  {
    "text": "this problem lies in understanding antibody affinity maturation (AM), the",
    "entities": []
  },
  {
    "text": "evolutionary process within germinal centers (GCs) that shapes the B cell and",
    "entities": []
  },
  {
    "text": "thus antibody response. Traditionally, AM has been viewed as favoring the",
    "entities": []
  },
  {
    "text": "selection of B cells with the highest-affinity B cell receptors (BCRs) through",
    "entities": []
  },
  {
    "text": "competitive interplays. However, emerging evidence suggests that GCs are more",
    "entities": []
  },
  {
    "text": "permissive, allowing B cells with a broad range of affinities to persist,",
    "entities": []
  },
  {
    "text": "thereby promoting clonal diversity and enabling the rare emergence of bnAbs.",
    "entities": [
      {
        "text": "bnAbs",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This review reassesses affinity-based selection models and proposes a new",
    "entities": []
  },
  {
    "text": "paradigm that integrates multifactorial processes, including stochastic B cell",
    "entities": []
  },
  {
    "text": "decisions within GC dynamics, antigen extraction efficiency influenced by",
    "entities": [
      {
        "text": "GC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "probabilistic bond rupture, and avidity-driven BCR binding alterations and",
    "entities": []
  },
  {
    "text": "representations on multivalent antigens. We highlight how advanced AM",
    "entities": []
  },
  {
    "text": "simulations that move beyond affinity as the sole determinant provide a more",
    "entities": []
  },
  {
    "text": "realistic and predictive representation of AM, marking a major step forward in",
    "entities": []
  },
  {
    "text": "developing strategies to promote effective immune responses against highly",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Nakarin and Sprenger.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Sprenger",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "12. ACS Med Chem Lett. 2025 Jun 10;16(7):1340-1345. doi:",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10;16(7):1340-1345",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.1021/acsmedchemlett.5c00214. eCollection 2025 Jul 10.",
    "entities": [
      {
        "text": "10.1021",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Effects of Oxygen Atom Position in Linear Side Chains of Ansellone Analogues on",
    "entities": []
  },
  {
    "text": "HIV Latency-Reversing Activity.",
    "entities": []
  },
  {
    "text": "(1)Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka",
    "entities": [
      {
        "text": "1)Graduate School of Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Osaka University",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(2)Department of Environmental and Molecular Health Sciences, Faculty of Medical",
    "entities": [
      {
        "text": "Environmental and Molecular Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku,",
    "entities": [
      {
        "text": "Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Kumamoto University",
        "label": "ORG"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "Chuo-ku",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)School of Pharmaceutical Sciences, Wakayama Medical University, 25-1",
    "entities": [
      {
        "text": "Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Wakayama Medical University",
        "label": "ORG"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Antiretroviral therapy can manage HIV infections, but a cure remains elusive",
    "entities": []
  },
  {
    "text": "owing to viral latency. The \"shock and kill\" strategy uses latency-reversing",
    "entities": []
  },
  {
    "text": "agents (LRAs) to reactivate viral production toward eliminating latent HIV.",
    "entities": []
  },
  {
    "text": "However, developing novel LRA scaffolds remains a critical challenge. This study",
    "entities": [
      {
        "text": "LRA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "focused on a structurally simplified hydrobenzopyran analogue of ansellone A, a",
    "entities": []
  },
  {
    "text": "natural product with latency-reversing activity. To investigate the influence of",
    "entities": []
  },
  {
    "text": "incorporating ether oxygen into the alkyl chain, thought to anchor to the",
    "entities": []
  },
  {
    "text": "biological membrane, on the biological activity, we designed and synthesized a",
    "entities": []
  },
  {
    "text": "series of hydrobenzopyran analogs with varying oxygen positions in their",
    "entities": []
  },
  {
    "text": "lipophilic side chains. Biological evaluation in J-Lat 10.6 and TZM-bl cells",
    "entities": [
      {
        "text": "10.6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "revealed that the oxygen atom position did not considerably influence the HIV",
    "entities": []
  },
  {
    "text": "latency-reversing activity. Furthermore, none of the compounds affected cell",
    "entities": []
  },
  {
    "text": "viability. These findings suggest that ether-containing hydrobenzopyran",
    "entities": []
  },
  {
    "text": "derivatives represent a viable and synthetically flexible scaffold for the",
    "entities": []
  },
  {
    "text": "development of novel LRAs.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 American Chemical Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "American Chemical Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Associations between ZIP code-level alcohol outlet density and binge drinking",
    "entities": []
  },
  {
    "text": "among people who inject drugs in 22 US Metropolitan Areas.",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Peddireddy SR, Beane S, Yarbrough C, Ibragimov U, Cummings JR, Haley DF, Linton",
    "entities": [
      {
        "text": "Peddireddy SR",
        "label": "PERSON"
      },
      {
        "text": "Beane S",
        "label": "PERSON"
      },
      {
        "text": "Yarbrough C",
        "label": "ORG"
      },
      {
        "text": "Ibragimov U",
        "label": "PERSON"
      },
      {
        "text": "Cummings JR",
        "label": "GPE"
      },
      {
        "text": "Haley DF",
        "label": "PERSON"
      },
      {
        "text": "Linton",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "SL, Cooper HLF.",
    "entities": [
      {
        "text": "SL",
        "label": "PERSON"
      },
      {
        "text": "Cooper HLF",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Although alcohol outlet density (AOD) is associated with drinking",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "behaviors in the general population, little evidence exists about this",
    "entities": []
  },
  {
    "text": "relationship among people who inject drugs (PWID). Establishing this connection",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "is particularly important, as alcohol use exacerbates the risk of opioid",
    "entities": []
  },
  {
    "text": "overdose. This study investigated 1) the association between ZIP code-level AOD",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and binge drinking among PWID who use opioids, and 2) the potential moderating",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "effect of race/ethnicity on the AOD-binge drinking relationship.",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This analysis linked 2018 National HIV Behavioral Surveillance (NHBS)",
    "entities": [
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "National HIV Behavioral Surveillance",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "data and 2016 ZIP code-level AOD data from the ZIP Code Business Pattern survey.",
    "entities": [
      {
        "text": "2016",
        "label": "DATE"
      },
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "the ZIP Code Business Pattern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hierarchical generalized linear models quantified the association between AOD",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      },
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and binge drinking, overall and by race/ethnicity.",
    "entities": []
  },
  {
    "text": "RESULTS: Of 9,660 PWID, 27% reported recent binge drinking. For Hispanic/Latinx",
    "entities": [
      {
        "text": "9,660",
        "label": "CARDINAL"
      },
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "27%",
        "label": "PERCENT"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "and White PWID, increases in AOD were associated with a 1% and 3% increase in",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "1% and",
        "label": "PERCENT"
      },
      {
        "text": "3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the odds of binge drinking, respectively (p < 0.05); AOD was unrelated to binge",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "drinking among Black PWID. However, when AOD was set to the median, binge",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "drinking probability was highest among Black PWID (PP: 0.28, 95% CI: 0.24-0.33).",
    "entities": [
      {
        "text": "PP",
        "label": "NORP"
      },
      {
        "text": "0.28",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.24-0.33",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Reducing AOD may decrease binge drinking among White and Latinx",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "Latinx",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "PWID. Our results suggest, however, that this strategy alone may be not be",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effective among Black PWID. Holistic strategies targeting structural",
    "entities": []
  },
  {
    "text": "determinants of alcohol and opioid co-use among Black PWID are needed to address",
    "entities": []
  },
  {
    "text": "inequities in drug-related harms.",
    "entities": []
  },
  {
    "text": "ZIP code-level alcohol outlet density and nonfatal overdose among people who",
    "entities": []
  },
  {
    "text": "inject drugs in 22 US metropolitan statistical areas: a multilevel modeling",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Alcohol outlet density (AOD) is associated with drinking behaviors",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and related harms across several populations. As alcohol consumption compounds",
    "entities": []
  },
  {
    "text": "the depressive effects of opioids to increase overdose risk among people who",
    "entities": []
  },
  {
    "text": "inject drugs (PWID), this study investigated 1) whether off-premise AOD is",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with the risk of nonfatal overdose among a large sample of PWID, and",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2) whether this relationship varies by individual race/ethnicity.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: We linked individual-level 2018 National HIV Behavioral Surveillance",
    "entities": [
      {
        "text": "2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(NHBS) data with ZIP code-level data on off-premise AOD in 2016 from the US",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "2016",
        "label": "DATE"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Census Bureau's ZIP Code Business Pattern survey. NHBS surveys PWID across 22",
    "entities": [
      {
        "text": "Census Bureau's",
        "label": "ORG"
      },
      {
        "text": "ZIP Code Business Pattern",
        "label": "ORG"
      },
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "metropolitan statistical areas. Hierarchical generalized linear models",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "quantified the association between AOD and nonfatal overdose, overall and by",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PWID race/ethnicity.",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The sample comprised 9,764 PWID who used opioids, 45% of whom were",
    "entities": [
      {
        "text": "9,764",
        "label": "CARDINAL"
      },
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "45%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "non-Hispanic/Latinx White, 38% non-Hispanic/Latinx Black, and 18%",
    "entities": [
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "38%",
        "label": "PERCENT"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "18%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Hispanic/Latinx. Over a quarter (28%) experienced an overdose in the past year.",
    "entities": [
      {
        "text": "Hispanic/Latinx",
        "label": "ORG"
      },
      {
        "text": "28%",
        "label": "PERCENT"
      },
      {
        "text": "the past year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The median outlet density was 4.0 outlets per square mile. The adjusted model",
    "entities": [
      {
        "text": "4.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "did not show a significant relationship between AOD and odds of overdose (OR:",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.01, 95% CI: 1.00-1.02), and the relationship remained null in the",
    "entities": [
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.00-1.02",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "race/ethnicity interaction model.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Regulating AOD alone may not effectively mitigate overdose risk",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "among PWID. Future research should explore why overdoses among PWID are not",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sensitive to changes in AOD. Possible explanations to consider are whether (1)",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "AOD is unassociated with alcohol consumption among PWID, or (2) PWID stagger the",
    "entities": [
      {
        "text": "AOD",
        "label": "ORG"
      },
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "timing of their alcohol consumption so it does not coincide with opioid",
    "entities": []
  },
  {
    "text": "15. Oxf Med Case Reports. 2025 Jul 14;2025(7):omaf104. doi: 10.1093/omcr/omaf104.",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A case of classic epidermodysplasia verruciformis associated with elephantiasis:",
    "entities": []
  },
  {
    "text": "an atypical presentation.",
    "entities": []
  },
  {
    "text": "(1)Department of Dermatology-Venereology, Mohamed VI University Hospital,",
    "entities": [
      {
        "text": "Dermatology-Venereology",
        "label": "ORG"
      },
      {
        "text": "Mohamed VI University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Faculty of Medicine and Pharmacy, M3MF+GCG, 90100, La Nouvelle Ville Ibn",
    "entities": [
      {
        "text": "Medicine and Pharmacy",
        "label": "ORG"
      },
      {
        "text": "90100",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Epidermodysplasia verruciformis (EV) is a rare genetic skin disorder",
    "entities": [
      {
        "text": "Epidermodysplasia",
        "label": "PERSON"
      },
      {
        "text": "EV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "characterized by increased susceptibility to human papillomavirus infections",
    "entities": []
  },
  {
    "text": "(HPV) and a high risk of cutaneous carcinomas. We report the case of a",
    "entities": []
  },
  {
    "text": "30-year-old female patient presenting with diffuse verrucous lesions,",
    "entities": [
      {
        "text": "30-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "predominantly affecting the extremities, associated with unilateral",
    "entities": []
  },
  {
    "text": "elephantiasis. The diagnosis was histologically confirmed, revealing vulgar",
    "entities": []
  },
  {
    "text": "warts consistent with EV. HIV serology was negative, and systemic retinoid",
    "entities": [
      {
        "text": "EV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therapy was initiated. EV is linked to mutations in the EVER1 and EVER2 genes,",
    "entities": [
      {
        "text": "EV",
        "label": "ORG"
      },
      {
        "text": "EVER1",
        "label": "ORG"
      },
      {
        "text": "EVER2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "predisposing patients to chronic infections with specific HPV types. Close",
    "entities": [
      {
        "text": "HPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "monitoring is crucial to prevent malignant transformation. This case highlights",
    "entities": []
  },
  {
    "text": "the diagnostic and therapeutic challenges of EV, emphasizing the importance of",
    "entities": [
      {
        "text": "EV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "an appropriate management strategy to control lesions and prevent complications.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interests.",
    "entities": []
  },
  {
    "text": "10.1177/08850666251359546. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/08850666251359546",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Severe Community-Acquired Pneumonia: Impact of HIV on Clinical Presentation,",
    "entities": []
  },
  {
    "text": "Microbiological and Laboratory Findings, and Outcome.",
    "entities": []
  },
  {
    "text": "Venturas JP(1), Titus A(2), Richards GA(3), Feldman C(4).",
    "entities": [
      {
        "text": "Venturas JP(1",
        "label": "PERSON"
      },
      {
        "text": "Titus A(2",
        "label": "PERSON"
      },
      {
        "text": "Richards",
        "label": "ORG"
      },
      {
        "text": "Feldman C(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Faculty of Health Sciences, University of",
    "entities": [
      {
        "text": "Internal Medicine, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Witwatersrand Medical School, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "the Witwatersrand Medical School",
        "label": "ORG"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Independent Statistician, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "2)Independent",
        "label": "CARDINAL"
      },
      {
        "text": "Statistician",
        "label": "NORP"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Dept of Surgery, Division of Critical Care, Faculty of Health Sciences,",
    "entities": [
      {
        "text": "Surgery, Division of Critical Care, Faculty of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of the Witwatersrand, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "University of the Witwatersrand",
        "label": "ORG"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, Faculty of Health Sciences, University of",
    "entities": [
      {
        "text": "Internal Medicine, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Witwatersrand, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "Witwatersrand",
        "label": "GPE"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Severe community-acquired pneumonia (SCAP) is associated with significant",
    "entities": [
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "morbidity and mortality, but there is a paucity of data regarding these",
    "entities": []
  },
  {
    "text": "infections in sub-Saharan Africa, especially among people living with HIV",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(PLWH). This study investigated the impact of HIV on clinical presentation,",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "microbial aetiology, laboratory findings, and outcome of SCAP. This was",
    "entities": [
      {
        "text": "microbial aetiology",
        "label": "ORG"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "additional analysis of data from a large, single-centre, retrospective,",
    "entities": []
  },
  {
    "text": "observational study conducted among consecutive adult patients (\u226518 years)",
    "entities": []
  },
  {
    "text": "admitted to the multidisciplinary ICU at the Charlotte Maxeke Johannesburg",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "the Charlotte Maxeke Johannesburg\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Academic Hospital, between 1 July 2007 and 31 May 2019, with SCAP. The current",
    "entities": [
      {
        "text": "Academic Hospital",
        "label": "ORG"
      },
      {
        "text": "between 1 July 2007",
        "label": "DATE"
      },
      {
        "text": "31 May 2019",
        "label": "DATE"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study describes 718 PLWH and 131 HIV-negative cases extracted from the initial",
    "entities": [
      {
        "text": "718",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "131",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cohort. The median age was 37 [IQR 30-46] years with PLWH significantly younger",
    "entities": [
      {
        "text": "37",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "than their HIV-negative counterparts (36 years [IQR 29-44] years vs 52 years",
    "entities": [
      {
        "text": "36 years",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "52 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "[IQR 34-65] years; P < .001). PLWH were more commonly female (P = .053), while",
    "entities": [
      {
        "text": "P < .001",
        "label": "ORG"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": ".053",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "more of the HIV-negative patients were male. The median CD4 count of the PLWH",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was 42 [IQR 14-108] cells/mm3 and only 15.5% were on anti-retroviral therapy",
    "entities": [
      {
        "text": "42",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "only 15.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(ART) prior to hospitalisation. Differences were noted in clinical, laboratory",
    "entities": []
  },
  {
    "text": "and radiological features between the groups. Overall, Mycobacterium",
    "entities": []
  },
  {
    "text": "tuberculosis was the most common microbial aetiology in both groups, followed by",
    "entities": []
  },
  {
    "text": "Streptococcus pneumoniae, which was associated with a significantly lower",
    "entities": []
  },
  {
    "text": "mortality, whereas mortality with Pneumocystis jirovecii infection, which",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "occurred only in PLWH, was high. Overall ICU mortality was high (48.9%), and",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "48.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "while HIV was an independent risk factor for mortality (OR 0.58, 95% CI",
    "entities": [
      {
        "text": "0.58",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.37-0.92; p = .02) on univariate analysis, this finding was not true when HIV",
    "entities": [
      {
        "text": "0.37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "considered within the multivariable analysis. This study describes one of the",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "largest cohorts of PLWH with SCAP and compares their findings with HIV-negative",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cases. HIV was not a significant predictor of mortality when considered in the",
    "entities": []
  },
  {
    "text": "context of other covariables on multivariable analysis.",
    "entities": []
  },
  {
    "text": "17. J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251358929. doi:",
    "entities": [
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "Int Assoc",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Epidemiology of Antiretroviral Therapy Related Adverse Drug Reactions and its",
    "entities": []
  },
  {
    "text": "Predictors Among Patients with Human Immunodeficiency Virus/AIDS in Ethiopia: A",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Systematic Review and Meta-analysis.",
    "entities": [
      {
        "text": "Systematic Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Pharmacology and Toxicology, Pharmacy Education and Clinical",
    "entities": [
      {
        "text": "Pharmacology and Toxicology",
        "label": "ORG"
      },
      {
        "text": "Pharmacy Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Services Directorate, College of Health Sciences, Debre Tabor University, Debre",
    "entities": [
      {
        "text": "College of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Debre Tabor University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Clinical Pharmacy, Pharmacy Education and Clinical Services",
    "entities": [
      {
        "text": "Clinical Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Pharmacy Education",
        "label": "ORG"
      },
      {
        "text": "Clinical Services",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor,",
    "entities": [
      {
        "text": "Directorate, College of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Debre Tabor University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ObjectiveAdverse drug reactions (ADRs) induce iatrogenic harm in antiretroviral",
    "entities": [
      {
        "text": "ObjectiveAdverse",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therapy (ART) care continuum. However, there is a dearth of concrete evidence in",
    "entities": []
  },
  {
    "text": "a resource-limited setting. Thus, this study was designed to consolidate",
    "entities": []
  },
  {
    "text": "existing knowledge, thereby informing policy and clinical care to improve",
    "entities": []
  },
  {
    "text": "patient safety.DesignSystematic review and meta-analysis.Data sourcesPubMed,",
    "entities": []
  },
  {
    "text": "CINAHL, Web of Science, and EMBASE databases were searched.Eligibility",
    "entities": [
      {
        "text": "EMBASE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "criteriaEmploying the condition, context, and population framework,",
    "entities": []
  },
  {
    "text": "observational primary studies were included.Data extraction and",
    "entities": []
  },
  {
    "text": "synthesisIndependent reviewers undertook data extraction and synthesis. This",
    "entities": [
      {
        "text": "synthesisIndependent",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "meta-analysis employed the random-effects restricted maximum likelihood (REML)",
    "entities": []
  },
  {
    "text": "method, with its protocol preregistered on the International Register of",
    "entities": [
      {
        "text": "the International Register of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Systematic Reviews (CRD42024546390).ResultsThe pooled prevalence of ADRs was",
    "entities": []
  },
  {
    "text": "36.7% [95% CI: 26.6-46.9, I2 = 99.64%].ConclusionAltogether, this study revealed",
    "entities": [
      {
        "text": "36.7%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "26.6-46.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "that ART-related ADRs in Ethiopia was 36.7%, underscoring rigorous monitoring.",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      },
      {
        "text": "36.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Giving special emphasis to patients with female gender, advanced disease,",
    "entities": []
  },
  {
    "text": "comorbidities, malnutrition, TB treatment, and poor adherence is a prudent",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Plain Language Summary: Epidemiology of ART-related Adverse Drug Reactions among",
    "entities": [
      {
        "text": "Adverse Drug Reactions",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Patients with HIV/AIDS in Ethiopia: A Systematic Review and",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Meta-analysisMedicines are crucial in the arena of the healthcare system.",
    "entities": []
  },
  {
    "text": "Despite the undeniable relevance of medicines, a substantial challenge is the",
    "entities": []
  },
  {
    "text": "potential for harmful drug reactions when used. Antiretroviral therapy (ART) is",
    "entities": []
  },
  {
    "text": "the application of antiretroviral medicines to combat human immunodeficiency",
    "entities": []
  },
  {
    "text": "virus (HIV). While it is pivotal in treating diseases, it is plugged with",
    "entities": []
  },
  {
    "text": "adverse drug reactions (ADRs). ADRs are harmful effects that can occur when",
    "entities": []
  },
  {
    "text": "people take medications. These undesirable drug effects are quite common and",
    "entities": []
  },
  {
    "text": "especially costly in the treatment of HIV. In countries with limited healthcare",
    "entities": []
  },
  {
    "text": "resources, there is limited information about how common these harmful effects",
    "entities": []
  },
  {
    "text": "are. This study aimed to bring together the available evidence about the rate of",
    "entities": []
  },
  {
    "text": "ADRs related to ART among people living with HIV in Ethiopia. In this study, we",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "reviewed the results of 29 studies involving 19,003 people living with HIV. We",
    "entities": [
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "19,003",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "found that about 4 in every 10 patients (36.7%) experienced ADRs from their",
    "entities": [
      {
        "text": "about 4",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "36.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "treatment. Our analysis also showed that certain groups, including women, those",
    "entities": []
  },
  {
    "text": "with lower education levels, advanced HIV disease, other chronic health",
    "entities": []
  },
  {
    "text": "problems, weaker immune systems (low CD4 counts), opportunistic infections,",
    "entities": []
  },
  {
    "text": "malnutrition, and those taking medications containing zidovudine or nevirapine,",
    "entities": []
  },
  {
    "text": "were more likely to face these ADRs. Patients receiving tuberculosis treatment",
    "entities": []
  },
  {
    "text": "at the same time or struggling with medication adherence were also at higher",
    "entities": []
  },
  {
    "text": "risk. Based on these findings, special attention should be given to monitoring",
    "entities": []
  },
  {
    "text": "these vulnerable groups to catch and manage ADRs early.",
    "entities": []
  },
  {
    "text": "PMID: 40665675 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665675",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Conflicting InterestsThe authors",
    "entities": []
  },
  {
    "text": "declared no potential conflicts of interest with respect to the research,",
    "entities": []
  },
  {
    "text": "authorship, and/or publication of this article. Data Availability StatementWe",
    "entities": [
      {
        "text": "Availability StatementWe",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "have provided all crude data that was utilized in this investigation as",
    "entities": []
  },
  {
    "text": "Challenges in assessing self-reported adherence to antiretroviral therapy among",
    "entities": []
  },
  {
    "text": "individuals living with HIV/AIDS and mental disorders.",
    "entities": []
  },
  {
    "text": "Studies focusing on individuals living with HIV and mental disorders are crucial",
    "entities": []
  },
  {
    "text": "to inform and enhance care for this inherently vulnerable population group,",
    "entities": []
  },
  {
    "text": "especially considering that people living with HIV/AIDS (PLHIV) are more likely",
    "entities": []
  },
  {
    "text": "to develop mental disorders compared to the general population, contributing to",
    "entities": []
  },
  {
    "text": "lower adherence to antiretroviral therapy (ART). This study cross-sectional",
    "entities": []
  },
  {
    "text": "study aimed to assess self-reported adherence to antiretroviral therapy among",
    "entities": []
  },
  {
    "text": "Sul, Brazil. Patient-reported data from PLHIV who received care in at least one",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "PLHIV",
        "label": "ORG"
      },
      {
        "text": "at least one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of the Psychosocial Care Network facilities of the Brazilian Unified Health",
    "entities": [
      {
        "text": "the Psychosocial Care Network",
        "label": "ORG"
      },
      {
        "text": "the Brazilian Unified Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "System from 2014 to 2018 were collected to assess the adherence to ART. Among",
    "entities": [
      {
        "text": "2014",
        "label": "DATE"
      },
      {
        "text": "2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the 76 participants eligible, 35 were included in the study. Substance",
    "entities": [
      {
        "text": "76",
        "label": "CARDINAL"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "use-related mental disorders were the most prevalent (45.7%), followed by mood",
    "entities": [
      {
        "text": "45.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "disorders (25.7%) and anxiety (11.4%). Most of the participants had a low ART",
    "entities": [
      {
        "text": "25.7%",
        "label": "PERCENT"
      },
      {
        "text": "11.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "adherence (62.9%), followed by insufficient adherence (22.9%) and good adherence",
    "entities": [
      {
        "text": "62.9%",
        "label": "PERCENT"
      },
      {
        "text": "22.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(14.3%). No significant associations were found between the adherence to ART and",
    "entities": [
      {
        "text": "14.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the study variables. Our findings suggest the importance of assessing adherence",
    "entities": []
  },
  {
    "text": "based on both direct and indirect measures, as biological markers and",
    "entities": []
  },
  {
    "text": "self-report.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PMID: 40665443 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665443",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This study was approved by the Human Subject Research Ethics",
    "entities": [
      {
        "text": "the Human Subject Research Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee of the Federal University of Mato Grosso do Sul, Brazil (protocol",
    "entities": [
      {
        "text": "the Federal University of Mato Grosso",
        "label": "ORG"
      },
      {
        "text": "Sul",
        "label": "ORG"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "number: 3,416,555; CAAE: 15431819.3.0000.0021). All procedures were performed in",
    "entities": [
      {
        "text": "3,416,555",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "accordance with relevant guidelines and regulations. Informed consent was",
    "entities": []
  },
  {
    "text": "obtained from all participants. The interviewers took care to explain the study",
    "entities": []
  },
  {
    "text": "clearly, using accessible language appropriate to the intellectual and",
    "entities": []
  },
  {
    "text": "educational level of each individual. Competing interests: We have read the",
    "entities": []
  },
  {
    "text": "journal\u2019s policy and the authors of this manuscript have the following competing",
    "entities": [
      {
        "text": "journal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interests: EFO serves as an Editorial Board Member of BMC Public Health.",
    "entities": [
      {
        "text": "Editorial Board",
        "label": "ORG"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "19. Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093/bjd/ljaf213. Online ahead of",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "Br J Dermatol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prurigo nodularis: disease burden, clinical features and approach to management.",
    "entities": []
  },
  {
    "text": "(1)Department of Dermatology, University of Maryland School of Medicine,",
    "entities": [
      {
        "text": "Dermatology, University of Maryland School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Maryland Itch Center, University of Maryland School of Medicine, Baltimore,",
    "entities": [
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University of Maryland School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Maryland, USA.",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Allergology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate",
    "entities": []
  },
  {
    "text": "Germany.",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Fraunhofer Institute for Translational Medicine and Pharmacology ITMP,",
    "entities": [
      {
        "text": "Institute for Translational Medicine and Pharmacology ITMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Immunology and Allergology Berlin, Berlin, Germany.",
    "entities": [
      {
        "text": "Allergology Berlin",
        "label": "GPE"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Dermatology, French Expert Itch Center, University Hospital,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Dermatology, University of Pennsylvania Perelman School of",
    "entities": [
      {
        "text": "Dermatology, University of Pennsylvania Perelman School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.",
    "entities": [
      {
        "text": "7)Regeneron Pharmaceuticals Inc.",
        "label": "ORG"
      },
      {
        "text": "Tarrytown",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Sanofi, Reading, UK.",
    "entities": [
      {
        "text": "Reading",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prurigo nodularis (PN) is a distinct, chronic inflammatory skin disease",
    "entities": []
  },
  {
    "text": "characterised by intensely pruritic, fibrotic nodular lesions. Despite continued",
    "entities": []
  },
  {
    "text": "progress in the field, lack of clarity regarding the definition of PN as a",
    "entities": []
  },
  {
    "text": "disease, clinical presentation and therapeutic options results in delayed",
    "entities": []
  },
  {
    "text": "diagnosis and management. PN can arise following other diseases, but once",
    "entities": []
  },
  {
    "text": "established, it is an independent disease. Here, we summarise the current",
    "entities": []
  },
  {
    "text": "knowledge of epidemiology, clinical characteristics, disease burden and",
    "entities": []
  },
  {
    "text": "management approaches that may help healthcare providers recognise PN as a",
    "entities": []
  },
  {
    "text": "primary diagnosis independent of triggers or associated comorbidities. PN is",
    "entities": []
  },
  {
    "text": "more common among patients aged 50-60 years, and some evidence suggests it is",
    "entities": [
      {
        "text": "50-60 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "more frequent among Black populations than White and Asian populations. A subset",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "of PN patients have an atopic background and can present with comorbid atopic",
    "entities": []
  },
  {
    "text": "dermatitis; however, PN can also exist without atopic comorbidities. Other",
    "entities": []
  },
  {
    "text": "comorbidities typically include diabetes, obesity, thyroid disease, kidney",
    "entities": []
  },
  {
    "text": "disease, chronic liver disease, hypertension, HIV infection, skin infections,",
    "entities": []
  },
  {
    "text": "malignancies and mental health disorders. Multiple intensely pruritic lesions",
    "entities": []
  },
  {
    "text": "induce chronic scratching, which leads to inflammation, hyperkeratotic nodules",
    "entities": []
  },
  {
    "text": "and perpetuation of a vicious itch-scratch cycle. PN is associated with a high",
    "entities": []
  },
  {
    "text": "disease burden and negative effect on quality of life; patients often report",
    "entities": []
  },
  {
    "text": "intense and relentless itching, poor sleep, absence from work, anxiety and",
    "entities": []
  },
  {
    "text": "depression. Early diagnosis of PN and identification of comorbidities are",
    "entities": []
  },
  {
    "text": "important to facilitate better disease management. By increasing their awareness",
    "entities": []
  },
  {
    "text": "of PN epidemiology, disease burden, clinical presentation and management,",
    "entities": []
  },
  {
    "text": "physicians may begin to identify the disease as a distinct condition independent",
    "entities": []
  },
  {
    "text": "of its triggers or associated comorbidities and provide patients with",
    "entities": []
  },
  {
    "text": "appropriate care earlier in their treatment journeys.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of British",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      },
      {
        "text": "British",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Association of Dermatologists. All rights reserved. For commercial re-use,",
    "entities": [
      {
        "text": "Association of Dermatologists",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "please contact reprints@oup.com for reprints and translation rights for",
    "entities": []
  },
  {
    "text": "reprints. All other permissions can be obtained through our RightsLink service",
    "entities": []
  },
  {
    "text": "via the Permissions link on the article page on our site\u2014for further information",
    "entities": [
      {
        "text": "Permissions",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "please contact journals.permissions@oup.com.",
    "entities": [
      {
        "text": "journals.permissions@oup.com",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "20. BMC Womens Health. 2025 Jul 16;25(1):349. doi: 10.1186/s12905-025-03876-z.",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Womens Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "16;25(1):349",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Incidence and predictors of pregnancy among reproductive-age women in an ART",
    "entities": []
  },
  {
    "text": "clinic of public health facilities in Arsi zone, southeastern ethiopia: a",
    "entities": [
      {
        "text": "Arsi zone",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "five-year retrospective cohort study.",
    "entities": [
      {
        "text": "five-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "SM(3), Aseffa M(4), Tadesse BL(5).",
    "entities": [
      {
        "text": "Aseffa",
        "label": "PERSON"
      },
      {
        "text": "Tadesse",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)College of Health Science, Department of Public Health, Arsi University,",
    "entities": [
      {
        "text": "Health Science, Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Arsi University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)College of Health Science, Department of Public Health, Arsi University,",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Health Science, Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Arsi University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)College of Health Science, Department of Pharmacy, Arsi University, Asella,",
    "entities": [
      {
        "text": "Health Science, Department of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Arsi University",
        "label": "ORG"
      },
      {
        "text": "Asella",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)College of Health Science, Department of Nursing, Arsi University, Asella,",
    "entities": [
      {
        "text": "Health Science, Department of Nursing",
        "label": "ORG"
      },
      {
        "text": "Arsi University",
        "label": "ORG"
      },
      {
        "text": "Asella",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)College of Health Science, Department of Pathology, Arsi University, Asella,",
    "entities": [
      {
        "text": "Health Science, Department of Pathology",
        "label": "ORG"
      },
      {
        "text": "Arsi University",
        "label": "ORG"
      },
      {
        "text": "Asella",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: According to global monitoring and UNAIDS estimates. In",
    "entities": [
      {
        "text": "UNAIDS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sub-Saharan African (SSA) countries, the number of pregnant women living with",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "HIV in 2020 was 1.2 million. A variety of studies revealed that people living",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "1.2 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with HIV desire reproduction in the absence of any ART administered to the",
    "entities": []
  },
  {
    "text": "mother; the rate of mother-to-child transmission (MTCT) of HIV is 25-45%.",
    "entities": [
      {
        "text": "MTCT",
        "label": "ORG"
      },
      {
        "text": "25-45%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Transmission and most child deaths related to HIV can be avoided with",
    "entities": []
  },
  {
    "text": "appropriate care during pregnancy, childbirth, and breastfeeding. So far, there",
    "entities": []
  },
  {
    "text": "is limited information on the incidence of pregnancy outcomes and their",
    "entities": []
  },
  {
    "text": "predictors in Ethiopia. Therefore, this study aims to determine pregnancy",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "incidence and associated factors among reproductive-age women living with",
    "entities": []
  },
  {
    "text": "HIV/AIDS who are on ART clinic follow-up in public health facilities of the Arsi",
    "entities": [
      {
        "text": "Arsi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: An institution-based retrospective cohort study was employed among 481",
    "entities": [
      {
        "text": "481",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reproductive-age women from December 2013 to April 2019 in ART clinics of",
    "entities": [
      {
        "text": "December 2013 to April 2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "selected public health facilities in the Arsi Zone, Ethiopia. Systematic random",
    "entities": [
      {
        "text": "the Arsi Zone",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sampling was used to select study subjects from each public health facility.",
    "entities": []
  },
  {
    "text": "Data were imported into Epidata version 3.2 and exported into Stata version 14.2",
    "entities": [
      {
        "text": "Epidata",
        "label": "ORG"
      },
      {
        "text": "3.2",
        "label": "CARDINAL"
      },
      {
        "text": "Stata",
        "label": "PRODUCT"
      },
      {
        "text": "14.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for analysis. The Cox proportional hazards model and Kaplan-Meier failure models",
    "entities": [
      {
        "text": "Cox",
        "label": "NORP"
      },
      {
        "text": "Kaplan-Meier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were used to determine pregnancy predictors and estimate incidence,",
    "entities": []
  },
  {
    "text": "respectively. Independent predictors of pregnancy were determined by looking at",
    "entities": []
  },
  {
    "text": "variables that showed significant results (P value < 0.05) in the multivariate",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: The study included 481 women in total, yielding a response rate of",
    "entities": [
      {
        "text": "481",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "96.2%. The overall incidence of pregnancy was found to be 45.47 per 1000",
    "entities": [
      {
        "text": "96.2%",
        "label": "PERCENT"
      },
      {
        "text": "45.47",
        "label": "CARDINAL"
      },
      {
        "text": "1000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "person-years. Being 35 years of age or older (AHR: 0.29; 95% (0.13, 0.64)),",
    "entities": [
      {
        "text": "35 years of age or older",
        "label": "DATE"
      },
      {
        "text": "AHR",
        "label": "ORG"
      },
      {
        "text": "0.29",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.13",
        "label": "CARDINAL"
      },
      {
        "text": "0.64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "being in a non-married couple (AHR: 0.14; 95% (0.04, 0.48)), being widowed or",
    "entities": [
      {
        "text": "AHR",
        "label": "ORG"
      },
      {
        "text": "0.14",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.48",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "divorced (AHR: 0.20; 95% (0.05, 0.83)), and being a single mother (AHR: 0.42;",
    "entities": [
      {
        "text": "AHR",
        "label": "ORG"
      },
      {
        "text": "0.20",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "0.83",
        "label": "CARDINAL"
      },
      {
        "text": "AHR",
        "label": "ORG"
      },
      {
        "text": "0.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% (0.19, 0.92)) were predictive factors of pregnancy incidence among women on",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.19",
        "label": "DATE"
      },
      {
        "text": "0.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION AND RECOMMENDATIONS: In this study, the incidence of pregnancy among",
    "entities": []
  },
  {
    "text": "women on ART was found to be notable. Pregnancy incidence among women on ART was",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "found to be negatively associated with being 35 years of age or older, being in",
    "entities": [
      {
        "text": "35 years of age or older",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a non-married couple, being widowed or divorced, and being a single mother. To",
    "entities": []
  },
  {
    "text": "lower the risks of pregnancy, effective counseling programs must be created,",
    "entities": []
  },
  {
    "text": "with an emphasis on young and married women living with HIVAIDS.",
    "entities": [
      {
        "text": "HIVAIDS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665276 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665276",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval: The study",
    "entities": []
  },
  {
    "text": "adhered to the principles of Helsinki declaration and received ethical approval",
    "entities": [
      {
        "text": "Helsinki",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from the college of health sciences ethical review committee at Arsi University",
    "entities": [
      {
        "text": "Arsi University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with an ethical reference number of A/CHS/RC/18 and the committee waived",
    "entities": [
      {
        "text": "A/CHS/RC/18",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "informed consent requirements because the study used secondary data. Consent for",
    "entities": []
  },
  {
    "text": "publication: N/A. Competing interests: The authors declare no competing",
    "entities": [
      {
        "text": "N/A. Competing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "21. BMC Infect Dis. 2025 Jul 15;25(1):917. doi: 10.1186/s12879-025-11318-2.",
    "entities": [
      {
        "text": "21",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Patterns of immune recovery in people living with HIV who initiated",
    "entities": []
  },
  {
    "text": "antiretroviral therapy as late presenters.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12879-025-11318-2",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Our study was approved by the ethics committee of the Instituto",
    "entities": []
  },
  {
    "text": "protocol number C59-15 and C15-16; and was conducted according to the principles",
    "entities": [
      {
        "text": "C59",
        "label": "ORG"
      },
      {
        "text": "C15-16",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "expressed in the Declaration of Helsinki. All individuals were adults (over 18",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "years old). All participants provided written informed consent. Consent for",
    "entities": [
      {
        "text": "years old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "publication: Not applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "22. BMC Infect Dis. 2025 Jul 15;25(1):920. doi: 10.1186/s12879-025-11319-1.",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "15;25(1):920",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      },
      {
        "text": "025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Experience of research nurses with oral encochleated amphotericin B for",
    "entities": []
  },
  {
    "text": "treatment of cryptococcal meningitis in a resource-limited setting.",
    "entities": [
      {
        "text": "meningitis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(1)Infectious Diseases Institute, College of Health Sciences, Makerere",
    "entities": [
      {
        "text": "Diseases Institute",
        "label": "ORG"
      },
      {
        "text": "College of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Infectious Diseases Institute, College of Health Sciences, Makerere",
    "entities": [
      {
        "text": "2)Infectious",
        "label": "CARDINAL"
      },
      {
        "text": "Diseases Institute",
        "label": "ORG"
      },
      {
        "text": "College of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Research, Infectious Diseases Institute, College of Health",
    "entities": [
      {
        "text": "Research, Infectious Diseases Institute",
        "label": "ORG"
      },
      {
        "text": "College of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Makerere University, P.O.BOX 22418, Kampala, Uganda.",
    "entities": [
      {
        "text": "Makerere University",
        "label": "ORG"
      },
      {
        "text": "22418",
        "label": "DATE"
      },
      {
        "text": "Kampala",
        "label": "GPE"
      },
      {
        "text": "Uganda",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medicine, Division of Infectious Diseases and International",
    "entities": [
      {
        "text": "Medicine, Division of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, University of Minnesota, Minneapolis, MN, USA.",
    "entities": [
      {
        "text": "Medicine, University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine, School of Medicine, College of Health Sciences,",
    "entities": [
      {
        "text": "Medicine, School of Medicine, College of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Besides the commonly used intravenous formulations of amphotericin",
    "entities": []
  },
  {
    "text": "B, an oral nanocrystal amphotericin B (MAT2203) formulation is being evaluated",
    "entities": []
  },
  {
    "text": "for efficacy to treat invasive fungal infections. This new experimental oral",
    "entities": []
  },
  {
    "text": "formulation has not been used before.",
    "entities": []
  },
  {
    "text": "METHODS: Herein, we describe our experiences with using oral amphotericin B for",
    "entities": []
  },
  {
    "text": "management of patients with HIV-associated cryptococcal meningitis in Uganda",
    "entities": [
      {
        "text": "Uganda",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "from a research nurse perspective.",
    "entities": []
  },
  {
    "text": "RESULTS: We found oral amphotericin B a better alternative to intravenous",
    "entities": []
  },
  {
    "text": "amphotericin B deoxycholate due to less toxicity, mostly limited to",
    "entities": []
  },
  {
    "text": "gastrointestinal-related toxicities only. We clinically observed no drug",
    "entities": []
  },
  {
    "text": "reactions like rigors, phlebitis, and less vomiting among patients on oral",
    "entities": []
  },
  {
    "text": "amphotericin B as compared to those on intravenous amphotericin B deoxycholate.",
    "entities": []
  },
  {
    "text": "Subjectively, meningitis symptoms of patients on oral amphotericin B seemed to",
    "entities": []
  },
  {
    "text": "overall clinically improve more rapidly compared to those receiving intravenous",
    "entities": []
  },
  {
    "text": "amphotericin B deoxycholate. Few adverse events were observed. A novel challenge",
    "entities": []
  },
  {
    "text": "with oral amphotericin was difficulty in monitoring adherence for the night",
    "entities": []
  },
  {
    "text": "doses in the absence of the healthcare providers.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Oral amphotericin B was generally safe and well tolerated. However,",
    "entities": []
  },
  {
    "text": "it requires some training for the nurse, patient and care takers for better",
    "entities": []
  },
  {
    "text": "administration, adherence and treatment outcomes.",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: This was observational sub-study that was nested under the",
    "entities": []
  },
  {
    "text": "EnACT trial. The EnACT trial was registered prospectively. ClincalTrials.gov:",
    "entities": []
  },
  {
    "text": "NCT04031833; Registration date: July 24, 2019; Last verified: March 31, 2023.",
    "entities": [
      {
        "text": "July 24, 2019",
        "label": "DATE"
      },
      {
        "text": "March 31, 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s12879-025-11319-1",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      },
      {
        "text": "025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665233 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665233",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: This was an observational sub-study that was nested under the ENACT",
    "entities": []
  },
  {
    "text": "trial which was approved by the Mulago Hospital Research Ethics Committee",
    "entities": [
      {
        "text": "the Mulago Hospital Research Ethics Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1195); University of Minnesota Ethics Committee (STUDY00000139); Uganda",
    "entities": [
      {
        "text": "1195",
        "label": "DATE"
      },
      {
        "text": "University of Minnesota Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "Uganda",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "National Council of Science & Technology (HS 2351); Uganda National Drug",
    "entities": [
      {
        "text": "National Council of Science & Technology",
        "label": "ORG"
      },
      {
        "text": "2351",
        "label": "DATE"
      },
      {
        "text": "Uganda National Drug",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Authority (854/NDA/DPS/08/2018); United States Food and Drug Administration (IND",
    "entities": [
      {
        "text": "854",
        "label": "CARDINAL"
      },
      {
        "text": "United States Food and Drug Administration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "72807). All participants were adults aged 18 years and above. Participants",
    "entities": [
      {
        "text": "72807",
        "label": "DATE"
      },
      {
        "text": "18 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "provided informed consent for study participation in the ENACT trial and all its",
    "entities": []
  },
  {
    "text": "sub-studies including storage of samples for future use. The study was carried",
    "entities": []
  },
  {
    "text": "out in compliance with the international good clinical practice guidelines and",
    "entities": []
  },
  {
    "text": "the Helsinki Declaration. Consent for publication: Not applicable. Competing",
    "entities": [
      {
        "text": "the Helsinki Declaration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "23. Infect Dis Ther. 2025 Jul 15. doi: 10.1007/s40121-025-01192-5. Online ahead",
    "entities": [
      {
        "text": "23",
        "label": "CARDINAL"
      },
      {
        "text": "Dis Ther",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Advanced Liver Disease Events in People with HIV and Hepatitis B Virus",
    "entities": [
      {
        "text": "Hepatitis B Virus",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Coinfection Initiating Antiretroviral Therapy in the United States.",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chuo CY(1), Zachry W(1), de Boer M(1), Telep L(1), Tao L(2).",
    "entities": [
      {
        "text": "Chuo CY(1",
        "label": "PERSON"
      },
      {
        "text": "Zachry W(1",
        "label": "LOC"
      },
      {
        "text": "Telep",
        "label": "PERSON"
      },
      {
        "text": "Tao L(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA.",
    "entities": [
      {
        "text": "Sciences, Inc.",
        "label": "ORG"
      },
      {
        "text": "333",
        "label": "CARDINAL"
      },
      {
        "text": "Foster City",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "94404",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA.",
    "entities": [
      {
        "text": "2)Gilead Sciences, Inc.",
        "label": "ORG"
      },
      {
        "text": "333",
        "label": "CARDINAL"
      },
      {
        "text": "Foster City",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "94404",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: HIV/hepatitis B virus (HBV) coinfection elevates the risk of",
    "entities": []
  },
  {
    "text": "liver-related complications compared to HIV or HBV mono-infections. While some",
    "entities": []
  },
  {
    "text": "antiretroviral therapy (ART) regimens slow liver disease progression, the",
    "entities": []
  },
  {
    "text": "long-term effects of tenofovir-based and non-tenofovir-based ART on advanced",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "liver disease events in people with HIV/HBV remain unclear.",
    "entities": []
  },
  {
    "text": "METHODS: People with HIV/HBV and aged \u2265 18 years or older who initiated ART",
    "entities": [
      {
        "text": "\u2265",
        "label": "GPE"
      },
      {
        "text": "18 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "between April 2016 and January 2024 were included from the US HealthVerity",
    "entities": [
      {
        "text": "between April 2016 and January 2024",
        "label": "DATE"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "claims database. Advanced liver disease events (cirrhosis, liver decompensation,",
    "entities": []
  },
  {
    "text": "hepatocellular carcinoma [HCC], and liver transplant) were evaluated overall and",
    "entities": []
  },
  {
    "text": "individually among people who received tenofovir alafenamide (TAF)-based,",
    "entities": []
  },
  {
    "text": "tenofovir disoproxil fumarate (TDF)-based, or non-tenofovir-based ART; people",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with events prior to ART initiation were excluded. The time to advanced liver",
    "entities": []
  },
  {
    "text": "disease events were estimated with Kaplan-Meier methods. Adjusted hazard ratios",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and 95% CIs were calculated using Cox proportional hazards models. To evaluate",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "Cox",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "liver function over time, alanine aminotransferase and aspartate",
    "entities": []
  },
  {
    "text": "aminotransferase levels before and after ART initiation were assessed for up to",
    "entities": []
  },
  {
    "text": "1 year using adjusted mixed-effect models.",
    "entities": [
      {
        "text": "1 year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: Among 3095 people included, 76% initiated TAF-based, 13% initiated",
    "entities": [
      {
        "text": "3095",
        "label": "CARDINAL"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "TAF",
        "label": "GPE"
      },
      {
        "text": "13%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "TDF-based, and 11% initiated non-tenofovir-based ART. TAF-based and TDF-based",
    "entities": [
      {
        "text": "11%",
        "label": "PERCENT"
      },
      {
        "text": "ART",
        "label": "ORG"
      },
      {
        "text": "TAF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ART had significantly longer times to any advanced liver disease event compared",
    "entities": []
  },
  {
    "text": "to non-tenofovir-based ART (log-rank P < 0.01). After adjustment, both TAF-based",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      },
      {
        "text": "TAF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and TDF-based ART retained significantly reduced the risk of any advanced liver",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disease event and TAF-based ART had a lower risk of cirrhosis and risk of HCC",
    "entities": [
      {
        "text": "TAF",
        "label": "GPE"
      },
      {
        "text": "ART",
        "label": "ORG"
      },
      {
        "text": "HCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compared with non-tenofovir-based ART (P < 0.05). Tenofovir-based ART was",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      },
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "associated with stable liver enzyme levels over time.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Tenofovir-based ART was associated with a reduced risk of severe",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "liver-related complications overall. TAF-based ART was associated with",
    "entities": [
      {
        "text": "TAF",
        "label": "GPE"
      },
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "progression to cirrhosis and HCC, relative to non-tenofovir-based ART in people",
    "entities": [
      {
        "text": "HCC",
        "label": "ORG"
      },
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with HIV/HBV. These findings highlight the importance of tenofovir-based ART",
    "entities": [
      {
        "text": "ART\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "regimens in improving outcomes for people with HIV/HBV.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s40121-025-01192-5",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflicts of Interest: Ching-Yi",
    "entities": [
      {
        "text": "Ching-Yi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Chuo, Woodie Zachry, Laura Telep, and Li Tao are employees and stockholders of",
    "entities": [
      {
        "text": "Woodie Zachry",
        "label": "PERSON"
      },
      {
        "text": "Laura Telep",
        "label": "PERSON"
      },
      {
        "text": "Li Tao",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Gilead Sciences, Inc. Melanie de Boer is a former employee and stockholder of",
    "entities": [
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      },
      {
        "text": "Melanie de Boer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Gilead Sciences, Inc. Ethical Approval: As this study involved secondary data",
    "entities": [
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "use of de-identified administrative claims data, institutional review board or",
    "entities": []
  },
  {
    "text": "independent ethics committee review was not required. The patient identifiers in",
    "entities": []
  },
  {
    "text": "all data sources were removed, and the data contained no patient identifiable",
    "entities": []
  },
  {
    "text": "fields. No informed consent was obtained to participate in this secondary",
    "entities": []
  },
  {
    "text": "analysis of existing data. However, informed consent may have been granted when",
    "entities": []
  },
  {
    "text": "the original study data were collected. This study was conducted according to",
    "entities": []
  },
  {
    "text": "the Good Pharmacoepidemiology Practice and in line with the relevant Modules of",
    "entities": [
      {
        "text": "the Good Pharmacoepidemiology Practice",
        "label": "ORG"
      },
      {
        "text": "Modules",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the Heads of Medicines Agencies Good Pharmacovigilance Practices.",
    "entities": [
      {
        "text": "the Heads of Medicines Agencies Good Pharmacovigilance Practices",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "24. Int J Clin Pharm. 2025 Jul 15. doi: 10.1007/s11096-025-01963-7. Online ahead",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Clin Pharm",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Sedative co-medication patterns across frailty states in people with HIV: a",
    "entities": []
  },
  {
    "text": "network-based study.",
    "entities": []
  },
  {
    "text": "Michael HU(1)(2), Brouillette MJ(3)(4)(5), Tamblyn R(6)(7), Fellows LK(8), Mayo",
    "entities": [
      {
        "text": "Michael HU(1)(2",
        "label": "PERSON"
      },
      {
        "text": "Brouillette MJ(3)(4)(5",
        "label": "PERSON"
      },
      {
        "text": "Tamblyn",
        "label": "ORG"
      },
      {
        "text": "Fellows LK(8",
        "label": "PERSON"
      },
      {
        "text": "Mayo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Division of Clinical and Translational Research, McGill University, Montreal,",
    "entities": [
      {
        "text": "Clinical and Translational Research",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center for Outcomes Research and Evaluation (CORE), Research Institute of the",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Outcomes Research and Evaluation",
        "label": "ORG"
      },
      {
        "text": "Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Psychiatry, Faculty of Medicine, McGill University, Montreal,",
    "entities": [
      {
        "text": "Psychiatry, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Chronic Viral Illness Service, McGill University Health Centre (MUHC),",
    "entities": [
      {
        "text": "Viral Illness Service",
        "label": "ORG"
      },
      {
        "text": "McGill University Health Centre",
        "label": "ORG"
      },
      {
        "text": "MUHC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Infectious Diseases and Immunity in Global Health Program, MUHC-RI, Montreal,",
    "entities": [
      {
        "text": "MUHC",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Clinical and Translational Research, McGill University, Montreal,",
    "entities": [
      {
        "text": "Clinical and Translational Research",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Epidemiology, Biostatistics and Occupational Health, Montreal,",
    "entities": [
      {
        "text": "Epidemiology, Biostatistics and Occupational Health,",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Neurology and Neurosurgery, Montreal Neurological Institute,",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "Montreal Neurological Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "McGill University, Montreal, QC, Canada.",
    "entities": [
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      },
      {
        "text": "QC",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Center for Outcomes Research and Evaluation (CORE), Research Institute of the",
    "entities": [
      {
        "text": "Outcomes Research and Evaluation",
        "label": "ORG"
      },
      {
        "text": "Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)School of Physical and Occupational Therapy, Faculty of Medicine and Health",
    "entities": []
  },
  {
    "text": "Sciences, McGill University, Montreal, QC, Canada.",
    "entities": [
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      },
      {
        "text": "QC",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: People with HIV are living longer, but frailty may increase",
    "entities": []
  },
  {
    "text": "vulnerability to adverse drug interactions, particularly with sedative",
    "entities": []
  },
  {
    "text": "medications.",
    "entities": []
  },
  {
    "text": "AIM: To describe sedative co-medication patterns across frailty states using",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "network-based analysis, and to identify key medications driving interaction",
    "entities": []
  },
  {
    "text": "complexity.",
    "entities": []
  },
  {
    "text": "METHOD: This cross-sectional study analyzed 321 participants using sedatives",
    "entities": [
      {
        "text": "METHOD",
        "label": "ORG"
      },
      {
        "text": "321",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "from the Positive Brain Health Now Cohort (mean age: 53 years), categorized as",
    "entities": [
      {
        "text": "the Positive Brain Health Now Cohort",
        "label": "ORG"
      },
      {
        "text": "53 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "robust (30.2%), prefrail (47.0%), or frail (22.7%). Sedative use was classified",
    "entities": [
      {
        "text": "30.2%",
        "label": "PERCENT"
      },
      {
        "text": "47.0%",
        "label": "PERCENT"
      },
      {
        "text": "22.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "using the Sedative Load Model, and frailty was assessed with a modified Fried",
    "entities": [
      {
        "text": "the Sedative Load Model",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Frailty Phenotype. Co-medication networks were constructed for robust, prefrail,",
    "entities": []
  },
  {
    "text": "and frail groups, with metrics such as Neighborhood Shift Scores (NESH) and",
    "entities": [
      {
        "text": "NESH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u0394Betweenness used to evaluate network dynamics. Edge-level Observed-to-Expected",
    "entities": []
  },
  {
    "text": "ratios highlighted significant drug pairings and interaction risks.",
    "entities": []
  },
  {
    "text": "RESULTS: Frail individuals exhibited the most interconnected sedative network",
    "entities": [
      {
        "text": "Frail",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(graph density: 0.24; average degree: 7.31) followed by prefrail (graph density:",
    "entities": [
      {
        "text": "0.24",
        "label": "CARDINAL"
      },
      {
        "text": "7.31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.18; average degree: 6.67) and robust groups (graph density: 0.13; average",
    "entities": [
      {
        "text": "0.18",
        "label": "CARDINAL"
      },
      {
        "text": "6.67",
        "label": "CARDINAL"
      },
      {
        "text": "0.13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "degree: 4.61). Medications with high network influence included mirtazapine",
    "entities": [
      {
        "text": "4.61",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(robust-to-prefrail: NESH = 2.05; \u0394Betweenness = 0.23), gabapentin",
    "entities": [
      {
        "text": "2.05",
        "label": "CARDINAL"
      },
      {
        "text": "0.23",
        "label": "CARDINAL"
      },
      {
        "text": "gabapentin\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(robust-to-frail: NESH = 2.46, \u0394Betweenness = 0.10), and pregabalin",
    "entities": [
      {
        "text": "2.46",
        "label": "CARDINAL"
      },
      {
        "text": "0.10",
        "label": "CARDINAL"
      },
      {
        "text": "pregabalin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(prefrail-to-frail: NESH = 2.55; \u0394Betweenness = 0.71). High-risk sedative pairs",
    "entities": [
      {
        "text": "2.55",
        "label": "CARDINAL"
      },
      {
        "text": "0.71",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in frail individuals included hydromorphone-clonazepam (Observed-to-Expected",
    "entities": []
  },
  {
    "text": "ratio: 3.07; interaction severity: D), amitriptyline-oxycodone",
    "entities": [
      {
        "text": "3.07",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(Observed-to-Expected ratio: 1.92; severity: D), and quetiapine-citalopram",
    "entities": [
      {
        "text": "1.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(Observed-to-Expected ratio: 2.12; severity: D). Prefrail individuals had",
    "entities": [
      {
        "text": "2.12",
        "label": "CARDINAL"
      },
      {
        "text": "Prefrail",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "intermediate-risk combinations, including clobazam-levetiracetam",
    "entities": []
  },
  {
    "text": "(Observed-to-Expected ratio: 81.5; severity: C), and gabapentin-hydroxyzine",
    "entities": [
      {
        "text": "81.5",
        "label": "CARDINAL"
      },
      {
        "text": "gabapentin-hydroxyzine",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(Observed-to-Expected ratio: 3.58; severity: D). Robust individuals showed fewer",
    "entities": [
      {
        "text": "3.58",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and lower-risk patterns, such as amitriptyline-pregabalin (Observed-to-Expected",
    "entities": []
  },
  {
    "text": "ratio: 4.00; severity: C). Network differences reflect increasing polypharmacy",
    "entities": [
      {
        "text": "4.00",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and adverse interaction risks with advancing frailty.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Sedative co-medication patterns vary meaningfully across frailty",
    "entities": []
  },
  {
    "text": "states in people with HIV. Frailty is associated with more complex networks and",
    "entities": []
  },
  {
    "text": "a greater likelihood of high-risk drug interactions. Medications influencing",
    "entities": []
  },
  {
    "text": "these patterns can help identify opportunities for safer prescribing. The",
    "entities": []
  },
  {
    "text": "prefrail stage may offer a timely window for interventions aimed at minimizing",
    "entities": []
  },
  {
    "text": "polypharmacy and improving safety in middle-aged and older adults with HIV.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Springer Nature Switzerland",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer Nature",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s11096-025-01963-7",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Ethics approval: The project was approved by the",
    "entities": []
  },
  {
    "text": "Research Ethics Board of the McGill University Health Center Research Institute",
    "entities": [
      {
        "text": "Research Ethics Board",
        "label": "ORG"
      },
      {
        "text": "the McGill University Health Center Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(Biomedical D Research Ethics Board protocol 13\u2013047, McGill University Health",
    "entities": [
      {
        "text": "Biomedical D Research Ethics Board",
        "label": "ORG"
      },
      {
        "text": "McGill University Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centre). Consent to participate: Informed consent was obtained from all",
    "entities": []
  },
  {
    "text": "individual participants included in the study.",
    "entities": []
  },
  {
    "text": "FDA approves first-in-class HIV prevention shot.",
    "entities": [
      {
        "text": "FDA",
        "label": "ORG"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "[No authors listed]",
    "entities": []
  },
  {
    "text": "A serological household survey on social determinants of the generalized HIV",
    "entities": []
  },
  {
    "text": "epidemic in southern Brazil.",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio",
    "entities": [
      {
        "text": "University of Health Sciences of Porto Alegre",
        "label": "ORG"
      },
      {
        "text": "Porto Alegre",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(5)Brazilian Ministry of Health, Bras\u00edlia, Distrito Federal, Brazil.",
    "entities": [
      {
        "text": "5)Brazilian Ministry of Health, Bras\u00edlia",
        "label": "ORG"
      },
      {
        "text": "Distrito Federal",
        "label": "ORG"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study explores HIV prevalence and its social determinants in the",
    "entities": []
  },
  {
    "text": "southernmost state in Brazil, where the HIV epidemic has historically been more",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "severe. A population-based serological household survey was conducted in 56",
    "entities": [
      {
        "text": "56",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sampled municipalities between 2020 and 2022. Adult residents completed",
    "entities": [
      {
        "text": "between 2020 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "electronic questionnaires and provided blood samples for HIV testing, following",
    "entities": []
  },
  {
    "text": "Brazilian guidelines. Statistical analysis employed survey-weighted methods and",
    "entities": [
      {
        "text": "Brazilian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "hierarchical robust Poisson regression models to investigate factors associated",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with HIV prevalence. Quality control measures and sensitivity analyses were",
    "entities": []
  },
  {
    "text": "included to ensure result robustness. Among 7978 analyzed participants, 81 HIV",
    "entities": [
      {
        "text": "7978",
        "label": "CARDINAL"
      },
      {
        "text": "81",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cases were serologically detected (51 also self-reported), resulting in an",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "estimated overall HIV prevalence of 0.99% (95% CI 0.56-1.75). A generalized HIV",
    "entities": [
      {
        "text": "0.99%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.56-1.75",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "epidemic was confirmed in the metropolitan health macro-region of Rio Grande do",
    "entities": [
      {
        "text": "Rio Grande",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sul, where HIV prevalence was 1.64% (95% CI 1.59-1.70). Socioeconomic position",
    "entities": [
      {
        "text": "1.64%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.59-1.70",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was the most important factor associated with HIV prevalence, even after",
    "entities": []
  },
  {
    "text": "adjustments. Disparities in HIV distribution across regions and subpopulations,",
    "entities": []
  },
  {
    "text": "combined with rising prevalence trends in other Brazilian states, support",
    "entities": [
      {
        "text": "Brazilian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "implementing a national serology household survey to create evidence-based",
    "entities": []
  },
  {
    "text": "policies addressing systemic social inequities. The high proportion of unknown",
    "entities": []
  },
  {
    "text": "HIV cases highlights the need for improved community-based testing strategies.",
    "entities": []
  },
  {
    "text": "PMID: 40664731 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664731",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1136/sextrans-2025-056556. Online ahead of print.",
    "entities": [
      {
        "text": "10.1136",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "'It does fill me with a bit of unease': a qualitative study of the",
    "entities": []
  },
  {
    "text": "acceptability, facilitators and barriers to reducing the frequency of screening",
    "entities": []
  },
  {
    "text": "for asymptomatic sexually transmitted infections among gay, bisexual and other",
    "entities": []
  },
  {
    "text": "men who have sex with men.",
    "entities": []
  },
  {
    "text": "Berners-Lee W(1)(2), Cabecinha M(3), Bell J(4), Phillips D(4), Witney T(5),",
    "entities": [
      {
        "text": "Cabecinha M(3",
        "label": "PERSON"
      },
      {
        "text": "Bell J(4",
        "label": "ORG"
      },
      {
        "text": "Phillips",
        "label": "PERSON"
      },
      {
        "text": "Witney",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pulford CV(4), Lorencatto F(6), Fifer H(4), Foster K(4), Mohammed H(4), Sinka",
    "entities": [
      {
        "text": "Pulford",
        "label": "PERSON"
      },
      {
        "text": "Lorencatto F(6",
        "label": "PRODUCT"
      },
      {
        "text": "Fifer",
        "label": "PERSON"
      },
      {
        "text": "Foster",
        "label": "PERSON"
      },
      {
        "text": "Mohammed",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV",
    "entities": [
      {
        "text": "1)Blood",
        "label": "ORDINAL"
      },
      {
        "text": "Sexually Transmitted Infections",
        "label": "ORG"
      },
      {
        "text": "STI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Division, UK Health Security Agency-Colindale, London, UK",
    "entities": [
      {
        "text": "Division",
        "label": "ORG"
      },
      {
        "text": "UK Health Security Agency-Colindale",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The National Institute for Health Research Health Protection Research Unit in",
    "entities": [
      {
        "text": "2)The National Institute for Health Research Health Protection Research Unit",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Blood Borne and Sexually Transmitted Infections at University College London in",
    "entities": [
      {
        "text": "Blood Borne",
        "label": "PERSON"
      },
      {
        "text": "Sexually Transmitted Infections",
        "label": "ORG"
      },
      {
        "text": "University College London",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Partnership with the UK Health Security Agency, London, UK.",
    "entities": [
      {
        "text": "the UK Health Security Agency",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Research Department for Primary Care and Population Health, UCL, London, UK.",
    "entities": [
      {
        "text": "Department for Primary Care and Population Health",
        "label": "ORG"
      },
      {
        "text": "UCL",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV",
    "entities": [
      {
        "text": "4)Blood",
        "label": "CARDINAL"
      },
      {
        "text": "Sexually Transmitted Infections",
        "label": "ORG"
      },
      {
        "text": "STI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Division, UK Health Security Agency-Colindale, London, UK.",
    "entities": [
      {
        "text": "Division",
        "label": "ORG"
      },
      {
        "text": "UK Health Security Agency-Colindale",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Infection and Population Health, UCL, London, UK.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Infection and Population Health",
        "label": "ORG"
      },
      {
        "text": "UCL",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Centre for Behaviour Change, UCL, London, UK.",
    "entities": [
      {
        "text": "UCL",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Institute of Epidemiology and Health, University College London, London, UK.",
    "entities": [
      {
        "text": "Epidemiology and Health, University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: The study aimed to explore the acceptability of reducing the",
    "entities": []
  },
  {
    "text": "frequency of asymptomatic Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae",
    "entities": [
      {
        "text": "Chlamydia",
        "label": "PERSON"
      },
      {
        "text": "Neisseria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(Ng) screening among gay, bisexual, and other men who have sex with men",
    "entities": []
  },
  {
    "text": "(GBMSM)(Although the term GBMSM is used for convenience, the study also includes",
    "entities": [
      {
        "text": "GBMSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nonbinary people who were assigned male at birth who have sex with men.).",
    "entities": []
  },
  {
    "text": "Additionally, it sought to identify barriers and facilitators to implementing",
    "entities": []
  },
  {
    "text": "such changes and to develop potential interventions that could support a shift",
    "entities": []
  },
  {
    "text": "in current screening guidelines.",
    "entities": []
  },
  {
    "text": "METHODS: This qualitative study explored stakeholder perspectives on reducing",
    "entities": []
  },
  {
    "text": "screening frequency and identified potential interventions that could support",
    "entities": []
  },
  {
    "text": "future guideline changes of this kind. Semistructured interviews were conducted",
    "entities": []
  },
  {
    "text": "with 22 GBMSM and 8 professional stakeholders. Data were thematically analysed",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "GBMSM",
        "label": "ORG"
      },
      {
        "text": "8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "using the Capabilty, Opportunity, Motivation - Behaviour (COM-B) and Theoretical",
    "entities": [
      {
        "text": "the Capabilty, Opportunity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Domains Framework (TDF). TDF domains were mapped to behaviour change techniques",
    "entities": [
      {
        "text": "Domains Framework",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "to inform intervention development. Candidate interventions were refined based",
    "entities": []
  },
  {
    "text": "on acceptability, practicability, effectiveness, affordability, side effects,",
    "entities": []
  },
  {
    "text": "equity.",
    "entities": []
  },
  {
    "text": "RESULTS: Overall, GBMSM stakeholder responses to discontinuing asymptomatic Ng",
    "entities": [
      {
        "text": "GBMSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Ct screening tended to be negative, while professional stakeholder opinions",
    "entities": []
  },
  {
    "text": "were mixed. Reducing the recommended screening frequency to 6 monthly was",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "generally more acceptable to both groups. Barriers and facilitators to guideline",
    "entities": []
  },
  {
    "text": "changes included issues of knowledge and trust, social influence and identity,",
    "entities": []
  },
  {
    "text": "habit. Ten candidate interventions were suggested. These involve providing",
    "entities": [
      {
        "text": "habit",
        "label": "ORG"
      },
      {
        "text": "Ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "information, social support, behavioural substitutions and feedback as well as",
    "entities": []
  },
  {
    "text": "facilitating discussions to resolve concerns.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Any reduction in the recommended frequency of asymptomatic screening",
    "entities": []
  },
  {
    "text": "will encounter a range of interrelated barriers, including knowledge gaps,",
    "entities": []
  },
  {
    "text": "social influences and emotional factors. We identified evidence-based",
    "entities": []
  },
  {
    "text": "interventions that could improve acceptance and minimise unintended",
    "entities": []
  },
  {
    "text": "consequences. Future research should incorporate stakeholder workshops to refine",
    "entities": []
  },
  {
    "text": "these strategies.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: None declared.",
    "entities": []
  },
  {
    "text": "28. Int J Pharm. 2025 Jul 13:125942. doi: 10.1016/j.ijpharm.2025.125942. Online",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Pharm",
        "label": "ORG"
      },
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Design of SLS 3D-printed pediatric combination printlets of lamivudine and",
    "entities": []
  },
  {
    "text": "tenofovir disoproxil fumarate by understanding the impact of formulation and",
    "entities": []
  },
  {
    "text": "process variables on flow, spectral, thermal and performance characteristics.",
    "entities": []
  },
  {
    "text": "(1)Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas",
    "entities": [
      {
        "text": "1)Irma",
        "label": "CARDINAL"
      },
      {
        "text": "Lerma Rangel College of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Texas A&M Health Science Center",
        "label": "ORG"
      },
      {
        "text": "Texas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A&M University, College Station, TX 77843, USA; The Department of Engineering",
    "entities": [
      {
        "text": "A&M University",
        "label": "ORG"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "77843",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "The Department of Engineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Technology and Industrial Distribution, Texas A&M University, College Station,",
    "entities": [
      {
        "text": "Texas A&M University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TX 77843, USA.",
    "entities": [
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "77843",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas",
    "entities": [
      {
        "text": "Lerma Rangel College of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Texas A&M Health Science Center",
        "label": "ORG"
      },
      {
        "text": "Texas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Adherence to pediatric HIV therapy continues to be a challenge for achieving the",
    "entities": []
  },
  {
    "text": "desired therapeutic outcomes in children due to various factors, the primary one",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "being the lack of availability of a dose-flexible pediatric combination",
    "entities": []
  },
  {
    "text": "formulation. The study thus aimed to create a pediatric-friendly combination of",
    "entities": []
  },
  {
    "text": "lamivudine (3TC) and tenofovir disoproxil fumarate (TDF) printlets by examining",
    "entities": [
      {
        "text": "lamivudine (3TC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "how formulation and process variables interact within selective laser sintering",
    "entities": []
  },
  {
    "text": "(SLS) 3D printing technology. A Plackett-Burman screening design was used to",
    "entities": []
  },
  {
    "text": "pinpoint critical factors impacting product quality. Eight factors, encompassing",
    "entities": [
      {
        "text": "Eight",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "both formulation and process parameters, were assessed to identify the main",
    "entities": []
  },
  {
    "text": "effects. These include the percentage of combination drug (30-40 %) in a 1:1",
    "entities": [
      {
        "text": "30-40 %",
        "label": "PERCENT"
      },
      {
        "text": "1:1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ratio, Kollicoat\u00ae IR (0-57 %), hydroxypropyl methyl cellulose (0-67 %), sucrose",
    "entities": [
      {
        "text": "Kollicoat\u00ae IR",
        "label": "ORG"
      },
      {
        "text": "0-57 %",
        "label": "PERCENT"
      },
      {
        "text": "0-67 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(0-67 %), and mannitol (0-57 %), surface (80-100 \u00b0C) and chamber temperature",
    "entities": [
      {
        "text": "0-67 %",
        "label": "PERCENT"
      },
      {
        "text": "mannitol",
        "label": "ORG"
      },
      {
        "text": "0-57 %",
        "label": "PERCENT"
      },
      {
        "text": "80-100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(60-80 \u00b0C), and laser scanning speed (250-300 mm/sec). The influence of these",
    "entities": [
      {
        "text": "60-80",
        "label": "DATE"
      },
      {
        "text": "250-300",
        "label": "CARDINAL"
      },
      {
        "text": "sec",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "factors was examined in relation to seven responses: angle of repose, hardness,",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disintegration time, assay of 3TC, assay of TDF, and dissolution of 3TC and TDF",
    "entities": [
      {
        "text": "3TC",
        "label": "CARDINAL"
      },
      {
        "text": "3TC",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at 10 min. The results showed that a 1:1 drug ratio with 40 % loading produced",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "1:1",
        "label": "CARDINAL"
      },
      {
        "text": "40 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "printlets meeting USP assay and dissolution standards. Surface temperature, KCIR",
    "entities": [
      {
        "text": "USP",
        "label": "ORG"
      },
      {
        "text": "KCIR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "amount, and laser scanning speed significantly influenced printlet performance",
    "entities": []
  },
  {
    "text": "(p < 0.05). Characterization techniques, including differential scanning",
    "entities": []
  },
  {
    "text": "calorimetry, X-ray diffraction, and near-infrared hyperspectral imaging,",
    "entities": []
  },
  {
    "text": "confirmed that both drugs were effectively incorporated in the printlets while",
    "entities": []
  },
  {
    "text": "maintaining stability and uniformity. Thus, by studying the interplay of",
    "entities": []
  },
  {
    "text": "variables and their outcomes alongside characterization studies, this research",
    "entities": []
  },
  {
    "text": "supports the use of SLS 3D printing as a promising method for developing",
    "entities": []
  },
  {
    "text": "pediatric-friendly combination antiviral therapies that enhance dosing",
    "entities": []
  },
  {
    "text": "flexibility and improve adherence potential.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier B.V. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest The authors",
    "entities": []
  },
  {
    "text": "declare that they have no known competing financial interests or personal",
    "entities": []
  },
  {
    "text": "relationships that could have appeared to influence the work reported in this",
    "entities": []
  },
  {
    "text": "Evaluating the Usability of an HIV Prevention Artificial Intelligence Chatbot in",
    "entities": []
  },
  {
    "text": "Malaysia: National Observational Study.",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "National Observational Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)School of Nursing, Yale University, 400 West Campus Drive, Orange, CT,",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Yale University",
        "label": "ORG"
      },
      {
        "text": "400",
        "label": "CARDINAL"
      },
      {
        "text": "Orange, CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "06477-3646, United States, 1 2037373039.",
    "entities": [
      {
        "text": "06477-3646",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      },
      {
        "text": "1 2037373039",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Interdisciplinary Research",
        "label": "ORG"
      },
      {
        "text": "CIRA",
        "label": "ORG"
      },
      {
        "text": "Yale University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Haven, CT, United States.",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Centre of Excellence for Research in Infectious Diseases & AIDS (CERiA),",
    "entities": [
      {
        "text": "3)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Excellence for Research in Infectious Diseases &",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Social and Preventive Medicine, Universiti Malaya, Kuala",
    "entities": [
      {
        "text": "Social and Preventive Medicine",
        "label": "ORG"
      },
      {
        "text": "Universiti Malaya",
        "label": "GPE"
      },
      {
        "text": "Kuala",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Infectious Disease Unit, Faculty of Medicine, Universiti Malaya, Kuala",
    "entities": [
      {
        "text": "Disease Unit,",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Universiti Malaya",
        "label": "GPE"
      },
      {
        "text": "Kuala",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Section of Infectious Disease, Department of Internal Medicine, Yale School",
    "entities": [
      {
        "text": "Infectious Disease, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Yale School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, New Haven, CT, United States.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of Epidemiology of Microbial Diseases, Yale School of Public Health,",
    "entities": [
      {
        "text": "Epidemiology of Microbial Diseases",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "New Haven, CT, United States.",
    "entities": [
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Malaysia, an upper middle-income country in the Asia-Pacific region,",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "the Asia-Pacific region",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "has an HIV epidemic that has transitioned from needle sharing to sexual",
    "entities": []
  },
  {
    "text": "transmission, mainly in men who have sex with men (MSM). MSM are the most",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "vulnerable population for HIV in Malaysia. In 2022, our team developed a",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "web-based artificial intelligence (AI) chatbot and tested its feasibility and",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acceptability among MSM in Malaysia to promote HIV testing. To enhance the",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "usability of the AI chatbot, we made it accessible to the public through the",
    "entities": [
      {
        "text": "AI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "website called MYHIV365 and tested it in an observational study.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study aimed to test the usability of an AI chatbot in promoting",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This observational study was conducted from August 2023 to March 2024",
    "entities": [
      {
        "text": "August 2023 to March 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "among 334 MSM. Participants were recruited through community outreach and",
    "entities": [
      {
        "text": "334",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "social-networking apps using flyers. The interactions between participants and",
    "entities": []
  },
  {
    "text": "the AI chatbot were documented and retrieved from the chatbot developer's",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "platform. Data were analyzed following a predefined metrics using R software",
    "entities": []
  },
  {
    "text": "(Posit Software, PBC).",
    "entities": [
      {
        "text": "Posit Software",
        "label": "ORG"
      },
      {
        "text": "PBC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The AI chatbot interacted with 334 participants, assisting them in",
    "entities": [
      {
        "text": "AI",
        "label": "PERSON"
      },
      {
        "text": "334",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "receiving free HIV self-testing kits, offering information on HIV, pre-exposure",
    "entities": []
  },
  {
    "text": "prophylaxis (PrEP), and mental health, and providing details of 220 MSM-friendly",
    "entities": [
      {
        "text": "220",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clinics, including their addresses, phone numbers, and operating hours. After",
    "entities": []
  },
  {
    "text": "the study, 393 human-chatbot interactions were documented on the chatbot",
    "entities": [
      {
        "text": "393",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "developer's platform. Most participants (304/334, 91.0%) interacted with the AI",
    "entities": [
      {
        "text": "91.0%",
        "label": "PERCENT"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "chatbot once, 30 (9.0%) engaged 2 or more times at different intervals.",
    "entities": [
      {
        "text": "chatbot",
        "label": "PERSON"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "9.0%",
        "label": "PERCENT"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Participants' interaction time with the chatbot varied, ranging from 1 to 31",
    "entities": [
      {
        "text": "1 to 31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "minutes. The AI chatbot properly addressed most participants' questions",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(362/393, 92.1%) about HIV and PrEP. However, in 31 interactions, participants",
    "entities": [
      {
        "text": "362/393",
        "label": "CARDINAL"
      },
      {
        "text": "92.1%",
        "label": "PERCENT"
      },
      {
        "text": "PrEP",
        "label": "PERSON"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "posed additional questions to the chatbot that were not programmed into the",
    "entities": []
  },
  {
    "text": "chatbot algorithms, resulting in unanswered interactions.",
    "entities": [
      {
        "text": "chatbot",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: The web-based AI chatbot demonstrated high usability in delivering",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HIV self-testing kits and providing clinical information on HIV testing, PrEP,",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and mental health services. To enhance its usability in community and clinical",
    "entities": []
  },
  {
    "text": "settings, the chatbot must offer personalized health information and precise",
    "entities": []
  },
  {
    "text": "interaction, powered by sophisticated machine learning algorithms. In addition,",
    "entities": []
  },
  {
    "text": "establishing an effective connection between the AI chatbot and health care",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "systems to eliminate stigma and discrimination toward MSM is crucial for the",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "future implementation of AI chatbots.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 Zhao Ni, Sunyoung Oh, Rumana Saifi, Iskandar Azwa, Frederick L Altice.",
    "entities": [
      {
        "text": "Zhao Ni",
        "label": "PERSON"
      },
      {
        "text": "Sunyoung Oh",
        "label": "PERSON"
      },
      {
        "text": "Rumana Saifi",
        "label": "PERSON"
      },
      {
        "text": "Iskandar Azwa",
        "label": "GPE"
      },
      {
        "text": "Frederick L Altice",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Originally published in JMIR Human Factors (https://humanfactors.jmir.org).",
    "entities": [
      {
        "text": "JMIR Human Factors",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40663792 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663792",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "30. Brain. 2025 Jul 15:awaf262. doi: 10.1093/brain/awaf262. Online ahead of",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Occludin modulates HIV and ischaemic stroke response via mitochondrial antiviral",
    "entities": []
  },
  {
    "text": "Torices S(1), Moreno T(2), Osborne OM(1), Ramaswamy S(1), Naranjo O(1), Teglas",
    "entities": [
      {
        "text": "Moreno T(2",
        "label": "ORG"
      },
      {
        "text": "Osborne OM(1",
        "label": "PERSON"
      },
      {
        "text": "Naranjo",
        "label": "PERSON"
      },
      {
        "text": "Teglas",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)University of Miami Miller School of Medicine, Department of Biochemistry and",
    "entities": [
      {
        "text": "1)University",
        "label": "CARDINAL"
      },
      {
        "text": "Miami Miller School of Medicine, Department of Biochemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Radiation Oncology, UCSF, San Francisco, CA 94143, USA.",
    "entities": [
      {
        "text": "Radiation Oncology",
        "label": "ORG"
      },
      {
        "text": "UCSF",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA 94143",
        "label": "FAC"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Specific cell types of the blood-brain barrier (BBB), such as pericytes, can be",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infected by HIV-1. Importantly, alterations of the expression of tight junction",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "protein occludin have been linked to regulation of HIV-1 infection. In the",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "present study, we hypothesized that occludin can influence HIV-1 infection via",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "modulating innate immunity responses. Unbiased transcriptome analysis was",
    "entities": []
  },
  {
    "text": "conducted on wild type and occludin-silenced primary human blood-brain barrier",
    "entities": []
  },
  {
    "text": "pericytes. The role of differentially expressed innate-immunity pathways was",
    "entities": []
  },
  {
    "text": "then evaluated in the context of mitochondrial dysfunction and HIV-1 infection.",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Using a model of ischemic stroke and occludin-deficient mice, we elucidated the",
    "entities": []
  },
  {
    "text": "functional role of occludin in cerebrovascular health in the presence of HIV-1",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "infection. Occludin silencing resulted in alterations of the gene expression",
    "entities": []
  },
  {
    "text": "signatures of IFN-stimulated genes and the antiviral retinoic acid-inducible",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gene-1 pathway, which functions as a regulator of the cytoplasmic sensors",
    "entities": []
  },
  {
    "text": "upstream of the mitochondrial antiviral signaling protein. Indeed, we observed",
    "entities": []
  },
  {
    "text": "dysfunctional mitochondrial bioenergetics, dynamics, and autophagy following",
    "entities": [
      {
        "text": "dysfunctional mitochondrial bioenergetics",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "occludin silencing. Alterations of mitochondrial bioenergetics and innate immune",
    "entities": []
  },
  {
    "text": "protection translated into worsened ischemic stroke outcomes in EcoHIV-infected",
    "entities": []
  },
  {
    "text": "occludin-deficient mice. Animal studies also confirmed that occludin-/- mice had",
    "entities": []
  },
  {
    "text": "higher EcoHIV load in plasma, spleen, and brain. Our results allow for a better",
    "entities": [
      {
        "text": "plasma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "understanding of the molecular mechanisms of viral infection in the brain and",
    "entities": []
  },
  {
    "text": "describe a previously unrecognized role of occludin as a key factor in the",
    "entities": []
  },
  {
    "text": "control of innate immune responses and mitochondrial dynamics at the blood-brain",
    "entities": []
  },
  {
    "text": "barrier level, which influence cerebral vascular disease outcomes such as",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of the",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guarantors of Brain.",
    "entities": [
      {
        "text": "Brain",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "31. Clin Infect Dis. 2025 Jul 15:ciaf375. doi: 10.1093/cid/ciaf375. Online ahead",
    "entities": [
      {
        "text": "31",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Infect Dis",
        "label": "PERSON"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression",
    "entities": [
      {
        "text": "VRC07-523LS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in Adults with HIV-1: ACTG A5357.",
    "entities": []
  },
  {
    "text": "D'Amico R(8), Rathod P(9), Bar K(10), Tebas P(10).",
    "entities": [
      {
        "text": "D'Amico R(8",
        "label": "PERSON"
      },
      {
        "text": "Tebas",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Northwestern University, Chicago, IL, USA.",
    "entities": [
      {
        "text": "1)Northwestern University",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Harvard T.H. Chan School of Public Health, Boston, MA, USA.",
    "entities": [
      {
        "text": "2)Harvard",
        "label": "CARDINAL"
      },
      {
        "text": "T.H. Chan School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Yale New Haven Health, New Haven, CT, USA.",
    "entities": [
      {
        "text": "New Haven Health",
        "label": "ORG"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)University of Nebraska Medical Center, Omaha, Nebraska, USA.",
    "entities": [
      {
        "text": "Nebraska Medical Center",
        "label": "ORG"
      },
      {
        "text": "Omaha",
        "label": "GPE"
      },
      {
        "text": "Nebraska",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Vaccine Research Center, National Institutes of Health, Bethesda, MD, USA.",
    "entities": [
      {
        "text": "Research Center",
        "label": "ORG"
      },
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH",
    "entities": [
      {
        "text": "National Institute of Allergy and Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "[Contractor], Bethesda, MD, USA.",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)ViiV Healthcare, Durham, NC, USA.",
    "entities": [
      {
        "text": "8)ViiV",
        "label": "CARDINAL"
      },
      {
        "text": "Healthcare",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)DLH Corporation, Bethesda, MD, USA.",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)University of Pennsylvania, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "10)University",
        "label": "CARDINAL"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Long-acting regimens are needed to expand antiretroviral therapy",
    "entities": []
  },
  {
    "text": "(ART) options for people with HIV-1 (PWH). Combining broadly neutralizing",
    "entities": [
      {
        "text": "HIV-1 (PWH",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "antibodies (bNAbs) with long-acting small-molecule antiretrovirals may offer an",
    "entities": []
  },
  {
    "text": "alternative to daily oral therapy.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a Phase 2, open-label, single-arm trial at AIDS Clinical",
    "entities": [
      {
        "text": "a Phase 2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Trials Group (ACTG) sites across the U.S. Eligible adults had HIV-1",
    "entities": [
      {
        "text": "Trials Group",
        "label": "ORG"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      },
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "virologically suppressed on ART for \u22652 years, CD4 \u2265350 cells/mm\u00b3, and",
    "entities": [
      {
        "text": "CD4 \u2265350",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "susceptibility to VRC07-523LS (IC50 \u22640.25 \u00b5g/mL; inhibition >98%). Participants",
    "entities": [
      {
        "text": "VRC07-523LS",
        "label": "ORG"
      },
      {
        "text": "98%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "completed an oral cabotegravir (CAB) lead-in (Step 1), then received intravenous",
    "entities": [
      {
        "text": "CAB",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for 48 weeks (Step 2), followed by a return to standard ART (Step 3). Primary",
    "entities": [
      {
        "text": "48 weeks",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcomes were treatment-related grade \u22653 adverse events (AEs), treatment",
    "entities": []
  },
  {
    "text": "discontinuation, and confirmed HIV-1 RNA \u2265200 copies/mL by week 44. Virologic",
    "entities": [
      {
        "text": "week 44",
        "label": "DATE"
      },
      {
        "text": "Virologic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "efficacy was assessed using Kaplan-Meier estimates.",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Seventy-four participants were enrolled (median age 54; 26% female; 51%",
    "entities": [
      {
        "text": "Seventy-four",
        "label": "CARDINAL"
      },
      {
        "text": "age 54",
        "label": "DATE"
      },
      {
        "text": "26%",
        "label": "PERCENT"
      },
      {
        "text": "51%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "White non-Hispanic). Twelve (17%) experienced a primary safety event: 11 (15%)",
    "entities": [
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "Twelve",
        "label": "CARDINAL"
      },
      {
        "text": "17%",
        "label": "PERCENT"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "had grade \u22653 Aes, primarily transient infusion reactions, and one discontinued",
    "entities": []
  },
  {
    "text": "due to a grade 1 infusion event. The cumulative probability of virologic failure",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "by week 44 was 7% (95% CI, 3%-16%). One participant developed the R263K",
    "entities": [
      {
        "text": "week 44",
        "label": "DATE"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "3%-16%",
        "label": "PERCENT"
      },
      {
        "text": "One",
        "label": "CARDINAL"
      },
      {
        "text": "R263K",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: The VRC07-523LS plus CAB-LA regimen maintained viral suppression in",
    "entities": [
      {
        "text": "CAB-LA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "93% of participants, with only transient infusion reactions observed; however,",
    "entities": [
      {
        "text": "93%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "instances of virologic breakthrough suggest that future studies should focus on",
    "entities": []
  },
  {
    "text": "optimizing efficacy outcomes. These results support continued investigation of",
    "entities": []
  },
  {
    "text": "bNAb-based long-acting ART combinations.",
    "entities": []
  },
  {
    "text": "Infectious Diseases Society of America. All rights reserved. For commercial",
    "entities": []
  },
  {
    "text": "re-use, please contact reprints@oup.com for reprints and translation rights for",
    "entities": []
  },
  {
    "text": "High prevalence of Strongyloides stercoralis in people living with HIV: A",
    "entities": [
      {
        "text": "Strongyloides",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "critical health challenge in the Peruvian Amazon Basin.",
    "entities": [
      {
        "text": "Peruvian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Infectious Diseases Unit, Alicante General University Hospital, Alicante,",
    "entities": [
      {
        "text": "Diseases Unit",
        "label": "ORG"
      },
      {
        "text": "Alicante General University Hospital",
        "label": "ORG"
      },
      {
        "text": "Alicante",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Spain.",
    "entities": [
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante,",
    "entities": [
      {
        "text": "Institute of Sanitary and Biomedical Research",
        "label": "ORG"
      },
      {
        "text": "Alicante",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Infectious Diseases and Tropical Medicine Service, Loreto Regional Hospital,",
    "entities": [
      {
        "text": "Diseases and Tropical Medicine Service",
        "label": "ORG"
      },
      {
        "text": "Loreto Regional Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Faculty of Human Medicine, National University of the Peruvian Amazon,",
    "entities": [
      {
        "text": "Human Medicine",
        "label": "ORG"
      },
      {
        "text": "National University of the Peruvian Amazon",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Laboratory for Research on Natural Antiparasitic Products of the Amazon",
    "entities": [
      {
        "text": "Research on Natural Antiparasitic Products",
        "label": "ORG"
      },
      {
        "text": "Amazon",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(LIPNAA-CIRNA), National University of the Peruvian Amazon, Iquitos, Peru.",
    "entities": [
      {
        "text": "National University of the Peruvian Amazon",
        "label": "ORG"
      },
      {
        "text": "Iquitos",
        "label": "GPE"
      },
      {
        "text": "Peru",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Clinical Laboratory, National University of the Peruvian Amazon, Iquitos,",
    "entities": [
      {
        "text": "Laboratory",
        "label": "ORG"
      },
      {
        "text": "National University of the Peruvian Amazon",
        "label": "ORG"
      },
      {
        "text": "Iquitos",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Medicine (Infectious Diseases) and Department of Pediatrics",
    "entities": [
      {
        "text": "Medicine (Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Department of Pediatrics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(Tropical Medicine), Baylor College of Medicine, Houston, Texas, United States",
    "entities": [
      {
        "text": "Baylor College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "Texas",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "of America.",
    "entities": [
      {
        "text": "America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Internal Medicine Department, Alicante General University Hospital,",
    "entities": [
      {
        "text": "10)Internal Medicine Department",
        "label": "ORG"
      },
      {
        "text": "Alicante General University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche, Elche,",
    "entities": [
      {
        "text": "11)Clinical Medicine Department",
        "label": "ORG"
      },
      {
        "text": "Miguel Hern\u00e1ndez University of Elche",
        "label": "ORG"
      },
      {
        "text": "Elche",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Strongyloidiasis is an important but underdiagnosed",
    "entities": [
      {
        "text": "Strongyloidiasis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "soil-transmitted helminthiasis, particularly in tropical areas and some",
    "entities": []
  },
  {
    "text": "sociodemographic factors of Strongyloides stercoralis infection in patients",
    "entities": [
      {
        "text": "Strongyloides",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "living with human immunodeficiency virus (PLWH) in an endemic area.",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: We performed a cross-sectional study of strongyloidiasis",
    "entities": []
  },
  {
    "text": "in 537 PLWH in two hospitals in Iquitos, Peru, from 20 Oct 2023 to 20 May 2024.",
    "entities": [
      {
        "text": "537",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Iquitos",
        "label": "GPE"
      },
      {
        "text": "Peru",
        "label": "GPE"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "May 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "We tested patient sera using Strongyloides IgG enzyme-linked immunosorbent assay",
    "entities": [
      {
        "text": "Strongyloides IgG",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(ELISA) and stool via the modified Baermann technique and/or charcoal fecal",
    "entities": [
      {
        "text": "ELISA",
        "label": "ORG"
      },
      {
        "text": "Baermann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "culture as highly sensitive parasitological techniques. We used multivariable",
    "entities": []
  },
  {
    "text": "logistic regression to identify factors associated with S. stercoralis",
    "entities": [
      {
        "text": "S.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection.",
    "entities": []
  },
  {
    "text": "RESULTS: Among the 339 PLWH whose stool samples were collected, 82 were positive",
    "entities": [
      {
        "text": "339",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "82",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Among the 534 PLWH whose serum samples were collected, 227 were positive",
    "entities": [
      {
        "text": "534",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "227",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(seroprevalence: 42.5%; 95% CI 38.1-47.5%). The kappa value for charcoal culture",
    "entities": [
      {
        "text": "42.5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "38.1-47.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and Baermann technique was 0.69. ELISA showed a sensitivity of 92.6% and a",
    "entities": [
      {
        "text": "Baermann",
        "label": "PERSON"
      },
      {
        "text": "0.69",
        "label": "CARDINAL"
      },
      {
        "text": "ELISA",
        "label": "ORG"
      },
      {
        "text": "92.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "negative predictive value of 96.9%. Significant risk factors for stool",
    "entities": [
      {
        "text": "96.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "positivity included living in a rural (unpaved) area (adjusted OR: 1.86),",
    "entities": [
      {
        "text": "1.86",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "whereas significant risk factors for both stool and seropositivity included",
    "entities": []
  },
  {
    "text": "living in a poor house (made of wood/leaves) (adjusted odds ratio (ORs): 2.18",
    "entities": [
      {
        "text": "2.18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 2.48, respectively), in the Loreto Regional Hospital catchment area",
    "entities": [
      {
        "text": "2.48",
        "label": "CARDINAL"
      },
      {
        "text": "the Loreto Regional Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(adjusted ORs: 5.66 and 5.37, respectively), or being infected by hookworms in",
    "entities": [
      {
        "text": "5.66",
        "label": "CARDINAL"
      },
      {
        "text": "5.37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stool (adjusted ORs: 23.88 and 9.78, respectively). Having a low level of",
    "entities": [
      {
        "text": "23.88",
        "label": "CARDINAL"
      },
      {
        "text": "9.78",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies was associated with seropositivity (adjusted OR 2.42).",
    "entities": [
      {
        "text": "2.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: The prevalence of S. stercoralis is high among PLWH in Iquitos,",
    "entities": [
      {
        "text": "S.",
        "label": "ORG"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "Iquitos",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "especially among those living in conditions of socioeconomic vulnerability or",
    "entities": []
  },
  {
    "text": "co-infected with hookworms. The negative predictive value of the S. stercoralis",
    "entities": [
      {
        "text": "S.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "ELISA was high, although this result should be taken with caution in severe",
    "entities": [
      {
        "text": "ELISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright: This is an open access article, free of all copyright, and may be",
    "entities": []
  },
  {
    "text": "freely reproduced, distributed, transmitted, modified, built upon, or otherwise",
    "entities": []
  },
  {
    "text": "used by anyone for any lawful purpose. The work is made available under the",
    "entities": []
  },
  {
    "text": "Creative Commons CC0 public domain dedication.",
    "entities": []
  },
  {
    "text": "PMID: 40663570 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663570",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: I have read the journal's policy and the authors",
    "entities": []
  },
  {
    "text": "of this manuscript have the following competing interests: Miguel Hernandez",
    "entities": [
      {
        "text": "Miguel Hernandez",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University has granted the research of J.M.-R in the field. Alicante Health and",
    "entities": [
      {
        "text": "Alicante Health",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Biomedical Research Institute (ISABIAL) and Instituto de Salud Carlos III",
    "entities": [
      {
        "text": "Biomedical Research Institute",
        "label": "ORG"
      },
      {
        "text": "Instituto de Salud Carlos III\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(ISCIII) have granted the research of S.O.-R in the field. None of the",
    "entities": [
      {
        "text": "S.O.-R",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "institutions had a role in study design, data collection, analysis, decision to",
    "entities": []
  },
  {
    "text": "publish, or preparation of the manuscript. The other authors declare that no",
    "entities": []
  },
  {
    "text": "competing interests exist.",
    "entities": []
  },
  {
    "text": "Within-country heterogeneity in patterns of social contact relevant for",
    "entities": []
  },
  {
    "text": "tuberculosis infection transmission, prevention, and care.",
    "entities": []
  },
  {
    "text": "LeGrand KE(1), Edwards A(2), Mohlamonyane M(3), Dayi N(2), Olivier S(2), Gareta",
    "entities": [
      {
        "text": "LeGrand KE(1",
        "label": "PERSON"
      },
      {
        "text": "Edwards A(2",
        "label": "PERSON"
      },
      {
        "text": "Mohlamonyane M(3",
        "label": "PERSON"
      },
      {
        "text": "Olivier S(2",
        "label": "PERSON"
      },
      {
        "text": "Gareta",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "P(1)(2), McCreesh N(1).",
    "entities": [
      {
        "text": "McCreesh N(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)TB Centre, London School of Hygiene & Tropical Medicine, London, United",
    "entities": [
      {
        "text": "London School of Hygiene & Tropical Medicine",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Kingdom of Great Britain and Northern Ireland.",
    "entities": [
      {
        "text": "Kingdom of Great Britain",
        "label": "GPE"
      },
      {
        "text": "Northern Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Africa Health Research Institute, KwaZulu-Natal, South Africa.",
    "entities": [
      {
        "text": "2)Africa",
        "label": "CARDINAL"
      },
      {
        "text": "Health Research Institute",
        "label": "ORG"
      },
      {
        "text": "KwaZulu-Natal",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Desmond Tutu HIV Centre, Department of Medicine, University of Cape Town,",
    "entities": [
      {
        "text": "3)Desmond",
        "label": "CARDINAL"
      },
      {
        "text": "Tutu HIV Centre",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine, University of Cape Town",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cape Town, South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Institute of Infectious Disease and Molecular Medicine, University of Cape",
    "entities": [
      {
        "text": "University of Cape",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Town, Cape Town, South Africa.",
    "entities": [
      {
        "text": "Town",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)School of Laboratory Medicine and Medical Sciences, University of",
    "entities": [
      {
        "text": "5)School of Laboratory Medicine and Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "KwaZulu-Natal, Durban, South Africa.",
    "entities": [
      {
        "text": "KwaZulu-Natal",
        "label": "ORG"
      },
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Mycobacterium tuberculosis (Mtb) transmission is driven by variable social,",
    "entities": []
  },
  {
    "text": "environmental, and biological factors, including the number and duration of",
    "entities": []
  },
  {
    "text": "indoor contacts. Social contact data can provide information on potential",
    "entities": []
  },
  {
    "text": "transmission patterns, but is underutilised outside the field of mathematical",
    "entities": []
  },
  {
    "text": "modelling. We explore three contexts where contact data can provide valuable",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "insights: 1) household contact tracing; 2) infection prevention and control",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "measures (IPC); and 3) contamination in cluster randomised trials (CRTs). A",
    "entities": [
      {
        "text": "IPC",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "social contact survey was conducted in adults aged 18 and older from three",
    "entities": [
      {
        "text": "aged 18 and older",
        "label": "DATE"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "communities with comparable population sizes in South Africa: an urban township",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and peri-urban and rural clinic catchment areas. Participants reported",
    "entities": []
  },
  {
    "text": "congregate settings visited over 24-hours, visit durations, and estimated number",
    "entities": [
      {
        "text": "24-hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "of people present. To correspond with the three contexts, we estimated the",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "proportion of contact hours occurring 1) within the home; 2) in congregate",
    "entities": [
      {
        "text": "hours",
        "label": "TIME"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "settings outside the home; and 3) outside the participants' communities.",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Participants reported a mean of 27.0 (rural), 55.2 (peri-urban), and 73.0",
    "entities": [
      {
        "text": "27.0",
        "label": "CARDINAL"
      },
      {
        "text": "55.2",
        "label": "DATE"
      },
      {
        "text": "73.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(urban) contact hours. The proportions of household contact were similar among",
    "entities": []
  },
  {
    "text": "rural and peri-urban participants (76.8% and 71.7%), compared to urban (48.6%).",
    "entities": [
      {
        "text": "76.8%",
        "label": "PERCENT"
      },
      {
        "text": "71.7%",
        "label": "PERCENT"
      },
      {
        "text": "48.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Congregate settings visited varied; urban participants spent the most contact",
    "entities": []
  },
  {
    "text": "hours in retail/office settings (19.9%), peri-urban participants in",
    "entities": [
      {
        "text": "hours",
        "label": "TIME"
      },
      {
        "text": "19.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "community-service buildings (20.4%), and rural participants in other peoples'",
    "entities": [
      {
        "text": "20.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "homes (25.5%). Urban participants reported the highest proportion of contact",
    "entities": [
      {
        "text": "25.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "outside the community (67.0%) compared to rural (38.8%) and peri-urban (21.5%)",
    "entities": [
      {
        "text": "67.0%",
        "label": "PERCENT"
      },
      {
        "text": "38.8%",
        "label": "PERCENT"
      },
      {
        "text": "21.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "participants. The observed heterogeneity in contact patterns has implications",
    "entities": []
  },
  {
    "text": "for TB interventions. Household contact tracing may be most effective in the",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rural community where household contact was highest. The diverse range of",
    "entities": []
  },
  {
    "text": "congregate settings visited suggests that prioritising IPC measures in these",
    "entities": [
      {
        "text": "IPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "locations may enhance their overall efficacy. Considering contact patterns when",
    "entities": []
  },
  {
    "text": "designing clusters may reduce contamination in CRTs. Tailored interventions,",
    "entities": []
  },
  {
    "text": "informed by local contexts, are essential to reduce TB burden.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 LeGrand et al. This is an open access article distributed",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "under the terms of the Creative Commons Attribution License, which permits",
    "entities": [
      {
        "text": "the Creative Commons Attribution License",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unrestricted use, distribution, and reproduction in any medium, provided the",
    "entities": []
  },
  {
    "text": "original author and source are credited.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors have declared that no competing",
    "entities": []
  },
  {
    "text": "interests exist.",
    "entities": []
  },
  {
    "text": "Teenage mothers report poor health and economic functioning in Western Kenya: A",
    "entities": [
      {
        "text": "Western Kenya",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "call to action.",
    "entities": []
  },
  {
    "text": "(1)Department of Public Health and Health Sciences, Northeastern University,",
    "entities": [
      {
        "text": "Public Health and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Northeastern University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, Massachusetts, United States of America.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Economics, Northeastern University, Boston, Massachusetts,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Economics",
        "label": "ORG"
      },
      {
        "text": "Northeastern University",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "United States of America.",
    "entities": [
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Vanderbilt, University Medical Center, Nashville, Tennessee, United States of",
    "entities": [
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "Tennessee",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "America.",
    "entities": [
      {
        "text": "America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Health, Migori County Government, Rongo, Kenya.",
    "entities": [
      {
        "text": "Health, Migori County Government",
        "label": "ORG"
      },
      {
        "text": "Rongo",
        "label": "GPE"
      },
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Cultures, Societies, and Global Studies, Northeastern",
    "entities": [
      {
        "text": "Cultures, Societies",
        "label": "ORG"
      },
      {
        "text": "Global Studies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Boston, Massachusetts, United States of America.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)African Centre for Community Investment in Health, Nginyang, Baringo County,",
    "entities": [
      {
        "text": "Centre for Community Investment in Health, Nginyang",
        "label": "ORG"
      },
      {
        "text": "Baringo County",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Integrated Initiative for Global Health, Northeastern University, Boston,",
    "entities": [
      {
        "text": "Northeastern University",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Massachusetts, United States of America.",
    "entities": [
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Teenage pregnancy remains a critical issue in Kenya, with 15% of girls aged",
    "entities": [
      {
        "text": "Kenya",
        "label": "GPE"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "15-19 having been pregnant. Counties in western Kenya experience high teenage",
    "entities": [
      {
        "text": "15-19",
        "label": "CARDINAL"
      },
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pregnancy rates (22-30%) along with high HIV prevalence and widespread poverty.",
    "entities": [
      {
        "text": "22-30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Long-term consequences of teenage pregnancy have been documented in high-income",
    "entities": []
  },
  {
    "text": "countries, but evidence from the Global South is lacking. Here, we examined the",
    "entities": [
      {
        "text": "the Global South",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "association between teenage pregnancy and adult socio-economic functioning in",
    "entities": []
  },
  {
    "text": "western Kenya using cross-sectional survey data from Migori County, Kenya. We",
    "entities": [
      {
        "text": "Kenya",
        "label": "GPE"
      },
      {
        "text": "Migori County",
        "label": "GPE"
      },
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "categorized women into three groups: adult mothers (first child \u226520 years),",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "teenage mothers to 1 child (had 1 child before age 20), and teenage mothers to",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "age 20",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2 + children (had 2 or more children before age 20). We then compared adult",
    "entities": [
      {
        "text": "2 +",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "age 20",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "socioeconomic and health outcomes of these groups. We found that among 6,089",
    "entities": [
      {
        "text": "6,089",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mothers, 45.2% had their first child during adolescence. Compared to adult",
    "entities": [
      {
        "text": "45.2%",
        "label": "PERCENT"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "mothers, teenage mothers were significantly less likely to complete primary",
    "entities": []
  },
  {
    "text": "education: a 12.2 percentage point (pp) reduction (95% CI: -14.9, -9.4) among",
    "entities": [
      {
        "text": "12.2",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "teenage mothers to 1 child and 27.6 pp reduction (95% CI: -31.4, -23.8) among",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "27.6",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "teenage mothers to 2 + children. Teenage mothers were also more likely to have",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "loans and experience food insecurity. The risk of experiencing the death of a",
    "entities": []
  },
  {
    "text": "child increased from 3.4% among adult mothers to 15.3% among teenage mothers to",
    "entities": [
      {
        "text": "3.4%",
        "label": "PERCENT"
      },
      {
        "text": "15.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "2 + children, a 4.5-fold increase (p < 0.001). Teenage mothers also reported",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "4.5-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "short birth spacing and poor mental health. Our study highlights that teenage",
    "entities": []
  },
  {
    "text": "motherhood is associated with worse health and economic functioning that",
    "entities": []
  },
  {
    "text": "persists into adulthood. Urgent policy action is needed to address teenage",
    "entities": []
  },
  {
    "text": "pregnancy in Kenya to support the economic development of youth and reduce the",
    "entities": [
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "risk of HIV infection.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Jakubowski et al. This is an open access article distributed",
    "entities": [
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "Jakubowski",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Editorial Note: The effect of counseling, antiretroviral therapy and",
    "entities": []
  },
  {
    "text": "relationship on disclosing HIV positive status to sexual partner among adult HIV",
    "entities": []
  },
  {
    "text": "patients in Ethiopia: A systematic review and meta-analysis.",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PLOS One Editors.",
    "entities": [
      {
        "text": "PLOS One Editors",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "Effectiveness of a national reflex laboratory cryptococcal antigen screening",
    "entities": []
  },
  {
    "text": "programme for people with advanced HIV disease in South Africa: a",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "nationwide-sampled cohort study (CAST-NET).",
    "entities": []
  },
  {
    "text": "AS(4), Mashau R(1), Sriruttan-Nel C(1), Skipper CP(5), Boulware DR(5),",
    "entities": [
      {
        "text": "Mashau R(1",
        "label": "DATE"
      },
      {
        "text": "Sriruttan-Nel",
        "label": "ORG"
      },
      {
        "text": "Skipper",
        "label": "GPE"
      },
      {
        "text": "Boulware",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)National Institute for Communicable Diseases, a Division of the National",
    "entities": [
      {
        "text": "Institute for Communicable Diseases",
        "label": "ORG"
      },
      {
        "text": "Division of the National\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Laboratory Service, 1 Modderfontein Road, Sandringham 2131, Johannesburg,",
    "entities": [
      {
        "text": "Health Laboratory Service",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2131",
        "label": "DATE"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Pathology, Faculty of Health Sciences, University of the",
    "entities": [
      {
        "text": "Pathology, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of the\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Witwatersrand, 7 York Road, Parktown 2193, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "Witwatersrand",
        "label": "GPE"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Medical Microbiology, Faculty of Health Sciences, University of",
    "entities": [
      {
        "text": "Medical Microbiology, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cape Town, Anzio Rd, Observatory 7935, Cape Town, South Africa; MRC Centre for",
    "entities": [
      {
        "text": "Anzio Rd",
        "label": "PERSON"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      },
      {
        "text": "MRC Centre",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Medical Mycology, University of Exeter, Stocker Road, Exeter EX4 4QD, United",
    "entities": [
      {
        "text": "Medical Mycology",
        "label": "ORG"
      },
      {
        "text": "University of Exeter",
        "label": "ORG"
      },
      {
        "text": "Stocker Road",
        "label": "ORG"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Division of Biostatistics and Health Science Data, School of Public Health,",
    "entities": [
      {
        "text": "Biostatistics and Health Science Data",
        "label": "ORG"
      },
      {
        "text": "School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Minnesota, Minneapolis, MN 55455, United States of America.",
    "entities": [
      {
        "text": "University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN 55455",
        "label": "ORG"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Infectious Diseases and International Medicine, Department of",
    "entities": [
      {
        "text": "International Medicine, Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, University of Minnesota, Minneapolis, MN 55455, United States of",
    "entities": [
      {
        "text": "Medicine, University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN 55455",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Cryptococcal antigen (CrAg) screening and pre-emptive treatment of",
    "entities": [
      {
        "text": "CrAg",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antigenaemia can reduce mortality among people living with HIV.",
    "entities": []
  },
  {
    "text": "SETTING: We evaluated the effectiveness of a national CrAg screening program in",
    "entities": [
      {
        "text": "CrAg",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We enrolled a retrospective cohort of adults aged \u226518 years with a CD4",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "count <100 cells/\u00b5L and antigenaemia at 442 facilities in a stratified-random",
    "entities": [
      {
        "text": "442",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sample of 27 sub-districts, 2017-2019. We determined a composite outcome of",
    "entities": [
      {
        "text": "27",
        "label": "CARDINAL"
      },
      {
        "text": "2017-2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "incident cryptococcal meningitis or death through 6-months.",
    "entities": [
      {
        "text": "6-months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: Overall, 99% (85,791/86,274) of eligible patients had CrAg testing in",
    "entities": [
      {
        "text": "99%",
        "label": "PERCENT"
      },
      {
        "text": "CrAg",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the study sub-districts; 5,124 (6.0%) tested CrAg-positive. Among 1,651 with",
    "entities": [
      {
        "text": "5,124",
        "label": "CARDINAL"
      },
      {
        "text": "6.0%",
        "label": "PERCENT"
      },
      {
        "text": "CrAg",
        "label": "PERSON"
      },
      {
        "text": "1,651",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "imaged medical records and without concurrent meningitis, 76% (1,261/1,651) were",
    "entities": [
      {
        "text": "76%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "outpatients. CrAg results were documented in records for 75% (1,245/1,651). Only",
    "entities": [
      {
        "text": "75%",
        "label": "PERCENT"
      },
      {
        "text": "1,245/1,651",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "39% (649/1,651) had a meningitis symptom review documented at a median of 14",
    "entities": [
      {
        "text": "39%",
        "label": "PERCENT"
      },
      {
        "text": "649/1,651",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days (IQR, 5-44) from their CrAg blood draw. Fluconazole was dispensed for 50%",
    "entities": [
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "5-44",
        "label": "DATE"
      },
      {
        "text": "CrAg",
        "label": "PERSON"
      },
      {
        "text": "Fluconazole",
        "label": "ORG"
      },
      {
        "text": "50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(827/1,651) but only 32% (523/1,651) had an adequate daily dose of \u2265800 mg",
    "entities": [
      {
        "text": "only 32%",
        "label": "PERCENT"
      },
      {
        "text": "523/1,651",
        "label": "CARDINAL"
      },
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "\u2265800",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "dispensed. The proportion with meningitis or death within 6-months was 23%",
    "entities": [
      {
        "text": "6-months",
        "label": "DATE"
      },
      {
        "text": "23%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(382/1,651; 95%CI, 19%-27%). Hospitalised patients had a 2.29 higher adjusted",
    "entities": [
      {
        "text": "382/1,651",
        "label": "CARDINAL"
      },
      {
        "text": "19%-27%",
        "label": "PERCENT"
      },
      {
        "text": "2.29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "odds of meningitis/death within 6-months versus outpatients (95% CI, 1.72-3.04;",
    "entities": [
      {
        "text": "6-months",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.72",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Nationwide reflex laboratory CrAg screening was successfully",
    "entities": [
      {
        "text": "CrAg",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "implemented. However, challenges existed for healthcare providers to act on",
    "entities": []
  },
  {
    "text": "positive CrAg results to exclude meningitis and dispense pre-emptive antifungal",
    "entities": [
      {
        "text": "CrAg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "therapy. Our findings emphasise the critical need for improved linkage from",
    "entities": []
  },
  {
    "text": "reflex CrAg screening to clinical care, in both ambulatory and in-patient",
    "entities": [
      {
        "text": "CrAg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "settings, to maintain the effectiveness of this intervention.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Wolters Kluwer Health, Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors report no conflicts of interest",
    "entities": []
  },
  {
    "text": "related to this work.",
    "entities": []
  },
  {
    "text": "37. South Med J. 2025 Jul;118(7):357-364. doi: 10.14423/SMJ.0000000000001852.",
    "entities": [
      {
        "text": "37",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.14423",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and",
    "entities": []
  },
  {
    "text": "Gender Minority Individuals in North Carolina.",
    "entities": [
      {
        "text": "Gender Minority Individuals",
        "label": "ORG"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Cunningham HE(1), Davis DA(2), Burns CM(1), Link K(1), LeGrand S, Kelley C(3),",
    "entities": [
      {
        "text": "Cunningham HE(1",
        "label": "PERSON"
      },
      {
        "text": "Davis DA(2",
        "label": "PERSON"
      },
      {
        "text": "Burns CM(1",
        "label": "PERSON"
      },
      {
        "text": "LeGrand S",
        "label": "PERSON"
      },
      {
        "text": "Kelley",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)From the Department of Infectious Diseases, Duke University Hospital.",
    "entities": [
      {
        "text": "the Department of Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Duke University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Implementation Science, Wake Forest University School of",
    "entities": [
      {
        "text": "Implementation Science, Wake Forest University School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Endocrinology, Duke University, Durham, North Carolina.",
    "entities": [
      {
        "text": "Duke University",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Sexual and gender minority (SGM) communities at increased risk of",
    "entities": []
  },
  {
    "text": "human immunodeficiency virus (HIV) may be underprescribed preexposure",
    "entities": []
  },
  {
    "text": "prophylaxis (PrEP), but PrEP research on SGM communities other than transgender",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "women and cisgender men who have sex with men is limited. We sought to better",
    "entities": []
  },
  {
    "text": "understand SGM individuals' vulnerability to HIV acquisition and awareness and",
    "entities": []
  },
  {
    "text": "perceptions of PrEP in North Carolina, with a focus on SGM groups less often",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "included in research.",
    "entities": []
  },
  {
    "text": "METHODS: We administered a 37-item online survey to adult SGM participants,",
    "entities": [
      {
        "text": "37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "examining differences in perceived and behavioral HIV risk based on",
    "entities": []
  },
  {
    "text": "self-reported behaviors. We also compared PrEP awareness, prescriptions, and",
    "entities": [
      {
        "text": "PrEP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "stigma between SGM identities and used logistic regression to examine",
    "entities": []
  },
  {
    "text": "associations between HIV risk and PrEP use.",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: In total, 372 participants completed the survey. Although 30.9%",
    "entities": [
      {
        "text": "372",
        "label": "CARDINAL"
      },
      {
        "text": "30.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "reported behaviors that increase the likelihood of HIV acquisition, only 9.5%",
    "entities": [
      {
        "text": "only 9.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "perceived their risk as elevated. Most (78.5%) were aware of PrEP, but only",
    "entities": [
      {
        "text": "78.5%",
        "label": "PERCENT"
      },
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "15.1% had been prescribed PrEP. PrEP stigma was most pervasive among cisgender",
    "entities": [
      {
        "text": "15.1%",
        "label": "PERCENT"
      },
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "women. Nonbinary and queer participants were more likely to have experienced",
    "entities": []
  },
  {
    "text": "mistreatment by a provider (20.3%, P < 0.0001; 19.2%, P < 0.01) and avoid care",
    "entities": [
      {
        "text": "20.3%",
        "label": "PERCENT"
      },
      {
        "text": "P < 0.0001",
        "label": "ORG"
      },
      {
        "text": "19.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "fearing mistreatment (31.9%, P < 0.001; 27.7%; P < 0.001) compared with the",
    "entities": [
      {
        "text": "31.9%",
        "label": "PERCENT"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      },
      {
        "text": "27.7%",
        "label": "PERCENT"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: PrEP is prescribed at low rates across many SGM communities, with",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "misperception of HIV risk, PrEP stigma, and mistreatment in health care",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identified as important barriers. Healthcare providers should take steps to",
    "entities": [
      {
        "text": "Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "create a safe environment for SGM patients and ask all patients about HIV risk",
    "entities": []
  },
  {
    "text": "factors and provide information about PrEP regardless of sexual orientation or",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40663120 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663120",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "38. Health Promot Int. 2025 Jul 1;40(4):daaf035. doi: 10.1093/heapro/daaf035.",
    "entities": [
      {
        "text": "38",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Peer-led public service announcement creation workshops for adolescent sexual",
    "entities": []
  },
  {
    "text": "and reproductive health education in Kenya.",
    "entities": [
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Medicine, University of California, San Francisco, 550 16th",
    "entities": [
      {
        "text": "Medicine, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "550 16th",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Street, Third Floor, San Francisco, CA 94158, USA.",
    "entities": [
      {
        "text": "Third Floor",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA 94158",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)University of California Global Programs, Kisumu, Kenya.",
    "entities": [
      {
        "text": "California Global Programs",
        "label": "ORG"
      },
      {
        "text": "Kisumu",
        "label": "GPE"
      },
      {
        "text": "Kenya",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Public service announcements (PSAs) are a type of media campaign aimed at",
    "entities": []
  },
  {
    "text": "creating awareness or influencing behavioral change among viewers. PSAs have",
    "entities": []
  },
  {
    "text": "been used to address a range of health issues aimed at varying populations and",
    "entities": []
  },
  {
    "text": "have frequently and successfully been used to target adolescents. Focus groups",
    "entities": []
  },
  {
    "text": "are conducted with adolescents to elicit ideas and topics, but the PSAs",
    "entities": []
  },
  {
    "text": "themselves are created by external media companies. In addition, few published",
    "entities": []
  },
  {
    "text": "studies describe the methods of their peer-led programming. The Maneno Yetu",
    "entities": [
      {
        "text": "Maneno Yetu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "study aimed to fill these gaps by providing descriptions of our PSA creation",
    "entities": []
  },
  {
    "text": "workshop process that was peer-driven from conception to completion. Nine PSAs",
    "entities": [
      {
        "text": "Nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were created focused on sexual and reproductive health (SRH) issues including",
    "entities": []
  },
  {
    "text": "family planning, substance abuse, peer pressure, HIV and sexually transmitted",
    "entities": []
  },
  {
    "text": "infections prevention, and sexual assault. The workshop participants enjoyed",
    "entities": []
  },
  {
    "text": "learning about storytelling and filmmaking and appreciated participating in a",
    "entities": []
  },
  {
    "text": "project that could have a beneficial impact on their peers. Our novel PSA",
    "entities": [
      {
        "text": "PSA\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "creation approach was peer-driven from ideation to production and centered on",
    "entities": []
  },
  {
    "text": "topics and messaging relevant to adolescents in the communities we were",
    "entities": []
  },
  {
    "text": "partnering with. Our approach provided a communication channel to convey",
    "entities": []
  },
  {
    "text": "important SRH information tailored to the needs of adolescents in the community.",
    "entities": []
  },
  {
    "text": "The PSAs were low-cost, making the approach accessible to adolescents outside of",
    "entities": []
  },
  {
    "text": "the framework of a study in resource-limited settings. Our peer-led PSA creation",
    "entities": []
  },
  {
    "text": "approach can be applied toward other public health interventions to generate",
    "entities": []
  },
  {
    "text": "messaging that resonates with adolescents.",
    "entities": []
  },
  {
    "text": "PMID: 40663016 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "39. AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004299. Online ahead of print.",
    "entities": [
      {
        "text": "39",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Evolving data on heart failure reshape prevention and treatment strategies for",
    "entities": []
  },
  {
    "text": "people with HIV.",
    "entities": []
  },
  {
    "text": "(1)Clinical affiliations: None.",
    "entities": []
  },
  {
    "text": "40. AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004298. Online ahead of print.",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Risk factors of incident physical frailty in middle-aged and older people with",
    "entities": []
  },
  {
    "text": "and without HIV: evidence from the CHART cohort.",
    "entities": [
      {
        "text": "CHART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Epidemiology, School of Public Health, and Key Laboratory of",
    "entities": [
      {
        "text": "Epidemiology, School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health Safety of Ministry of Education, Fudan University, Shanghai,",
    "entities": [
      {
        "text": "Public Health Safety of Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Public Health, Key Laboratory of Tropical Translational Medicine of",
    "entities": []
  },
  {
    "text": "Ministry of Education, Hainan Medical University, Haikou 571199, Hainan",
    "entities": [
      {
        "text": "Ministry of Education",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical University",
        "label": "ORG"
      },
      {
        "text": "Hainan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, China.",
    "entities": [
      {
        "text": "Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Taizhou City Center for Disease Control and Prevention, Zhejiang Province,",
    "entities": [
      {
        "text": "3)Taizhou City Center for Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University,",
    "entities": [
      {
        "text": "4)Shanghai Institute of Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Yi-Wu Research Institute, Fudan University, Shanghai, China.",
    "entities": [
      {
        "text": "5)Yi-Wu Research Institute",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to identify risk factors for physical frailty",
    "entities": []
  },
  {
    "text": "incidence among people with HIV (PWH) and HIV-negative individuals and further",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "explore the dynamic relationship between major chronic diseases and frailty.",
    "entities": []
  },
  {
    "text": "METHODS: PWH and HIV-negative individuals aged \u226540 years from the Comparative",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "HIV and Aging Research in Taizhou (CHART) cohort were included. Univariate and",
    "entities": [
      {
        "text": "Aging Research",
        "label": "ORG"
      },
      {
        "text": "Taizhou",
        "label": "GPE"
      },
      {
        "text": "CHART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multivariate Cox regression models were used to estimate the hazard ratio (HR)",
    "entities": []
  },
  {
    "text": "and 95% confidence interval (CI) of the association between risk factors and",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "physical frailty.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 3,968 participants (1,279 cases and 2,689 controls) were",
    "entities": [
      {
        "text": "3,968",
        "label": "CARDINAL"
      },
      {
        "text": "1,279",
        "label": "CARDINAL"
      },
      {
        "text": "2,689",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included. Regardless of HIV status, the overall trend of physical frailty",
    "entities": []
  },
  {
    "text": "incidence density increased with age, and aging significantly elevated the risk",
    "entities": []
  },
  {
    "text": "of frailty. Central obesity (aHR=2.15, 95% CI: 1.09-4.23), hypertension",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(aHR=2.06, 95% CI: 1.03-4.11) and current unsuppressed HIV viral load (aHR=2.20,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.03-4.11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI: 1.01-4.80) increased the risk of frailty incident among PWH, while",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression (aHR=1.93, 95% CI: 1.06-3.50) and diabetes (aHR=1.85, 95% CI:",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "1.06-3.50",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.18-2.90) increased the risk of frailty among HIV-negative controls. Dynamic",
    "entities": [
      {
        "text": "1.18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Change analyses showed that incident depression, incident neurocognitive",
    "entities": []
  },
  {
    "text": "impairment, and persistent hypertension during a 3.18-year follow-up were",
    "entities": [
      {
        "text": "3.18-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "associated with a higher risk of frailty among PWH. In contrast, incident",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression, persistent depression, and persistent diabetes were significantly",
    "entities": []
  },
  {
    "text": "associated with frailty incidence among HIV-negative controls.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Aging was significantly associated with a higher risk of physical",
    "entities": []
  },
  {
    "text": "frailty regardless of HIV status. Risk factors and the association between",
    "entities": []
  },
  {
    "text": "dynamic changes in major chronic diseases and frailty were different between",
    "entities": []
  },
  {
    "text": "HIV-positive and HIV-negative individuals.",
    "entities": []
  },
  {
    "text": "41. J Virol. 2025 Jul 15:e0056425. doi: 10.1128/jvi.00564-25. Online ahead of",
    "entities": [
      {
        "text": "41",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1128",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A novel aptamer-based dNTP assay reveals that intact HIV virions are highly",
    "entities": []
  },
  {
    "text": "stable and do not contain enough dNTPs to support DNA synthesis.",
    "entities": []
  },
  {
    "text": "(1)Cell Biology and Molecular Genetics, Bioscience Research Building, University",
    "entities": [
      {
        "text": "1)Cell",
        "label": "CARDINAL"
      },
      {
        "text": "Bioscience Research Building",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Maryland, College Park, Maryland, USA.",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "College Park",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "HIV virions contain high concentrations of IP6 (inositol hexakisphosphate),",
    "entities": []
  },
  {
    "text": "which stabilize capsids by binding to pores that allow dNTP to import into",
    "entities": []
  },
  {
    "text": "capsids during infection. The concentration of dNTPs in virions, however, is not",
    "entities": []
  },
  {
    "text": "known. The low cellular concentrations (~5 \u00b5M each) predict only ~1 copy of each",
    "entities": []
  },
  {
    "text": "dNTP in a virion, unless a mechanism for concentrating exists, as it does for",
    "entities": []
  },
  {
    "text": "IP6. Reports indicating significant DNA synthesis occurring in virions would",
    "entities": []
  },
  {
    "text": "require larger amounts of packaged dNTPs or import of dNTPs. We developed a",
    "entities": []
  },
  {
    "text": "novel aptamer-based assay capable of detecting 1 femtomole of dNTP, enabling",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dNTP measurements in virions. Virions from HEK 293T cells contained dNTPs with",
    "entities": [
      {
        "text": "dNTP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "dTTP >dCTP \u2248 dATP >dGTP. This order was also observed in uninfected cells.",
    "entities": []
  },
  {
    "text": "Concentrations of dNTPs in virions were 2-fold to 4-fold lower than in cells,",
    "entities": [
      {
        "text": "2-fold",
        "label": "CARDINAL"
      },
      {
        "text": "4-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "although it was unclear if this resulted from uncertainties associated with",
    "entities": []
  },
  {
    "text": "estimating virion and cell volumes or real differences. Virions were highly",
    "entities": []
  },
  {
    "text": "stable and did not \"leak\" dNTPs as associated dNTPs were not released, even",
    "entities": []
  },
  {
    "text": "after incubation at 60\u00b0C for 90 min or several freeze-thaw cycles, a result that",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "implies diffusion-mediated import of dNTPs into virions is also unlikely.",
    "entities": []
  },
  {
    "text": "Overall, results show that dNTPs in intact virions are at or below",
    "entities": []
  },
  {
    "text": "concentrations in cells, and even the most abundant dNTP (dTTP) is present at ~1",
    "entities": []
  },
  {
    "text": "copy per virion. This precludes significant DNA synthesis in intact virions,",
    "entities": []
  },
  {
    "text": "although it is important to note that our assays may not represent all virion",
    "entities": []
  },
  {
    "text": "states. The results support a mechanism where dNTPs are passively captured",
    "entities": []
  },
  {
    "text": "IMPORTANCE: HIV virions presumably package small molecules (e.g., amino acids,",
    "entities": []
  },
  {
    "text": "cations, and nucleotides) passively during budding. Therefore, they would be",
    "entities": []
  },
  {
    "text": "present in virions at cellular levels, unless there is a mechanism for",
    "entities": []
  },
  {
    "text": "concentration or exclusion of the molecule (e.g., inositol hexakisphosphate",
    "entities": []
  },
  {
    "text": "[IP6], which stabilizes the viral capsid, is present at several-fold greater",
    "entities": [
      {
        "text": "several-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "concentration in the virion compared with cells). Reports of DNA synthesis",
    "entities": []
  },
  {
    "text": "occurring in HIV virions suggest that HIV may also package dNTPs at levels much",
    "entities": []
  },
  {
    "text": "higher than predicted by their cellular concentrations, or virions are permeable",
    "entities": []
  },
  {
    "text": "to dNTPs. However, we show here that virion dNTP levels are at or below cellular",
    "entities": []
  },
  {
    "text": "levels with 1 or fewer molecules of each dNTP in an average virion. Furthermore,",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "virions did not leak dNTPs when exposed to elevated temperatures or",
    "entities": []
  },
  {
    "text": "freeze-thawing, suggesting that they were not permeable. The results suggest",
    "entities": []
  },
  {
    "text": "that virions demonstrating significant DNA synthesis may be structurally altered",
    "entities": []
  },
  {
    "text": "relative to those measured here.",
    "entities": []
  },
  {
    "text": "42. J Infect Dis. 2025 Jul 15:jiaf362. doi: 10.1093/infdis/jiaf362. Online ahead",
    "entities": [
      {
        "text": "42",
        "label": "CARDINAL"
      },
      {
        "text": "Infect Dis",
        "label": "LOC"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Fetal Defects in Mice Treated with Integrase Strand Transfer Inhibitors:",
    "entities": [
      {
        "text": "Fetal Defects",
        "label": "ORG"
      },
      {
        "text": "Mice Treated",
        "label": "ORG"
      },
      {
        "text": "Integrase Strand Transfer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Comparison of Dolutegravir, Raltegravir, Bictegravir and Cabotegravir.",
    "entities": [
      {
        "text": "Comparison of Dolutegravir",
        "label": "ORG"
      },
      {
        "text": "Raltegravir",
        "label": "GPE"
      },
      {
        "text": "Bictegravir",
        "label": "LOC"
      },
      {
        "text": "Cabotegravir",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Jao J(2), Sled JG(3)(4)(5), Greene NDE(6), Copp AJ(6), Serghides L(1)(7).",
    "entities": [
      {
        "text": "Sled JG(3)(4)(5",
        "label": "PERSON"
      },
      {
        "text": "Greene NDE(6",
        "label": "PERSON"
      },
      {
        "text": "Copp",
        "label": "PERSON"
      },
      {
        "text": "Serghides L(1)(7",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Toronto General Hospital Research Institute, University Health Network,",
    "entities": [
      {
        "text": "General Hospital Research Institute",
        "label": "ORG"
      },
      {
        "text": "University Health Network",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics, Department of Medicine, Northwestern University",
    "entities": [
      {
        "text": "Pediatrics, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Northwestern University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Feinberg School of Medicine, Chicago, IL, USA.",
    "entities": [
      {
        "text": "Feinberg School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Developmental Biology & Cancer Department, UCL Great Ormond Street Institute",
    "entities": [
      {
        "text": "3)Developmental Biology & Cancer Department",
        "label": "ORG"
      },
      {
        "text": "UCL Great Ormond Street Institute",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "of Child Health, University College London, London, UK.",
    "entities": [
      {
        "text": "Child Health",
        "label": "ORG"
      },
      {
        "text": "University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Mouse Imaging Center, The Hospital for Sick Children, Toronto, Ontario,",
    "entities": [
      {
        "text": "4)Mouse Imaging Center",
        "label": "ORG"
      },
      {
        "text": "The Hospital for Sick Children",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical Biophysics, University of Toronto, Toronto, Ontario,",
    "entities": [
      {
        "text": "Medical Biophysics, University of Toronto",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Translational Medicine, The Hospital for Sick Children, Toronto, Ontario,",
    "entities": [
      {
        "text": "The Hospital for Sick Children",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Immunology and Institute of Medical Sciences, University of",
    "entities": [
      {
        "text": "Immunology and Institute of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are preferred for",
    "entities": []
  },
  {
    "text": "treatment of HIV. However, safety data in pregnancy are limited for newer",
    "entities": []
  },
  {
    "text": "INSTIs.",
    "entities": []
  },
  {
    "text": "METHODS: Pregnant C57BL/6 mice were randomly allocated to control (water),",
    "entities": []
  },
  {
    "text": "doses, administered orally with tenofovir disoproxil fumarate and emtricitabine,",
    "entities": []
  },
  {
    "text": "once daily from gestational day (GD) 0.5 to sacrifice (GD15.5). Fetuses were",
    "entities": [
      {
        "text": "GD",
        "label": "ORG"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "assessed for gross anomalies. Descriptive statistics were used to compare",
    "entities": []
  },
  {
    "text": "proportions of gross anomalies.",
    "entities": []
  },
  {
    "text": "bictegravir, 93 cabotegravir) were assessed. Raltegravir was associated with the",
    "entities": [
      {
        "text": "93 cabotegravir",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "highest fetal weight, placental weight, and fetal weight/placenta weight ratio",
    "entities": []
  },
  {
    "text": "(placental efficiency). Fetal weight, placental efficiency, and litter size,",
    "entities": []
  },
  {
    "text": "were lowest in bictegravir and cabotegravir. Neural tube defects were only",
    "entities": []
  },
  {
    "text": "observed in INSTI groups with litter prevalence rates of 0.66% in raltegravir,",
    "entities": [
      {
        "text": "0.66%",
        "label": "PERCENT"
      },
      {
        "text": "raltegravir",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "control. Tail defects, eye defects, bleeding defects, cranial swelling, and",
    "entities": [
      {
        "text": "Tail",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "growth restriction were significantly more common in all INSTI groups versus",
    "entities": []
  },
  {
    "text": "control. Overall rates of defects were lowest in dolutegravir. Compared to",
    "entities": []
  },
  {
    "text": "dolutegravir, limb and tail defects (indicative of spinal dysraphism) were",
    "entities": []
  },
  {
    "text": "significantly more prevalent in the raltegravir group, while bleeding defects",
    "entities": [
      {
        "text": "the raltegravir group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were significantly more prevalent in the bictegravir and cabotegravir groups.",
    "entities": []
  },
  {
    "text": "INTERPRETATION: While INSTIs represent a critical advance in the management of",
    "entities": []
  },
  {
    "text": "HIV infection, the findings of this study demonstrate a link between INSTI",
    "entities": [
      {
        "text": "INSTI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therapy and adverse fetal outcomes. This highlights the need for continued",
    "entities": []
  },
  {
    "text": "surveillance of pregnancy outcomes in women exposed to INSTIs.",
    "entities": []
  },
  {
    "text": "43. HIV Med. 2025 Jul 15. doi: 10.1111/hiv.70074. Online ahead of print.",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Impact of three different interventions designed to improve the implementation",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of an opt-in targeted strategy of HIV testing in emergency departments.",
    "entities": []
  },
  {
    "text": "R(11), Caba\u00f1as J(12), Manzanares J\u00c1(13), Mir\u00f3 \u00d2(14); Emergency HIV Network",
    "entities": [
      {
        "text": "Caba\u00f1as J(12",
        "label": "PERSON"
      },
      {
        "text": "Mir\u00f3",
        "label": "GPE"
      },
      {
        "text": "Emergency HIV Network",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Investigators.",
    "entities": []
  },
  {
    "text": "(1)Emergency Department, IdISSC, Universidad Complutense, Madrid, Spain.",
    "entities": [
      {
        "text": "Department",
        "label": "GPE"
      },
      {
        "text": "IdISSC",
        "label": "GPE"
      },
      {
        "text": "Universidad Complutense",
        "label": "GPE"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Emergency Department, Hospital Universitario Dr. Negr\u00edn, Gran Canaria, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario Dr.",
        "label": "ORG"
      },
      {
        "text": "Negr\u00edn",
        "label": "PERSON"
      },
      {
        "text": "Gran Canaria",
        "label": "PERSON"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Emergency Department, Hospital Universitario de Galdakao, Bilbao, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario de Galdakao",
        "label": "ORG"
      },
      {
        "text": "Bilbao",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Emergency Department, Hospital Universitario de Navarra, Pamplona, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario de Navarra",
        "label": "ORG"
      },
      {
        "text": "Pamplona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Emergency Department, Hospital Universitario San Cecilio, Granada, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario San Cecilio",
        "label": "ORG"
      },
      {
        "text": "Granada",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IDISCAM, Toledo, Spain.",
    "entities": [
      {
        "text": "Toledo",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Emergency Department, Hospital Universitario Rio Hortega, Valladolid, Spain.",
    "entities": [
      {
        "text": "13)Emergency Department",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario",
        "label": "FAC"
      },
      {
        "text": "Rio Hortega",
        "label": "GPE"
      },
      {
        "text": "Valladolid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Barcelona, Spain.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Undiagnosed HIV infection remains the main driver of new HIV cases",
    "entities": []
  },
  {
    "text": "in Western countries. Emergency Departments (EDs) offer a key opportunity for",
    "entities": []
  },
  {
    "text": "detection. In 2020, Spanish emergency and infectious diseases societies",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "recommended an opt-in strategy for targeted conditions for HIV testing in EDs.",
    "entities": []
  },
  {
    "text": "This study evaluates the efficacy of three strategies for targeted HIV testing.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: Twelve Spanish EDs, selected based on predefined structural criteria,",
    "entities": [
      {
        "text": "Twelve",
        "label": "CARDINAL"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "assessed HIV testing from April to June 2024. Hospitals applied: no strategy",
    "entities": [
      {
        "text": "April to June 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(control, three EDs), an educational programme (strategy A, three EDs), strategy",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A plus preconfigured electronic orders (strategy B, three EDs) or strategy B",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "plus electronic alerts in medical records (strategy C, three EDs). The impact on",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HIV testing was measured overall and by targeted condition, using absolute",
    "entities": []
  },
  {
    "text": "differences with 95% confidence intervals (CIs).",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: Of the 612 909 ED visits, 210 039 occurred in control hospitals (1232",
    "entities": [
      {
        "text": "612 909",
        "label": "CARDINAL"
      },
      {
        "text": "210",
        "label": "CARDINAL"
      },
      {
        "text": "1232",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients [0.59%] had targeted conditions), 172 806 in hospitals applying",
    "entities": [
      {
        "text": "0.59%",
        "label": "PERCENT"
      },
      {
        "text": "172 806",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strategy A (1497 [0.87%]), 132 835 in strategy B hospitals (1761 [1.33%]) and",
    "entities": [
      {
        "text": "1497",
        "label": "DATE"
      },
      {
        "text": "0.87%",
        "label": "PERCENT"
      },
      {
        "text": "132 835",
        "label": "CARDINAL"
      },
      {
        "text": "1761",
        "label": "DATE"
      },
      {
        "text": "1.33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "97 229 in hospitals applying strategy C (1269 [1.31%]). Testing rates were",
    "entities": [
      {
        "text": "97 229",
        "label": "CARDINAL"
      },
      {
        "text": "1269",
        "label": "CARDINAL"
      },
      {
        "text": "1.31%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "0.16%, 0.38%, 1.17% and 2.16% in the control, and strategy A, B and C EDs.,",
    "entities": [
      {
        "text": "0.16%",
        "label": "PERCENT"
      },
      {
        "text": "0.38%",
        "label": "PERCENT"
      },
      {
        "text": "1.17%",
        "label": "PERCENT"
      },
      {
        "text": "2.16%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "respectively. Among patients with targeted conditions, testing reached 13.1%,",
    "entities": [
      {
        "text": "13.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "22.9%, 30.7% and 78.1%. Compared to no strategy, testing increased by 0.22% (95%",
    "entities": [
      {
        "text": "22.9%",
        "label": "PERCENT"
      },
      {
        "text": "30.7%",
        "label": "PERCENT"
      },
      {
        "text": "78.1%",
        "label": "PERCENT"
      },
      {
        "text": "0.22%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 0.18-0.25) with strategy A, 0.79% (95% CI = 0.73-0.86) with B, and 0.98%",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.18-0.25",
        "label": "CARDINAL"
      },
      {
        "text": "0.79%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.73",
        "label": "CARDINAL"
      },
      {
        "text": "0.98%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(95% CI = 0.88-1.09) with C. In targeted conditions, testing rose by 9.8%, 7.8%",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.88-1.09",
        "label": "CARDINAL"
      },
      {
        "text": "C.",
        "label": "NORP"
      },
      {
        "text": "9.8%",
        "label": "PERCENT"
      },
      {
        "text": "7.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and 47.5% for strategies A, B and C, respectively. All strategies improved",
    "entities": [
      {
        "text": "47.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "testing in sexually transmitted infections (STI), meningitis/neurological",
    "entities": [
      {
        "text": "STI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "syndromes and community-acquired pneumonia (CAP); strategy C also increased",
    "entities": [
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "testing in herpes zoster (HZ) and post-exposure prophylaxis.",
    "entities": []
  },
  {
    "text": "CONCLUSION: All the strategies evaluated enhanced targeted HIV testing,",
    "entities": []
  },
  {
    "text": "especially strategy C (electronic alerts), which was associated with the highest",
    "entities": []
  },
  {
    "text": "testing rates observed, particularly in STI, CAP and HZ.",
    "entities": [
      {
        "text": "STI",
        "label": "ORG"
      },
      {
        "text": "CAP",
        "label": "ORG"
      },
      {
        "text": "HZ",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "\u00a9 2025 British HIV Association.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "British HIV Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "44. Sex Transm Dis. 2025 Jul 15. doi: 10.1097/OLQ.0000000000002222. Online ahead",
    "entities": [
      {
        "text": "44",
        "label": "CARDINAL"
      },
      {
        "text": "Sex Transm Dis",
        "label": "PERSON"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097/OLQ.0000000000002222",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Visit types and linkage to HIV prevention among individuals seeking mpox",
    "entities": []
  },
  {
    "text": "vaccination in an urban specialized sexual health clinic.",
    "entities": []
  },
  {
    "text": "Shah P, Germain C(1), Ard KL, Parker RA, Bassett IV, Jarolimova J.",
    "entities": [
      {
        "text": "Shah P, Germain C(1",
        "label": "ORG"
      },
      {
        "text": "Parker RA",
        "label": "PERSON"
      },
      {
        "text": "Bassett IV",
        "label": "GPE"
      },
      {
        "text": "Jarolimova J.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Division of Infectious Disease, Massachusetts General Hospital, Boston, MA.",
    "entities": [
      {
        "text": "Massachusetts General Hospital",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Individuals attending mpox vaccine-only visits at an STI clinic were more likely",
    "entities": [
      {
        "text": "STI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to be new patients with high socioeconomic status and identify as White than",
    "entities": []
  },
  {
    "text": "those vaccinated during non-mpox related visits. A small number received HIV",
    "entities": []
  },
  {
    "text": "PrEP or testing following vaccination; this may represent a missed opportunity",
    "entities": []
  },
  {
    "text": "for HIV prevention.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 American Sexually Transmitted Diseases Association. All rights",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "American",
        "label": "NORP"
      },
      {
        "text": "Sexually Transmitted Diseases Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of interest: JJ has received in-kind",
    "entities": []
  },
  {
    "text": "research support from binx health. All other authors declare no disclosures.",
    "entities": []
  },
  {
    "text": "Toxoplasma gondii Coinfection in HIV-Positive Patients at a Tertiary Care",
    "entities": [
      {
        "text": "Toxoplasma gondii Coinfection in HIV-Positive Patients",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Medical Microbiology, Ministry of Health, Ankara Etlik City",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "Ministry of Health",
        "label": "ORG"
      },
      {
        "text": "Ankara Etlik City",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Biochemistry, Ministry of Health, Ankara Etlik City",
    "entities": [
      {
        "text": "Medical Biochemistry, Ministry of Health",
        "label": "ORG"
      },
      {
        "text": "Ankara Etlik City",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Microbiology, At\u0131l\u0131m University Faculty of Medicine,",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "At\u0131l\u0131m University Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Toxoplasma gondii (T. gondii) can cause serious complications in",
    "entities": [
      {
        "text": "T.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "both immunocompetent and immunosuppressed individuals. This study aims to assess",
    "entities": []
  },
  {
    "text": "the seroprevalence of T. gondii among HIV-positive individuals and to",
    "entities": [
      {
        "text": "T.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "investigate its association with age, sex, CD4+ T cell count, HIV RNA levels,",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and hematological parameters.",
    "entities": []
  },
  {
    "text": "METHODS: This study included 247 HIV-positive individuals followed up at a",
    "entities": [
      {
        "text": "247",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "tertiary care hospital between November 1, 2022, and November 30, 2024. We",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      },
      {
        "text": "between November 1, 2022",
        "label": "DATE"
      },
      {
        "text": "November 30, 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "analyzed serum samples for T. gondii IgG antibodies using",
    "entities": [
      {
        "text": "T.",
        "label": "NORP"
      },
      {
        "text": "IgG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The prevalence of T. gondii IgG seropositivity was found to be 32.8%",
    "entities": [
      {
        "text": "T. gondii",
        "label": "ORG"
      },
      {
        "text": "IgG",
        "label": "ORG"
      },
      {
        "text": "32.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(n=81; 95% CI: 26.9-39). The median age of seropositive individuals was 52 years",
    "entities": [
      {
        "text": "n=81",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "26.9-39",
        "label": "CARDINAL"
      },
      {
        "text": "52 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(IQR: 42-61), which was significantly higher compared to seronegative",
    "entities": [
      {
        "text": "42-61",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individuals (p<0.001). The highest IgG seropositivity rate (66.7%) was observed",
    "entities": [
      {
        "text": "IgG",
        "label": "ORG"
      },
      {
        "text": "66.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "in the 61-80 age group. Hemoglobin levels were significantly lower in IgG",
    "entities": [
      {
        "text": "61-80",
        "label": "DATE"
      },
      {
        "text": "Hemoglobin",
        "label": "PERSON"
      },
      {
        "text": "IgG",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "seropositive individuals (p=0.040). Logistic regression analysis indicated an",
    "entities": []
  },
  {
    "text": "increased risk of T. gondii infection with advancing age. The odds ratio for the",
    "entities": [
      {
        "text": "T.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "41-60 age group was 13.3 (95% CI: 1.6-106, p=0.02), while for the 61-80 age",
    "entities": [
      {
        "text": "41",
        "label": "CARDINAL"
      },
      {
        "text": "13.3",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.6-106",
        "label": "CARDINAL"
      },
      {
        "text": "61-80",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "group, it was 28 (95% CI: 3.3-240, p=0.002).",
    "entities": [
      {
        "text": "28",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DISCUSSION: The seroprevalence of T. gondii in HIV-positive individuals was",
    "entities": [
      {
        "text": "T.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "lower than both global and regional averages. Age was identified as an",
    "entities": []
  },
  {
    "text": "independent risk factor for T. gondii seropositivity. Additionally,",
    "entities": [
      {
        "text": "T.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hematological alterations associated with anemia were observed in seropositive",
    "entities": []
  },
  {
    "text": "individuals. Further large-scale, multi-center, and regionally representative",
    "entities": []
  },
  {
    "text": "studies are required to optimize T. gondii infection management and screening",
    "entities": [
      {
        "text": "T. gondii",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "strategies in people living with HIV.",
    "entities": []
  },
  {
    "text": "CONCLUSION: These findings suggest that T. gondii infection in HIV-positive",
    "entities": [
      {
        "text": "T.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "individuals increases with age and may be associated with anemia, highlighting",
    "entities": []
  },
  {
    "text": "the need for age-focused screening and management strategies.",
    "entities": []
  },
  {
    "text": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at",
    "entities": [
      {
        "text": "Bentham Science Publishers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "46. Clin Infect Dis. 2025 Jul 15:ciaf368. doi: 10.1093/cid/ciaf368. Online ahead",
    "entities": [
      {
        "text": "46",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Infect Dis",
        "label": "PERSON"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Potential impact of frequent testing for hepatitis C virus among people who",
    "entities": []
  },
  {
    "text": "inject drugs toward hepatitis C elimination in the United States.",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Zhu L(1), Furukawa NW(2), Thompson WW(2), Reitsma MB(1), Randall LM(3), Asher",
    "entities": [
      {
        "text": "Zhu L(1",
        "label": "PERSON"
      },
      {
        "text": "Furukawa NW(2",
        "label": "ORG"
      },
      {
        "text": "Thompson",
        "label": "PERSON"
      },
      {
        "text": "Reitsma MB(1",
        "label": "PERSON"
      },
      {
        "text": "Randall LM(3",
        "label": "PERSON"
      },
      {
        "text": "Asher",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Health Policy, School of Medicine, Stanford University,",
    "entities": [
      {
        "text": "Health Policy, School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Stanford, CA, USA.",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for",
    "entities": [
      {
        "text": "Viral Hepatitis",
        "label": "ORG"
      },
      {
        "text": "STD",
        "label": "ORG"
      },
      {
        "text": "TB Prevention, Centers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention, Atlanta, GA, USA.",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Bureau of Infectious Disease and Laboratory Sciences, Massachusetts",
    "entities": [
      {
        "text": "3)Bureau",
        "label": "CARDINAL"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Department of Public Health, Boston, MA, USA.",
    "entities": [
      {
        "text": "Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Section of Infectious Disease, Department of Medicine, Boston Medical Center,",
    "entities": [
      {
        "text": "Infectious Disease, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Boston Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, MA, USA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Epidemiology, Boston University School of Public Health,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Boston University School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Current hepatitis C virus (HCV) guidelines recommend testing at",
    "entities": []
  },
  {
    "text": "least once in a lifetime for all adults and periodic testing for people with",
    "entities": []
  },
  {
    "text": "ongoing risk factors. However, the testing frequency required for these",
    "entities": []
  },
  {
    "text": "populations including people who inject drugs (PWID) remains unknown.",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We developed a dynamic network model to simulate HCV transmission among",
    "entities": []
  },
  {
    "text": "PWID via sharing of injection equipment. We simulated different testing",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "frequencies among PWID, paired with a treatment cascade of direct-acting",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antiviral therapy, and compared their impact on HCV infection prevalence,",
    "entities": []
  },
  {
    "text": "incidence, and HCV-related deaths over 10 years. We conducted sensitivity",
    "entities": [
      {
        "text": "10 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "analyses on key parameters and assumptions.",
    "entities": []
  },
  {
    "text": "RESULTS: In the main analysis, testing on average once per six months reduced",
    "entities": [
      {
        "text": "six months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "HCV infection prevalence, incidence, and HCV-related deaths by up to 45%, 37%,",
    "entities": [
      {
        "text": "up to 45%",
        "label": "PERCENT"
      },
      {
        "text": "37%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and 42%, respectively. In the sensitivity analyses, increased coverage (access",
    "entities": [
      {
        "text": "42%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and utilization) had the greatest impact on all three outcomes, and reinfection",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "risk after cure had a substantial impact on incidence. Lower transmission risk,",
    "entities": []
  },
  {
    "text": "higher cessation rate of injection, and longer partnership duration decreased",
    "entities": []
  },
  {
    "text": "the three outcomes with or without HCV testing.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Frequent HCV testing with treatment had a substantial impact on",
    "entities": []
  },
  {
    "text": "hepatitis C elimination outcomes. However, it alone in the context of current",
    "entities": []
  },
  {
    "text": "continuum of care among PWID is unlikely to be sufficient to achieving",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elimination. Improving access to and utilization of hepatitis C care and",
    "entities": []
  },
  {
    "text": "harm-reduction services among PWID are crucial to achieving elimination.",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul 15.",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Pathogenic SIV infection is associated with acceleration of epigenetic age in",
    "entities": []
  },
  {
    "text": "Gordevicius J(3), Mil\u010di\u016bt\u0117 M(3), Brooke RT(3), Sette P(1)(2), He T(2),",
    "entities": [
      {
        "text": "Gordevicius",
        "label": "ORG"
      },
      {
        "text": "Mil\u010di\u016bt\u0117 M(3",
        "label": "PERSON"
      },
      {
        "text": "Brooke RT(3",
        "label": "PERSON"
      },
      {
        "text": "Sette P(1)(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Brocca-Cofano E(1), Policicchio BB(4), Nayak K(2), Talwar S(2), Annapureddy",
    "entities": [
      {
        "text": "Brocca-Cofano E(1",
        "label": "PERSON"
      },
      {
        "text": "Policicchio BB(4",
        "label": "ORG"
      },
      {
        "text": "Nayak",
        "label": "PERSON"
      },
      {
        "text": "Talwar S(2",
        "label": "PERSON"
      },
      {
        "text": "Annapureddy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Division of Infectious Diseases, Department of Medicine and.",
    "entities": [
      {
        "text": "Department of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pathology, School of Medicine, University of Pittsburgh,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Pathology, School of Medicine, University of Pittsburgh",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Epigenetic Clock Development Foundation, Torrance, California, USA.",
    "entities": [
      {
        "text": "Clock Development Foundation",
        "label": "ORG"
      },
      {
        "text": "Torrance",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Infectious Diseases and Microbiology, Graduate School of Public",
    "entities": [
      {
        "text": "Infectious Diseases and Microbiology",
        "label": "ORG"
      },
      {
        "text": "Graduate School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.",
    "entities": [
      {
        "text": "Health, University of Pittsburgh",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "HIV infection accelerates biological aging, but the contribution of the host's",
    "entities": []
  },
  {
    "text": "age to this process is unknown. We investigated the influence of SIV infection",
    "entities": [
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in macaques (SIVmac) on the risk of comorbidities and aging in young and old",
    "entities": [
      {
        "text": "SIVmac",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rhesus macaques (RMs) by assessing pathogenesis markers, DNA methylation-based",
    "entities": []
  },
  {
    "text": "epigenetic age (EA), and EA acceleration (EAA) in blood and tissues. Initially,",
    "entities": [
      {
        "text": "EA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "upon SIV infection, the young RMs showed greater resilience to CD4+ T cell",
    "entities": []
  },
  {
    "text": "depletion, better control of T cell activation, hypercoagulation, and excessive",
    "entities": []
  },
  {
    "text": "inflammation, yet this resilience was progressively lost in the advanced stages",
    "entities": []
  },
  {
    "text": "of infection. During the late stages of infection, the young RMs, but not the",
    "entities": []
  },
  {
    "text": "aged ones, showed an increase in EA in PBMCs; also, EAA in the cerebellum and",
    "entities": [
      {
        "text": "EA",
        "label": "GPE"
      },
      {
        "text": "EAA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "heart of young RMs was higher compared with old RMs. SIV infection was more",
    "entities": []
  },
  {
    "text": "pathogenic in aged animals in early stages, leading to a more rapid disease",
    "entities": []
  },
  {
    "text": "progression; however, accelerated aging mostly affected young animals, so that",
    "entities": []
  },
  {
    "text": "the levels of multiple key pathogenesis markers in the young RMs converged",
    "entities": []
  },
  {
    "text": "toward those specific to aged ones in the late stages of infection. We conclude",
    "entities": []
  },
  {
    "text": "that SIV infection-driven age acceleration is tissue specific, and that host age",
    "entities": [
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "influences the susceptibility of different tissues to enhanced aging.",
    "entities": []
  },
  {
    "text": "PMID: 40662355 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662355",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "48. Virus Evol. 2025 May 20;11(1):veaf048. doi: 10.1093/ve/veaf048. eCollection",
    "entities": [
      {
        "text": "48",
        "label": "CARDINAL"
      },
      {
        "text": "Virus Evol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Evidence for circulation of high-virulence HIV-1 subtype B variants in the",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "United Kingdom.",
    "entities": [
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)MRC Centre for Global Infectious Disease Analysis, Department of Infectious",
    "entities": [
      {
        "text": "Centre for Global Infectious Disease Analysis",
        "label": "ORG"
      },
      {
        "text": "Department of Infectious\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Epidemiology, School of Public Health, Imperial College London, 90 Wood",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Imperial College London",
        "label": "ORG"
      },
      {
        "text": "90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Lane, London W12 0BZ, United Kingdom.",
    "entities": [
      {
        "text": "Lane",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "0BZ",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Antiviral Unit, Virus Reference Department, UK Health Security Agency, 61",
    "entities": [
      {
        "text": "2)Antiviral",
        "label": "CARDINAL"
      },
      {
        "text": "Virus Reference Department",
        "label": "ORG"
      },
      {
        "text": "UK Health Security Agency",
        "label": "ORG"
      },
      {
        "text": "61",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Colindale Avenue, London NW9 5EQ, United Kingdom.",
    "entities": [
      {
        "text": "Colindale Avenue",
        "label": "FAC"
      },
      {
        "text": "London NW9 5EQ",
        "label": "PERSON"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute for Global Health, University College London, Rowland Hill Street,",
    "entities": [
      {
        "text": "Global Health, University College London",
        "label": "ORG"
      },
      {
        "text": "Rowland Hill Street",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "London NW3 2PF, United Kingdom.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)MRC Clinical Trials Unit at University College London, 90 High Holborn,",
    "entities": [
      {
        "text": "Clinical Trials Unit",
        "label": "ORG"
      },
      {
        "text": "University College London",
        "label": "ORG"
      },
      {
        "text": "90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "London WC1V 6LJ, United Kingdom.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "6LJ",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The evolution of HIV-1 virulence has significant implications for epidemic",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "control. Recent phylogenomic analyses identified low-prevalence HIV-1 variants",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "exhibiting significant differences in disease progression. We analysed 40 888",
    "entities": [
      {
        "text": "40 888",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "partial HIV-1 pol sequences from the UK HIV Drug Resistance Database (UKRDB)",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      },
      {
        "text": "the UK HIV Drug Resistance Database",
        "label": "ORG"
      },
      {
        "text": "UKRDB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "across subtypes B, C, A1, and CRF02AG. We identified phylotypes with putative",
    "entities": [
      {
        "text": "A1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "differences in transmission/phylogenetic patterns and assessed their virulence",
    "entities": []
  },
  {
    "text": "trends using pretreatment viral loads, CD4 cell counts, and four statistical",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "methods. We classified three subtype B phylotypes-PT.B.40.UK, PT.B.69.UK, and",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PT.B.133.UK -as variants of interest (VOIs) due to significantly higher viral",
    "entities": []
  },
  {
    "text": "loads and/or accelerated CD4 decline. PT.B.40.UK and PT.B.69.UK exhibited higher",
    "entities": [
      {
        "text": "loads and/or accelerated CD4 decline",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "viral loads, 4.93 log10 copies/ml (95% CI: 4.73-5.13) and 4.87 (4.65-5.10),",
    "entities": [
      {
        "text": "4.93",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "4.73",
        "label": "CARDINAL"
      },
      {
        "text": "4.87",
        "label": "CARDINAL"
      },
      {
        "text": "4.65-5.10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "representing 0.30-0.36 log10 copies/ml higher than the reference group (4.57;",
    "entities": [
      {
        "text": "0.30",
        "label": "CARDINAL"
      },
      {
        "text": "4.57",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "4.55-4.59). Despite uncertainties in baseline CD4 counts, all three VOIs reached",
    "entities": [
      {
        "text": "4.55-4.59",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the clinically relevant threshold of 350 CD4 cells/mm3 significantly faster than",
    "entities": [
      {
        "text": "350",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the reference group (3.5 years, 3.1-3.9 years): 2.3 years (1.0-5.1) for",
    "entities": [
      {
        "text": "3.5 years",
        "label": "DATE"
      },
      {
        "text": "3.1-3.9 years",
        "label": "DATE"
      },
      {
        "text": "2.3 years",
        "label": "DATE"
      },
      {
        "text": "1.0-5.1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PT.B.40.UK, 2.0 years (10.8 months-4.4 years) for PT.B.69.UK, and 1.8 years",
    "entities": [
      {
        "text": "2.0 years",
        "label": "DATE"
      },
      {
        "text": "10.8 months-4.4 years",
        "label": "DATE"
      },
      {
        "text": "1.8 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(10.8 months-3.6 years) for PT.B.133.UK. These VOIs and their closest relatives",
    "entities": [
      {
        "text": "10.8 months-3.6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "have been circulating in the UK for decades with limited international spread",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and did not exhibit unusually rapid growth rates. Although these findings",
    "entities": []
  },
  {
    "text": "suggest a heritable high-virulence HIV-1 phenotype, we did not find evidence",
    "entities": []
  },
  {
    "text": "that convergent genetic polymorphisms or switches in coreceptor usage explained",
    "entities": []
  },
  {
    "text": "these differences. The small fraction of HIV-1 subtype B variants in the UK",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "evolving towards higher virulence is unlikely to pose a public health concern,",
    "entities": []
  },
  {
    "text": "given the ongoing decline in new HIV diagnoses following the widespread adoption",
    "entities": []
  },
  {
    "text": "of pre-exposure prophylaxis and targeted prevention campaigns. However, this",
    "entities": []
  },
  {
    "text": "study-alongside the detection of the VB variant in the Netherlands-demonstrates",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "that more virulent variants are not rare and can emerge independently in",
    "entities": []
  },
  {
    "text": "multiple countries. Consequently, HIV-1 genomic surveillance remains crucial to",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "monitor HIV-1 virulence and mitigate its healthcare impact.",
    "entities": []
  },
  {
    "text": "Prevalence, associated factors and etiologic agents of oral candidiasis among",
    "entities": []
  },
  {
    "text": "HIV-positive patients in a Vietnamese general hospital.",
    "entities": [
      {
        "text": "Vietnamese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)National Institute of Malariology, Parasitology and Entomology, Nam Tu Liem,",
    "entities": [
      {
        "text": "Institute of Malariology, Parasitology and Entomology",
        "label": "ORG"
      },
      {
        "text": "Nam Tu Liem",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)The Tropical Diseases Center, Nghe An General Friendship Hospital, Vinh, Nghe",
    "entities": [
      {
        "text": "3)The Tropical Diseases Center",
        "label": "ORG"
      },
      {
        "text": "Nghe",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Scientific and Training Management Department, National Institute of",
    "entities": [
      {
        "text": "Training Management Department",
        "label": "ORG"
      },
      {
        "text": "National Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Malariology, Parasitology and Entomology, Nam Tu Liem, Ha Noi, Vietnam.",
    "entities": [
      {
        "text": "Nam Tu Liem",
        "label": "PERSON"
      },
      {
        "text": "Ha Noi",
        "label": "PERSON"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Parasitology, Vietnam Military Medical University, Vietnam.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Parasitology",
        "label": "GPE"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND AND PURPOSE: Oral candidiasis (OC) is a common condition in",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "OC",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "HIV-infected individuals. This study aimed to identify the prevalence,",
    "entities": []
  },
  {
    "text": "associated factors, and causative agents of OC among HIV-infected patients in a",
    "entities": [
      {
        "text": "OC",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: The study involved 393 HIV-infected individuals treated",
    "entities": [
      {
        "text": "393",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at The Tropical Diseases Center, Nghe An General Friendship Hospital, Vinh, Nghe",
    "entities": [
      {
        "text": "The Tropical Diseases Center",
        "label": "ORG"
      },
      {
        "text": "Nghe",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "An, Vietnam from January 2022 to May 2024. The sample collected from the buccal",
    "entities": [
      {
        "text": "Vietnam",
        "label": "GPE"
      },
      {
        "text": "January 2022",
        "label": "DATE"
      },
      {
        "text": "May 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mucosa was seeded onto CHROMagarTM Candida to isolate and identify the causative",
    "entities": [
      {
        "text": "mucosa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "yeasts. Molecular identification was performed with restriction fragment length",
    "entities": []
  },
  {
    "text": "polymorphism assay using MspI restriction enzyme and sequencing of the internal",
    "entities": []
  },
  {
    "text": "transcribed spacer (ITS) region.",
    "entities": [
      {
        "text": "transcribed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The prevalence of OC was 10.7% (95% confidence interval 7.6 - 13.8).",
    "entities": [
      {
        "text": "OC",
        "label": "ORG"
      },
      {
        "text": "10.7%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "7.6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Patients with late WHO HIV clinical stage, poorer hygienic condition, or use of",
    "entities": []
  },
  {
    "text": "prosthetic were at a higher risk of OC. Ten yeast species were isolated, and 10",
    "entities": [
      {
        "text": "OC",
        "label": "ORG"
      },
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(23.8%) patients carried more than one type of yeast species. Out of 54 obtained",
    "entities": [
      {
        "text": "23.8%",
        "label": "PERCENT"
      },
      {
        "text": "more than one",
        "label": "CARDINAL"
      },
      {
        "text": "54",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "isolates, Candida albicans comprised the most (62.9% isolates and 80.9%",
    "entities": [
      {
        "text": "Candida",
        "label": "GPE"
      },
      {
        "text": "62.9%",
        "label": "PERCENT"
      },
      {
        "text": "80.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients), followed by C. tropicalis (16.4% and 21.4% respectively). Overall, 27",
    "entities": [
      {
        "text": "16.4%",
        "label": "PERCENT"
      },
      {
        "text": "21.4%",
        "label": "PERCENT"
      },
      {
        "text": "27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients (64.3%) were infected with C. albicans, and 15 patients (35.7%) were",
    "entities": [
      {
        "text": "64.3%",
        "label": "PERCENT"
      },
      {
        "text": "C.",
        "label": "NORP"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "35.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "infected with non- albicans Candida, alone or in combination with C. albicans.",
    "entities": [
      {
        "text": "Candida",
        "label": "GPE"
      },
      {
        "text": "C.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CONCLUSION: The prevalence of OC in HIV-infected patients was low and associated",
    "entities": [
      {
        "text": "OC",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with both systemic and local factors. C. albicans was still the most common",
    "entities": []
  },
  {
    "text": "species but non- albicans Candida or coexistence of Candida species is frequent.",
    "entities": [
      {
        "text": "Candida",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright: \u00a9 2021, Published by Mazandaran University of Medical Sciences on",
    "entities": [
      {
        "text": "2021",
        "label": "DATE"
      },
      {
        "text": "Mazandaran University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "behalf of Iranian Society of Medical Mycology and Invasive Fungi Research",
    "entities": [
      {
        "text": "Iranian Society of Medical Mycology and Invasive Fungi Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Authors of the present study declare no",
    "entities": []
  },
  {
    "text": "conflicts of interest.",
    "entities": []
  },
  {
    "text": "Blood Donor Serological Screening in Makkah, Saudi Arabia: A 7-Year",
    "entities": [
      {
        "text": "Makkah",
        "label": "ORG"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      },
      {
        "text": "7-Year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Retrospective Study on Transfusion-Transmitted Infections.",
    "entities": [
      {
        "text": "Transfusion-Transmitted Infections",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Clinical Laboratory Sciences, Faculty of Applied Medical",
    "entities": [
      {
        "text": "Clinical Laboratory Sciences",
        "label": "ORG"
      },
      {
        "text": "Faculty of Applied Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.",
    "entities": [
      {
        "text": "Umm Al-Qura University",
        "label": "PERSON"
      },
      {
        "text": "Makkah",
        "label": "ORG"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Laboratory and Blood Bank, King Abdulaziz Hospital, Ministry of",
    "entities": [
      {
        "text": "Blood Bank",
        "label": "ORG"
      },
      {
        "text": "King Abdulaziz Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Biology, Faculty of Applied Science, Umm Al-Qura University,",
    "entities": [
      {
        "text": "Biology, Faculty of Applied Science",
        "label": "ORG"
      },
      {
        "text": "Al-Qura University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Central Blood Bank Department, Health Affairs in Makkah Region, Saudi Arabia",
    "entities": [
      {
        "text": "Blood Bank Department",
        "label": "ORG"
      },
      {
        "text": "Health Affairs",
        "label": "ORG"
      },
      {
        "text": "Makkah Region",
        "label": "ORG"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ministry of Health (MOH), Makkah, Saudi Arabia.",
    "entities": [
      {
        "text": "Ministry of Health",
        "label": "ORG"
      },
      {
        "text": "Makkah",
        "label": "ORG"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Introduction: Screening donated blood for transfusion-transmitted infections",
    "entities": []
  },
  {
    "text": "(TTIs) is a critical component of transfusion safety, particularly in",
    "entities": []
  },
  {
    "text": "high-demand regions such as Makkah City, Saudi Arabia. This study is aimed at",
    "entities": [
      {
        "text": "Makkah City",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "assessing the seroprevalence of TTI markers among blood donors at King Abdulaziz",
    "entities": [
      {
        "text": "TTI",
        "label": "ORG"
      },
      {
        "text": "King Abdulaziz",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hospital-Makkah (KAHM) over a 7-year period. Methods: In this retrospective",
    "entities": [
      {
        "text": "Hospital-Makkah",
        "label": "ORG"
      },
      {
        "text": "KAHM",
        "label": "ORG"
      },
      {
        "text": "7-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "study, 17,661 individuals who donated blood at the KAHM, Saudi Arabia, from",
    "entities": [
      {
        "text": "17,661",
        "label": "CARDINAL"
      },
      {
        "text": "KAHM",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "January 2017 to December 2023, were included. The prevalence of TTI markers was",
    "entities": [
      {
        "text": "January 2017 to December 2023",
        "label": "DATE"
      },
      {
        "text": "TTI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assessed and categorized by year, gender, age, type of donors (whole blood and",
    "entities": [
      {
        "text": "year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "apheresis), and category of donation (replacement and volunteer). In addition to",
    "entities": []
  },
  {
    "text": "ABO group testing, commercially available kits were used for serological tests.",
    "entities": [
      {
        "text": "ABO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Results: Among donors, 74 (0.42%) were reactive for HBsAg, 1419 (8.03%) for",
    "entities": [
      {
        "text": "74",
        "label": "DATE"
      },
      {
        "text": "0.42%",
        "label": "PERCENT"
      },
      {
        "text": "HBsAg",
        "label": "GPE"
      },
      {
        "text": "1419",
        "label": "DATE"
      },
      {
        "text": "8.03%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "HBcAb, and 1295 (7.33%) for HBsAb. Other reactive cases included HCV (0.29%),",
    "entities": [
      {
        "text": "HBcAb",
        "label": "ORG"
      },
      {
        "text": "1295",
        "label": "DATE"
      },
      {
        "text": "7.33%",
        "label": "PERCENT"
      },
      {
        "text": "0.29%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "HIV (0.06%), HTLV-I/II (0.05%), and syphilis (0.44%). No cases of malaria were",
    "entities": [
      {
        "text": "0.06%",
        "label": "PERCENT"
      },
      {
        "text": "0.05%",
        "label": "PERCENT"
      },
      {
        "text": "0.44%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "reported. Statistically significant variations were observed across years for",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "HBsAg (p = 0.007), HBsAb, and HBcAb (p < 0.001), suggesting changes in infection",
    "entities": [
      {
        "text": "0.007",
        "label": "CARDINAL"
      },
      {
        "text": "HBcAb",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exposure, immunity, or donor screening efficiency. Male donors represented",
    "entities": []
  },
  {
    "text": "97.17% of the cohort, and replacement donors were more prevalent (54.75%) than",
    "entities": [
      {
        "text": "97.17%",
        "label": "PERCENT"
      },
      {
        "text": "54.75%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "volunteers. Conclusion: The overall prevalence of TTIs among blood donors in",
    "entities": []
  },
  {
    "text": "Makkah was low, affirming the effectiveness of current screening protocols.",
    "entities": [
      {
        "text": "Makkah",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "However, the relatively high prevalence of hepatitis B core antibodies indicates",
    "entities": []
  },
  {
    "text": "prior exposure among a notable proportion of donors. Yearly fluctuations in",
    "entities": [
      {
        "text": "Yearly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "seropositivity suggest evolving epidemiological patterns, warranting continuous",
    "entities": []
  },
  {
    "text": "surveillance and targeted public health interventions.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Amr J. Halawani et al. International Journal of Microbiology",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Amr J. Halawani",
        "label": "PERSON"
      },
      {
        "text": "al.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "published by John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "51. Ther Adv Infect Dis. 2025 Jul 13;12:20499361251351302. doi:",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1177/20499361251351302. eCollection 2025 Jan-Dec.",
    "entities": [
      {
        "text": "10.1177/20499361251351302",
        "label": "DATE"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jan-Dec.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Emergence of HCV genotype 6 and its new variants among intravenous drug users in",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Manipur, a north-eastern state of India.",
    "entities": [
      {
        "text": "Manipur",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Indian Council of Medical Research, National Institute for Research in",
    "entities": [
      {
        "text": "1)Indian Council of Medical Research",
        "label": "ORG"
      },
      {
        "text": "National Institute for Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bacterial Infections (NIRBI), West Bengal, India.",
    "entities": [
      {
        "text": "Bacterial Infections",
        "label": "ORG"
      },
      {
        "text": "NIRBI",
        "label": "ORG"
      },
      {
        "text": "West Bengal",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Virus Laboratory, National Institute for Research in Bacterial",
    "entities": [
      {
        "text": "Virus Laboratory",
        "label": "ORG"
      },
      {
        "text": "National Institute for Research in Bacterial",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infections, Indian Council of Medical Research, P-33, C.I.T. Road, Scheme-XM,",
    "entities": [
      {
        "text": "Infections",
        "label": "ORG"
      },
      {
        "text": "Indian Council of Medical Research",
        "label": "ORG"
      },
      {
        "text": "P-33",
        "label": "PRODUCT"
      },
      {
        "text": "C.I.T. Road",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "BACKGROUND: Manipur, a north-eastern state of India, has a high incidence of",
    "entities": [
      {
        "text": "Manipur",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "intravenous drug use with an equally high prevalence of Hepatitis C virus (HCV)",
    "entities": [
      {
        "text": "Hepatitis C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: This cross-sectional study aimed to evaluate the impact of certain",
    "entities": []
  },
  {
    "text": "risk factors enhancing the susceptibility of acquiring HCV.",
    "entities": [
      {
        "text": "HCV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DESIGN: A total of 1008 participants from various risk groups, from nine",
    "entities": [
      {
        "text": "1008",
        "label": "DATE"
      },
      {
        "text": "nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "districts across the state, were enrolled. Blood samples along with demographic",
    "entities": []
  },
  {
    "text": "data were collected from the study participants.",
    "entities": []
  },
  {
    "text": "METHODS: HCV RNA was isolated and nested RT-PCR was performed followed by Sanger",
    "entities": [
      {
        "text": "RT-PCR",
        "label": "ORG"
      },
      {
        "text": "Sanger\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "sequencing for genotyping. Phylogenetic and phylogeographic studies were further",
    "entities": []
  },
  {
    "text": "conducted.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the total, 493 (48.90%) samples were HCV sero-reactive. Among the",
    "entities": [
      {
        "text": "493",
        "label": "CARDINAL"
      },
      {
        "text": "48.90%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "sero-reactive samples, 406 (82.35%) were HCV RNA positive. In case of the",
    "entities": [
      {
        "text": "406",
        "label": "CARDINAL"
      },
      {
        "text": "82.35%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "subgroup PWID + HIV, sero-reactivity (82.22%) and viremia (90.54%) were observed",
    "entities": [
      {
        "text": "PWID",
        "label": "ORG"
      },
      {
        "text": "82.22%",
        "label": "PERCENT"
      },
      {
        "text": "90.54%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "to be exceptionally high. It was noted that HCV sero-reactivity increased four",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "times in people living with HIV (PLHIV) who continued to inject drugs. Three HCV",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "genotypes and eight subtypes were circulating in this study population.",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: In PLHIV who continued to inject drugs, HCV sero-reactivity",
    "entities": []
  },
  {
    "text": "increased four-fold. About 40% of the population living with HCV belonged to",
    "entities": [
      {
        "text": "four-fold",
        "label": "CARDINAL"
      },
      {
        "text": "About 40%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "genotype 6, while genotype 1 showed a noticeable decline. Phylogeographic",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analyses and spatiotemporal reconstructions revealed that most of the subtypes",
    "entities": []
  },
  {
    "text": "migrated from far south-east Asian countries like Thailand, Malaysia, Myanmar,",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "Myanmar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "\u00a9 The Author(s), 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "52. Open Forum Infect Dis. 2025 Jun 18;12(7):ofaf362. doi: 10.1093/ofid/ofaf362.",
    "entities": [
      {
        "text": "52",
        "label": "CARDINAL"
      },
      {
        "text": "Jun",
        "label": "PERSON"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Achieving Greater Transparency Regarding Molecular HIV Surveillance: A Proposal",
    "entities": []
  },
  {
    "text": "to Move Beyond the Status Quo.",
    "entities": [
      {
        "text": "Move Beyond the Status Quo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Moore-O'Neal SM(5), Neighbors C(6), Saldana C(7), Sugarman J(1)(2).",
    "entities": [
      {
        "text": "Moore-O'Neal",
        "label": "ORG"
      },
      {
        "text": "Saldana",
        "label": "GPE"
      },
      {
        "text": "Sugarman",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland,",
    "entities": [
      {
        "text": "Institute of Bioethics",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins University",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Johns Hopkins University",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Epidemiology, Rollins School of Public Health, Emory",
    "entities": [
      {
        "text": "Epidemiology, Rollins School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Emory",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Atlanta, Georgia, USA.",
    "entities": [
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of International Health, Bloomberg School of Public Health, Johns",
    "entities": [
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Bloomberg School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Johns",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hopkins University, Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Hopkins University",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)The Center for HIV Law and Policy, Brooklyn, New York, USA.",
    "entities": [
      {
        "text": "Brooklyn",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Population Health Sciences, Duke University School of Medicine,",
    "entities": [
      {
        "text": "Population Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Duke University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Durham, North Carolina, USA.",
    "entities": [
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Medicine, Division of Infectious Diseases, Emory University",
    "entities": [
      {
        "text": "Medicine, Division of Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Emory University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Atlanta, Georgia, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Molecular HIV surveillance is used to in effort to enhance HIV prevention",
    "entities": []
  },
  {
    "text": "efforts by identifying emerging clusters of rapid HIV transmission. In the",
    "entities": []
  },
  {
    "text": "United States, it relies upon data from antiretroviral resistance testing done",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in the context of clinical care. However, information about the public health",
    "entities": []
  },
  {
    "text": "uses of these data are not always disclosed to patients at the time of testing,",
    "entities": []
  },
  {
    "text": "which raises ethical concerns. Building upon accumulating data about this",
    "entities": []
  },
  {
    "text": "practice, a multidisciplinary group argues that there is a need to increase",
    "entities": []
  },
  {
    "text": "transparency of the practice through active disclosure.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Potential conflicts of interest. J. S. is a",
    "entities": [
      {
        "text": "J. S.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "consultant to Merck KGaA, IQVIA, and Merck; and a member of Aspen Neurosciences'",
    "entities": [
      {
        "text": "Merck KGaA",
        "label": "ORG"
      },
      {
        "text": "IQVIA",
        "label": "ORG"
      },
      {
        "text": "Merck",
        "label": "ORG"
      },
      {
        "text": "Aspen Neurosciences'",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clinical Advisory Panel. None of these activities is directly related to the",
    "entities": []
  },
  {
    "text": "information discussed in this paper. No other authors had relevant interests to",
    "entities": []
  },
  {
    "text": "disclose. All other authors report no potential conflicts.",
    "entities": []
  },
  {
    "text": "53. Interdiscip Perspect Infect Dis. 2025 Jul 7;2025:3730719. doi:",
    "entities": [
      {
        "text": "53",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1155/ipid/3730719. eCollection 2025.",
    "entities": [
      {
        "text": "10.1155",
        "label": "CARDINAL"
      },
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Prevalence and Determinants of Drug-Resistant Tuberculosis (DR-TB) Among",
    "entities": [
      {
        "text": "Determinants of Drug-Resistant Tuberculosis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tuberculosis Patients in Pokhara Metropolitan City, Gandaki Province, Nepal.",
    "entities": [
      {
        "text": "Pokhara Metropolitan City",
        "label": "GPE"
      },
      {
        "text": "Gandaki Province",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Pharmacy, Institute of Medicine (IOM), Maharajgunj Medical",
    "entities": [
      {
        "text": "Pharmacy, Institute of Medicine",
        "label": "ORG"
      },
      {
        "text": "IOM",
        "label": "ORG"
      },
      {
        "text": "Maharajgunj Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Campus (MMC), Tribhuvan University, Kathmandu, Nepal.",
    "entities": [
      {
        "text": "MMC",
        "label": "ORG"
      },
      {
        "text": "Tribhuvan University",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pharmacy, Little Buddha College of Health Science, Purbanchal",
    "entities": [
      {
        "text": "Little Buddha College of Health Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Kathmandu, Nepal.",
    "entities": [
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Central Department of Public Health (CDPH), Institute of Medicine (IOM),",
    "entities": [
      {
        "text": "3)Central Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Institute of Medicine",
        "label": "ORG"
      },
      {
        "text": "IOM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tribhuvan University, Kathmandu, Nepal.",
    "entities": [
      {
        "text": "Tribhuvan University",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Background: Drug-resistant tuberculosis (DR-TB) remains a significant global",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "public health challenge, particularly in regions with a high burden of TB.",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nepal, one such country, has been witnessing a rise in DR-TB cases, posing",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "serious challenges to TB control efforts. Despite this growing concern, there is",
    "entities": []
  },
  {
    "text": "a lack of localized data on the risk factors contributing to DR-TB, especially",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in urban areas like Pokhara. This study aims to fill that gap by assessing the",
    "entities": [
      {
        "text": "Pokhara",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prevalence of DR-TB and identifying associated demographic, behavioral, and",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "clinical factors among TB patients in Pokhara Metropolitan City, Gandaki",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "Pokhara Metropolitan City",
        "label": "GPE"
      },
      {
        "text": "Gandaki",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, Nepal. Methods: A retrospective cross-sectional analysis was conducted",
    "entities": []
  },
  {
    "text": "using 617 TB patient records from the Pokhara Metropolitan Health Office for the",
    "entities": [
      {
        "text": "617",
        "label": "CARDINAL"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "the Pokhara Metropolitan Health Office",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fiscal year 2078/79 (July 2021 to July 2022). Data on demographic",
    "entities": [
      {
        "text": "fiscal year 2078/79",
        "label": "DATE"
      },
      {
        "text": "July 2021 to July 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "characteristics, clinical history, treatment regimens, and behavioral factors",
    "entities": []
  },
  {
    "text": "such as smoking and alcohol consumption were extracted. Descriptive statistics",
    "entities": []
  },
  {
    "text": "were used to determine the prevalence of DR-TB, and bivariate logistic",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "regression was applied to identify statistically significant risk factors",
    "entities": []
  },
  {
    "text": "associated with DR-TB. Results: Among the 617 TB patients, the prevalence of",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "617",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DR-TB was 2.6%. Most patients were male (57.4%) and within the 21-30 age group",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "2.6%",
        "label": "PERCENT"
      },
      {
        "text": "57.4%",
        "label": "PERCENT"
      },
      {
        "text": "21-30",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(26.9%). Pulmonary bacteriologically confirmed TB was the most common type",
    "entities": [
      {
        "text": "26.9%",
        "label": "PERCENT"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(53.6%), predominantly affecting adults (98.1%). The primary treatment regimen",
    "entities": [
      {
        "text": "53.6%",
        "label": "PERCENT"
      },
      {
        "text": "98.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "administered was 2HRZE + 4HR (78.8%). TB-HIV co-infection was found in 1.9% of",
    "entities": [
      {
        "text": "2HRZE + 4HR",
        "label": "DATE"
      },
      {
        "text": "78.8%",
        "label": "PERCENT"
      },
      {
        "text": "1.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "cases, with all co-infected patients receiving antiretroviral therapy. In a",
    "entities": []
  },
  {
    "text": "bivariate analysis, individuals with current smoking status (UOR: 9.384; CI:",
    "entities": [
      {
        "text": "9.384",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "3.342-26.351), exposure to smoking (UOR: 8.550: CI: 2.916-25.064), and current",
    "entities": [
      {
        "text": "3.342",
        "label": "CARDINAL"
      },
      {
        "text": "8.550",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.916-25.064",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "alcohol consumption (UOR: 4.553, CI: 1.406-14.745) had a higher likelihood of",
    "entities": [
      {
        "text": "4.553",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.406-14.745",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DR-TB. In a multivariate analysis, exposure to smoking (AOR: 5.317; CI:",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "5.317",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.394-20.274) and current alcohol consumption (AOR: 6.84; CI: 2.071-22.58)",
    "entities": [
      {
        "text": "1.394",
        "label": "CARDINAL"
      },
      {
        "text": "6.84",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.071-22.58",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "emerged as independent predictors associated with an increased risk of DR-TB.",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conclusion: The study revealed a relatively low prevalence of DR-TB among TB",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients in Pokhara, with strong associations between DR-TB and lifestyle",
    "entities": [
      {
        "text": "Pokhara",
        "label": "GPE"
      },
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "factors such as smoking and alcohol use. These findings underscore the need for",
    "entities": []
  },
  {
    "text": "targeted public health interventions addressing behavioral risk factors to",
    "entities": []
  },
  {
    "text": "reduce DR-TB incidence. Enhanced surveillance, public awareness, and preventive",
    "entities": []
  },
  {
    "text": "strategies should be integrated into TB control programs to mitigate the spread",
    "entities": []
  },
  {
    "text": "of DR-TB in this region. Moreover, targeted behavioral interventions may be",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "crucial in curbing the emergence of DR-TB, particularly in high-burden urban",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Shiv Kumar Sah et al. Interdisciplinary Perspectives on",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Shiv Kumar Sah",
        "label": "PERSON"
      },
      {
        "text": "Interdisciplinary Perspectives",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Infectious Diseases published by John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "54. Risk Manag Healthc Policy. 2025 Jul 9;18:2323-2333. doi:",
    "entities": [
      {
        "text": "54",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jul 9;18:2323-2333",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "10.2147/RMHP.S529797. eCollection 2025.",
    "entities": [
      {
        "text": "10.2147",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Awareness, Knowledge, Attitude, and Source of Information on HIV Infection Among",
    "entities": [
      {
        "text": "Attitude",
        "label": "PERSON"
      },
      {
        "text": "Source of Information on HIV Infection",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Infectious Diseases, First Affiliated Hospital of Xiamen",
    "entities": [
      {
        "text": "First Affiliated Hospital of Xiamen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, School of Medicine, Xiamen University, Xiamen, People's Republic of",
    "entities": [
      {
        "text": "University, School of Medicine, Xiamen University",
        "label": "ORG"
      },
      {
        "text": "Xiamen",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Infectious Diseases, Nanfang Hospital, Southern Medical",
    "entities": [
      {
        "text": "Nanfang Hospital",
        "label": "PERSON"
      },
      {
        "text": "Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Guangzhou, People's Republic of China.",
    "entities": [
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of General Practice, Nanfang Hospital, Southern Medical",
    "entities": [
      {
        "text": "General Practice",
        "label": "ORG"
      },
      {
        "text": "Nanfang Hospital",
        "label": "ORG"
      },
      {
        "text": "Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To evaluate the college students' awareness, knowledge, attitude, and",
    "entities": []
  },
  {
    "text": "source of information on human immunodeficiency virus (HIV).",
    "entities": []
  },
  {
    "text": "METHODS: This is a multicenter study with 490 college students participated in",
    "entities": [
      {
        "text": "490",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the questionnaire survey. Among them, 261 are medical students and 229 are",
    "entities": [
      {
        "text": "261",
        "label": "CARDINAL"
      },
      {
        "text": "229",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "non-medical students. A questionnaire was used to collect socio-demographic data",
    "entities": []
  },
  {
    "text": "and investigate the awareness of and knowledge about HIV infection, the practice",
    "entities": []
  },
  {
    "text": "of preventive measures, and sources of HIV-related information.",
    "entities": []
  },
  {
    "text": "RESULTS: There is no significantly different on self-report awareness of HIV",
    "entities": []
  },
  {
    "text": "infection between medical and non-medical students (P = 0.919). However, a",
    "entities": [
      {
        "text": "0.919",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "higher proportion of non-medical students misunderstand the HIV transmission",
    "entities": []
  },
  {
    "text": "routes. For the sources of knowledge, non-medical students were more likely to",
    "entities": []
  },
  {
    "text": "obtain from the Internet (P=0.029), TV medias (P=0.027) and others (P=0.032).",
    "entities": []
  },
  {
    "text": "The proportion of medical students acquiring HIV-related knowledge from doctors",
    "entities": []
  },
  {
    "text": "was significantly higher (P<0.001). A higher percentage of non-medical students",
    "entities": []
  },
  {
    "text": "indicated a lack of HIV knowledge and expressed a need for more HIV related",
    "entities": []
  },
  {
    "text": "education (P=0.002). Non-medical students expressed a preference for HIV",
    "entities": []
  },
  {
    "text": "education that covers a broader spectrum of HIV-related knowledge (P=0.046),",
    "entities": []
  },
  {
    "text": "indicating a desire for more comprehensive understanding beyond basic",
    "entities": []
  },
  {
    "text": "HIV-related awareness. In contrast, medical students indicated a preference for",
    "entities": []
  },
  {
    "text": "more frequent sessions with longer durations (P=0.038).",
    "entities": []
  },
  {
    "text": "CONCLUSION: Medical students were significantly more aware of HIV related",
    "entities": []
  },
  {
    "text": "knowledge than the non-medical students. Our research can provide relevant data",
    "entities": []
  },
  {
    "text": "support for further improving the methods and content of health education for",
    "entities": []
  },
  {
    "text": "young people.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest in",
    "entities": []
  },
  {
    "text": "55. Front Digit Health. 2025 Jun 30;7:1559203. doi: 10.3389/fdgth.2025.1559203.",
    "entities": [
      {
        "text": "55",
        "label": "CARDINAL"
      },
      {
        "text": "Front Digit Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jun",
        "label": "PERSON"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Impact of the use of the ultra-portable digital x-ray with CAD4TB for active",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "case finding for tuberculosis in Nigeria.",
    "entities": [
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Programs, Society for Family Health, Abuja, Nigeria.",
    "entities": [
      {
        "text": "Society for Family Health",
        "label": "ORG"
      },
      {
        "text": "Abuja, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)HIV AIDS & TB Office, United States Agency for International Development,",
    "entities": [
      {
        "text": "AIDS & TB Office",
        "label": "ORG"
      },
      {
        "text": "United States Agency for International Development",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)National Tuberculosis Research Task Team, Abuja, Nigeria.",
    "entities": [
      {
        "text": "Tuberculosis Research Task Team",
        "label": "ORG"
      },
      {
        "text": "Abuja, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Programs, Institute of Human Virology, Abuja, Nigeria.",
    "entities": [
      {
        "text": "Institute of Human Virology",
        "label": "ORG"
      },
      {
        "text": "Abuja, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Programs, Center for Integrated Health Program, Abuja, Nigeria.",
    "entities": [
      {
        "text": "Center for Integrated Health Program",
        "label": "ORG"
      },
      {
        "text": "Abuja, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Digital Health, Stop TB Partnership, Geneva, Switzerland.",
    "entities": [
      {
        "text": "Health, Stop TB Partnership",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Public Health, Federal Ministry of Health, Abuja, Nigeria.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Federal Ministry of Health",
        "label": "ORG"
      },
      {
        "text": "Abuja, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Paediatrics, University of Calabar/University of Calabar",
    "entities": [
      {
        "text": "Paediatrics, University of Calabar/University of Calabar",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Teaching Hospital, Calabar, Nigeria.",
    "entities": [
      {
        "text": "Calabar",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The ultra-portable digital x-ray (UPDX) with computer-aided",
    "entities": [
      {
        "text": "UPDX",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "detection (CAD) is a new technology aimed at bringing tuberculosis (TB)",
    "entities": [
      {
        "text": "CAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "screening innovations to hard-to-reach communities and strengthening the active",
    "entities": []
  },
  {
    "text": "case-finding (ACF) interventions for TB. As TB control measures remain critical",
    "entities": [
      {
        "text": "ACF",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "globally and in Nigeria, the country acquired and rolled out 10 UPDX with",
    "entities": [
      {
        "text": "Nigeria",
        "label": "GPE"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "UPDX",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "computer-aided detection (CAD4TB) software in eight states. This study seeks to",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "evaluate the efficiency and impact of the UPDX with CAD4TB for TB case finding",
    "entities": [
      {
        "text": "UPDX",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: A retrospective cross-sectional study involving the review of records",
    "entities": []
  },
  {
    "text": "of individuals 4 years and above who had presented for TB screening during ACF",
    "entities": [
      {
        "text": "4 years",
        "label": "DATE"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "ACF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "activities conducted using the UPDX with CAD4TB between January 2022 and",
    "entities": [
      {
        "text": "UPDX",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "between January 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 94,694 subjects aged 4 years and above were screened for TB",
    "entities": [
      {
        "text": "94,694",
        "label": "CARDINAL"
      },
      {
        "text": "4 years",
        "label": "DATE"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with an average presumptive TB proportion of 10.84 \u00b1 5.42% and 10% confirmed TB",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "10.84",
        "label": "CARDINAL"
      },
      {
        "text": "5.42%",
        "label": "PERCENT"
      },
      {
        "text": "10%",
        "label": "PERCENT"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(r = 0.684, p = 0.03 and r(df) = 0.867, p = 0.001). The number needed to screen",
    "entities": [
      {
        "text": "0.684",
        "label": "CARDINAL"
      },
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "0.867",
        "label": "CARDINAL"
      },
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(NNS) to find one TB case in Northern Nigeria was 39 as against 37 for the South",
    "entities": [
      {
        "text": "NNS",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "Northern Nigeria",
        "label": "LOC"
      },
      {
        "text": "39",
        "label": "DATE"
      },
      {
        "text": "37",
        "label": "CARDINAL"
      },
      {
        "text": "South",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(\u03c7 2 = 108, p = 0.25), with correlations (r = -0.422, p = 0.17 and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "108",
        "label": "CARDINAL"
      },
      {
        "text": "0.25",
        "label": "CARDINAL"
      },
      {
        "text": "0.17",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "r(df) = -0.575, p = 0.05). Similarly, a comparison of the number needed to test",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(NNT) to find one TB case in Northern and Southern Nigeria gave a North total of",
    "entities": [
      {
        "text": "NNT",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "Northern and",
        "label": "LOC"
      },
      {
        "text": "Southern Nigeria",
        "label": "GPE"
      },
      {
        "text": "North",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "four against a South total of five (\u03c7 2 = 60, p = 0.3), with correlations",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "South",
        "label": "LOC"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(r = -0.033, p = 0.92 and r(df) = -0.212, p = 0.51). Among the TB cases",
    "entities": [
      {
        "text": "0.92",
        "label": "CARDINAL"
      },
      {
        "text": "0.51",
        "label": "CARDINAL"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "confirmed, 3.4% were asymptomatic with cough and fever absent in 18.2% and",
    "entities": [
      {
        "text": "3.4%",
        "label": "PERCENT"
      },
      {
        "text": "18.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "83.2%, respectively. The average time to diagnosis (TTD) was 2.0 \u00b1 1.04 days",
    "entities": [
      {
        "text": "83.2%",
        "label": "PERCENT"
      },
      {
        "text": "TTD",
        "label": "NORP"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "1.04 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "while the average time to treatment (TTT) was 4.2 \u00b1 1.14 days, with 50.6%",
    "entities": [
      {
        "text": "TTT",
        "label": "ORG"
      },
      {
        "text": "4.2",
        "label": "DATE"
      },
      {
        "text": "1.14 days",
        "label": "DATE"
      },
      {
        "text": "50.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "receiving same-day diagnosis and 34.5% receiving same-day treatment. The",
    "entities": [
      {
        "text": "34.5%",
        "label": "PERCENT"
      },
      {
        "text": "same-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "cumulative risks of radiation exposure on healthcare workers using UPDX with",
    "entities": [
      {
        "text": "UPDX",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CAD4TB and adhering to personal protective practices were found to be low.",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: We documented the usefulness of UPDX with CAD showing a high TB",
    "entities": [
      {
        "text": "UPDX",
        "label": "ORG"
      },
      {
        "text": "CAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prevalence and test positivity rate, with significant burden of subclinical TB.",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This has highlighted the need to scale up its use for ACF for TB and select CAD",
    "entities": [
      {
        "text": "ACF",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "CAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "thresholds for both children and adults.",
    "entities": []
  },
  {
    "text": "DOI: 10.3389/fdgth.2025.1559203",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Inferring fitness seascapes from evolutionary histories.",
    "entities": []
  },
  {
    "text": "Gao Y, Lee B, Barton JP.",
    "entities": [
      {
        "text": "Gao Y",
        "label": "PERSON"
      },
      {
        "text": "Lee B",
        "label": "PERSON"
      },
      {
        "text": "Barton",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Evolutionary dynamics are often conceptualized as walks on an adaptive",
    "entities": []
  },
  {
    "text": "landscape, with populations climbing toward optimal fitness peaks. However,",
    "entities": []
  },
  {
    "text": "environmental changes can transform static landscapes into dynamic \"fitness",
    "entities": []
  },
  {
    "text": "seascapes\" where natural selection fluctuates in time. Here, we used a path",
    "entities": []
  },
  {
    "text": "integral approach derived from statistical physics to reveal time-varying",
    "entities": []
  },
  {
    "text": "selection pressures from genetic sequence data. We found that constraints on the",
    "entities": []
  },
  {
    "text": "fitness seascape are determined by the screened Poisson equation, which also",
    "entities": [
      {
        "text": "Poisson",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "describes the screening of electric fields in media with mobile charge carriers.",
    "entities": []
  },
  {
    "text": "In our model, changes in mutation frequencies act as \"charges\" that reveal the",
    "entities": []
  },
  {
    "text": "underlying fitness seascape, which is analogous to an electrostatic potential.",
    "entities": []
  },
  {
    "text": "After validating our method in simulations, we applied it to study how HIV-1",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "evolves to escape immune control by T cells within individual hosts. Our",
    "entities": []
  },
  {
    "text": "analysis showed that the fitness benefit of immune escape declines as T cell",
    "entities": []
  },
  {
    "text": "responses approach their peak intensity, suggesting that functional exhaustion",
    "entities": []
  },
  {
    "text": "may impair the effectiveness of the immune response against HIV-1. Overall, our",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "approach provides a general framework for capturing the complex dynamics of",
    "entities": []
  },
  {
    "text": "natural selection in rapidly evolving populations.",
    "entities": []
  },
  {
    "text": "Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer",
    "entities": [
      {
        "text": "Paracrine Signals",
        "label": "PERSON"
      },
      {
        "text": "HIV-1 Infected Immune Cells Reprogram Cervical Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pathways.",
    "entities": []
  },
  {
    "text": "Persistent infection with human papillomavirus (HPV) is the primary cause of",
    "entities": [
      {
        "text": "HPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cervical cancer worldwide. Notably, women co-infected with HPV and human",
    "entities": [
      {
        "text": "HPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immunodeficiency virus type 1 (HIV-1) have a six-fold higher lifetime risk of",
    "entities": [
      {
        "text": "six-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "developing cervical cancer compared to those without HIV, even when adhering to",
    "entities": []
  },
  {
    "text": "antiretroviral therapy (ART) and achieving T-cell reconstitution. While chronic",
    "entities": []
  },
  {
    "text": "HIV-1 infection is known to cause inflammation, how paracrine signals from",
    "entities": []
  },
  {
    "text": "immune cells alter signaling in cervical cells remain poorly understood. To",
    "entities": []
  },
  {
    "text": "address this, we conducted global transcriptomics analysis on cervical swabs",
    "entities": []
  },
  {
    "text": "from Kenyan women with HPV, stratified by HIV-1 and cancer status. Strikingly,",
    "entities": [
      {
        "text": "Kenyan",
        "label": "NORP"
      },
      {
        "text": "HPV",
        "label": "ORG"
      },
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "women with HIV-1 showed cancer-like gene expression patterns in non-cancerous",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "cervical epithelial cells. Complementary global mass spectrometry (MS)",
    "entities": []
  },
  {
    "text": "proteomics of cervical cells exposed to the secretome of HIV-1 infected primary",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CD4+ T-cells revealed altered expression of proteins in MAPK, PI3K-AKT, and",
    "entities": []
  },
  {
    "text": "\u03b2-catenin signaling pathways. Integrative network analyses of transcriptomic and",
    "entities": []
  },
  {
    "text": "proteomic datasets revealed that HIV-1 altered gene expression in key pathways",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "known to drive cervical cancer, including genes commonly mutated in HIV-1-na\u00efve",
    "entities": [
      {
        "text": "HIV-1-na\u00efve",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "disease. Notably, IRS-1, a key PI3K-AKT pathway activator, was found to be",
    "entities": [
      {
        "text": "IRS-1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "consistently upregulated in both participant samples and cell culture models, as",
    "entities": []
  },
  {
    "text": "were interferon-stimulated genes. Phosphoproteomics MS analysis confirmed",
    "entities": []
  },
  {
    "text": "PI3K-AKT pathway activation in cervical cells exposed to conditioned media from",
    "entities": []
  },
  {
    "text": "HIV-1-infected T-cells. Together, our findings uncover how HIV-1 reshapes",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cervical cell signaling via paracrine mechanisms and highlights the PI3K pathway",
    "entities": []
  },
  {
    "text": "as a potential therapeutic target in HIV-associated cervical cancer.",
    "entities": []
  },
  {
    "text": "The real-world association between male circumcision and risk of HIV infection",
    "entities": []
  },
  {
    "text": "in sub-Saharan Africa: a household fixed-effects analysis of 279,351 men from 29",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "279,351",
        "label": "CARDINAL"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "countries.",
    "entities": []
  },
  {
    "text": "INTRODUCTION: While voluntary medical male circumcision (VMMC) reduces the",
    "entities": []
  },
  {
    "text": "individual- level risk of HIV acquisition by approximately 60% in",
    "entities": [
      {
        "text": "approximately 60%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "randomised-controlled trials, little is known about the 'real-world' long-term",
    "entities": []
  },
  {
    "text": "effect of medical and traditional male circumcision on the cumulative risk of",
    "entities": []
  },
  {
    "text": "HIV infection. We estimate the association between these for the first time",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "using a quasi-experimental study design-a household fixed-effects analysis-for",
    "entities": []
  },
  {
    "text": "sub- Saharan Africa, the global region with the largest HIV burden.",
    "entities": [
      {
        "text": "Saharan Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: We pooled individual-level cross-sectional data from the",
    "entities": []
  },
  {
    "text": "nationally-representative Demographic and Health Surveys and AIDS Indicator",
    "entities": [
      {
        "text": "Demographic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Surveys across all sub-Saharan African countries in which the surveys included",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "data on both male circumcision and HIV status. We estimated the association",
    "entities": []
  },
  {
    "text": "between male circumcision and HIV status using modified Poisson regression",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "models with household fixed-effects-which control for unobserved and observed",
    "entities": []
  },
  {
    "text": "confounding shared by men living in the same household-and included additional",
    "entities": []
  },
  {
    "text": "individual- level controls for demographic characteristics, socio-economic",
    "entities": []
  },
  {
    "text": "factors, and sexual behaviour.",
    "entities": []
  },
  {
    "text": "RESULTS: We included individual data from 279,351 male participants in 48",
    "entities": [
      {
        "text": "279,351",
        "label": "CARDINAL"
      },
      {
        "text": "48",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nationally- representative surveys conducted in 29 countries between 2003-2018.",
    "entities": [
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "2003-2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The mean survey-level prevalence of male circumcision was 65.9% (median 84.5%,",
    "entities": [
      {
        "text": "65.9%",
        "label": "PERCENT"
      },
      {
        "text": "84.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "IQR 28.8%-68.1%) and HIV was 5.6% (median 2.5%, IQR 1.2%-10.2%). We estimated",
    "entities": [
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "28.8%-68.1%",
        "label": "PERCENT"
      },
      {
        "text": "5.6%",
        "label": "PERCENT"
      },
      {
        "text": "2.5%",
        "label": "PERCENT"
      },
      {
        "text": "1.2%-10.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "that male circumcision was significantly associated with a nearly one-fifth",
    "entities": [
      {
        "text": "nearly one-fifth",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reduction in the cumulative risk of HIV infection (adjusted risk ratio 0.81, 95%",
    "entities": [
      {
        "text": "0.81",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI 0.73-0.89).",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.73-0.89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Male circumcision was associated with a significant reduction in",
    "entities": []
  },
  {
    "text": "the risk of HIV infection in sub-Saharan Africa over the past two decades.",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "the past two decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Increased political and financial commitment to VMMC could likely lead to",
    "entities": []
  },
  {
    "text": "further reductions in HIV prevalence, especially when rolled out as a HIV",
    "entities": []
  },
  {
    "text": "prevention option in combination with other interventions.",
    "entities": []
  },
  {
    "text": "Lingering sex and age disparities in dolutegravir uptake among adults with HIV:",
    "entities": []
  },
  {
    "text": "A multi-country observational cohort study.",
    "entities": []
  },
  {
    "text": "Nash D.",
    "entities": [
      {
        "text": "Nash D.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Since July 2019, the World Health Organization (WHO) has",
    "entities": [
      {
        "text": "July 2019",
        "label": "DATE"
      },
      {
        "text": "the World Health Organization (WHO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recommended dolutegravir (DTG)-based regimens as preferred first-line",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "antiretroviral therapy (ART) for adults and adolescents living with HIV",
    "entities": []
  },
  {
    "text": "(DTG-for-All), a reversal of a 2018 safety alert on use of DTG-based regimens by",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "women of reproductive age (WRA). We examined sex and age disparities in DTG",
    "entities": [
      {
        "text": "WRA",
        "label": "ORG"
      },
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "uptake before and after DTG-for-All in the International epidemiology Databases",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We included patients \u226516 years on or initiating treatment between",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "January 2017 and July 2021 in 14 low- and middle-income countries where initial",
    "entities": [
      {
        "text": "January 2017 and July 2021",
        "label": "DATE"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "guidelines on DTG-based regimens for first-line ART either restricted use by WRA",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "WRA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "or had no such restrictions. We estimated the cumulative incidence of DTG uptake",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CI-DTG) by sex and age group (aged 16-49 years vs. 50+ years), stratified by",
    "entities": [
      {
        "text": "CI-DTG",
        "label": "ORG"
      },
      {
        "text": "16-49 years",
        "label": "DATE"
      },
      {
        "text": "50+ years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patient, clinic and setting characteristics.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 177,706 patients on ART during the study period, 51% were females",
    "entities": [
      {
        "text": "177,706",
        "label": "CARDINAL"
      },
      {
        "text": "51%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "aged 16-49 years, with 25% males aged 16-49, and 13% and 11%, respectively,",
    "entities": [
      {
        "text": "16-49 years",
        "label": "DATE"
      },
      {
        "text": "25%",
        "label": "PERCENT"
      },
      {
        "text": "16-49",
        "label": "DATE"
      },
      {
        "text": "13% and 11%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "females and males aged 50+. At the time of DTG-for-All, overall CI-DTG was 29.6%",
    "entities": [
      {
        "text": "50+",
        "label": "DATE"
      },
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "CI-DTG",
        "label": "ORG"
      },
      {
        "text": "29.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(95%CI: 29.4, 29.8); it was lower among females aged 16-49 (16.2%; 95%CI:",
    "entities": [
      {
        "text": "29.4",
        "label": "CARDINAL"
      },
      {
        "text": "29.8",
        "label": "CARDINAL"
      },
      {
        "text": "16-49",
        "label": "DATE"
      },
      {
        "text": "16.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "16.0-16.5) than males (41.1%; 95%CI: 40.6, 41.5), with no sex disparities among",
    "entities": [
      {
        "text": "16.0",
        "label": "CARDINAL"
      },
      {
        "text": "41.1%",
        "label": "PERCENT"
      },
      {
        "text": "95%CI",
        "label": "CARDINAL"
      },
      {
        "text": "40.6",
        "label": "CARDINAL"
      },
      {
        "text": "41.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients aged 50+ (females: 46.0%; males: 47.0%). While DTG uptake subsequently",
    "entities": [
      {
        "text": "50+",
        "label": "DATE"
      },
      {
        "text": "46.0%",
        "label": "PERCENT"
      },
      {
        "text": "47.0%",
        "label": "PERCENT"
      },
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increased among all groups, by July 2021, it remained substantially lower among",
    "entities": [
      {
        "text": "July 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "females 16-49 (66.4%; 95%CI: 66.1, 66.7), compared with males 16-49 and older",
    "entities": [
      {
        "text": "16-49",
        "label": "DATE"
      },
      {
        "text": "66.4%",
        "label": "PERCENT"
      },
      {
        "text": "95%CI",
        "label": "CARDINAL"
      },
      {
        "text": "66.1",
        "label": "CARDINAL"
      },
      {
        "text": "66.7",
        "label": "DATE"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "females and males (75.8% to 77.5%). Concentrated in countries where initial",
    "entities": [
      {
        "text": "75.8%",
        "label": "PERCENT"
      },
      {
        "text": "77.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "guidelines on DTG restricted use by WRA, disparities in DTG uptake persisted at",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "WRA",
        "label": "ORG"
      },
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "all health system levels and in both low-income and lower-middle income",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: While sex-age differentials in DTG uptake narrowed after WHO's",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "WHO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DTG-for-All recommendation, lingering disparities uptake underscore the",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "challenges of policy de-implementation when new evidence emerges.",
    "entities": []
  },
  {
    "text": "KEY MESSAGES: What is already known on this topic: Prior research illuminated",
    "entities": []
  },
  {
    "text": "substantial sex and age group disparities in uptake of dolutegravir (DTG)-based",
    "entities": []
  },
  {
    "text": "antiretroviral therapy (ART) regimens among people with HIV (PLHIV)-disparities",
    "entities": []
  },
  {
    "text": "that emerged after the World Health Organization (WHO) issued a May 2018 drug",
    "entities": [
      {
        "text": "the World Health Organization (WHO",
        "label": "ORG"
      },
      {
        "text": "May 2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "safety alert for women of reproductive age (WRA) and persisted after subsequent",
    "entities": []
  },
  {
    "text": "guidance in July 2019 recommending DTG-based regimens as preferred first-line",
    "entities": [
      {
        "text": "July 2019",
        "label": "DATE"
      },
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "treatment for all adults and adolescents, irrespective of age and sex.What this",
    "entities": []
  },
  {
    "text": "study adds: Drawing on real-world service delivery data from 72 clinics in 14",
    "entities": [
      {
        "text": "72",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "countries, this study documents the persistence of sex and age group disparities",
    "entities": []
  },
  {
    "text": "in DTG-based regimen uptake. Concentrated in low- and lower-middle income",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "countries where national guidelines initially contained restrictions on use of",
    "entities": []
  },
  {
    "text": "DTG by WRA, these disparities remained substantial at two and three years after",
    "entities": [
      {
        "text": "DTG",
        "label": "ORG"
      },
      {
        "text": "WRA",
        "label": "ORG"
      },
      {
        "text": "two and three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "WHO's \"dolutegravir for all\" guidance among treatment-na\u00efve and",
    "entities": []
  },
  {
    "text": "treatment-experienced PLHIV and were observed at all health system levels.How",
    "entities": []
  },
  {
    "text": "this study might affect research, practice or policy: Our study underscores the",
    "entities": []
  },
  {
    "text": "substantial lags that can occur in updating, disseminating, and translating new",
    "entities": [
      {
        "text": "substantial lags",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "policy guidance into practice, as well as the challenges of de-implementing",
    "entities": []
  },
  {
    "text": "outdated policy recommendations when new evidence emerges-challenges that will",
    "entities": []
  },
  {
    "text": "remain relevant with new treatment regimens, such as injectable ART, on the",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Magnitude and Associated Factors of Early Index Case Testing Among Adult HIV",
    "entities": [
      {
        "text": "Magnitude",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Index Cases at Debre Markos Town High Load Health Facilities 2023.",
    "entities": []
  },
  {
    "text": "Alemayehu D(4), Teshome M(2).",
    "entities": [
      {
        "text": "Teshome",
        "label": "ORG"
      },
      {
        "text": "M(2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Debre Markos Comprehensive Specialized",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Markos Comprehensive Specialized",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Public Health, Debre Markos University, Debre Markos, Ethiopia.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Markos University",
        "label": "ORG"
      },
      {
        "text": "Markos",
        "label": "PERSON"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Laboratory Science, Debre Markos University, Debre",
    "entities": [
      {
        "text": "Medical Laboratory Science",
        "label": "ORG"
      },
      {
        "text": "Markos University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Surgery, Debre Markos University, Debre Markos, Ethiopia.",
    "entities": [
      {
        "text": "Surgery",
        "label": "GPE"
      },
      {
        "text": "Markos University",
        "label": "ORG"
      },
      {
        "text": "Markos",
        "label": "PERSON"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Introduction: Early human immunodeficiency virus (HIV) testing of partners or",
    "entities": []
  },
  {
    "text": "families of the index case is an innovative type of testing which is performed",
    "entities": []
  },
  {
    "text": "within 14 days after contact elicitation using a contractual referral approach.",
    "entities": [
      {
        "text": "14 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Testing within this time is very important because it helps to identify contacts",
    "entities": []
  },
  {
    "text": "early and enroll them for intervention timely. In most health facilities, the",
    "entities": []
  },
  {
    "text": "contractual approach was not practiced; by implementing this early index case",
    "entities": []
  },
  {
    "text": "testing, most contacts could be tested early and it could prevent them from",
    "entities": []
  },
  {
    "text": "HIV-related death. Objective: This study aimed to assess the magnitude and",
    "entities": []
  },
  {
    "text": "associated factors of early index case testing among adult HIV index cases in",
    "entities": []
  },
  {
    "text": "Debre Markos town high case load health facilities. Methods: Institution-based",
    "entities": [
      {
        "text": "Markos",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "cross-sectional study was conducted on adult index cases who started",
    "entities": []
  },
  {
    "text": "antiretroviral therapy from December 1/2018 to August 30/2022. A total of 384",
    "entities": [
      {
        "text": "December 1/2018 to August 30/2022",
        "label": "DATE"
      },
      {
        "text": "384",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "index case charts were selected by the systematic random sampling technique",
    "entities": []
  },
  {
    "text": "using their medical record number from January 23/2023 up to February 28/2023.",
    "entities": [
      {
        "text": "January 23/2023",
        "label": "DATE"
      },
      {
        "text": "February 28/2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "After the data were collected using a structured checklist, they were entered",
    "entities": []
  },
  {
    "text": "into EpiData Version 4.6 and then exported to SPSS software Version 25 for data",
    "entities": [
      {
        "text": "EpiData Version",
        "label": "ORG"
      },
      {
        "text": "4.6",
        "label": "CARDINAL"
      },
      {
        "text": "SPSS",
        "label": "ORG"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cleaning, coding, categorizing, and further analysis. The Hosmer-Lemeshow test",
    "entities": []
  },
  {
    "text": "goodness of fit was checked for model fitness. Both bivariable and multivariable",
    "entities": []
  },
  {
    "text": "logistic regression analyses were used to identify significant factors with",
    "entities": []
  },
  {
    "text": "early testing of index cases' families. Finally, variables having pvalue < 0.05",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with 95% CI in the multivariable logistic regression are considered as",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "significant factors. Result: In this study, the magnitude of early index case",
    "entities": []
  },
  {
    "text": "testing among adult index patients was 28.6% (95% CI: 27.17%-30.0%). Being",
    "entities": [
      {
        "text": "28.6%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "27.17%-30.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "95% CI (1.16-3.03)), and having disclosure status (AOR = 2.34, 95% CI",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.16",
        "label": "CARDINAL"
      },
      {
        "text": "2.34",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1.40-3.92)) were significantly associated with early index case testing.",
    "entities": [
      {
        "text": "1.40-3.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conclusion: This study examines the prevalence and key factors influencing early",
    "entities": []
  },
  {
    "text": "index case HIV testing among adult patients in Debre Markos town. By identifying",
    "entities": [
      {
        "text": "Markos",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "critical determinants such as gender, residence, and disclosure status, it",
    "entities": []
  },
  {
    "text": "provides valuable insights into how early testing can be enhanced to reduce",
    "entities": []
  },
  {
    "text": "transmission and improve health outcomes.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Dessie Tarekegn et al. AIDS Research and Treatment published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Dessie Tarekegn",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.61. J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251359438. doi:",
    "entities": [
      {
        "text": "Int Assoc",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Advancing SRHR for Women Living With HIV: The Role of Meaningful Engagement in",
    "entities": []
  },
  {
    "text": "(1)Department of Theology and Religious Education, De La Salle University,",
    "entities": [
      {
        "text": "Theology and Religious Education",
        "label": "ORG"
      },
      {
        "text": "De La Salle University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Conflicting InterestsThe author",
    "entities": []
  },
  {
    "text": "authorship, and/or publication of this article.",
    "entities": []
  },
  {
    "text": "Cost and clinical flow of point-of-care urine tenofovir testing for treatment",
    "entities": []
  },
  {
    "text": "monitoring among people living with HIV initiating ART in South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Global Health, University of Washington, Seattle, Washington,",
    "entities": [
      {
        "text": "Global Health, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)National Health Laboratory Service (NHLS), Durban, South Africa.",
    "entities": [
      {
        "text": "Health Laboratory Service",
        "label": "ORG"
      },
      {
        "text": "NHLS",
        "label": "ORG"
      },
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Centre for the AIDS Program of Research in South Africa (CAPRISA), University",
    "entities": [
      {
        "text": "3)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "the AIDS Program of Research",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      },
      {
        "text": "CAPRISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of KwaZulu-Natal, Durban, South Africa.",
    "entities": [
      {
        "text": "KwaZulu-Natal",
        "label": "ORG"
      },
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South",
    "entities": [
      {
        "text": "4)eThekwini",
        "label": "CARDINAL"
      },
      {
        "text": "Municipality Health Unit",
        "label": "ORG"
      },
      {
        "text": "eThekwini Municipality",
        "label": "GPE"
      },
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Africa.",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(5)Nuffield Department of Primary Care Health Sciences, University of Oxford,",
    "entities": [
      {
        "text": "Department of Primary Care Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Oxford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Oxford, UK.",
    "entities": [
      {
        "text": "Oxford",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)School of Medicine, University of California, San Francisco, California, USA.",
    "entities": [
      {
        "text": "Medicine, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Discipline of Public Health Medicine, School of Nursing and Public Health,",
    "entities": [
      {
        "text": "Public Health Medicine, School of Nursing and Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of KwaZulu-Natal, Durban, South Africa.",
    "entities": [
      {
        "text": "University of KwaZulu-Natal",
        "label": "ORG"
      },
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Medicine, University of Washington, Seattle, Washington, USA.",
    "entities": [
      {
        "text": "Medicine, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Epidemiology, University of Washington, Seattle, Washington,",
    "entities": [
      {
        "text": "Epidemiology, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Point-of-care (POC) urine tenofovir (TFV) tests can provide timely",
    "entities": []
  },
  {
    "text": "information regarding antiretroviral therapy (ART) adherence to support",
    "entities": []
  },
  {
    "text": "management of HIV treatment in clinics. However, there are limited data on the",
    "entities": []
  },
  {
    "text": "costs and feasibility of integrating POC testing into HIV clinics in sub-Saharan",
    "entities": []
  },
  {
    "text": "Africa. We characterized clinic flow and implementation costs of POC adherence",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "testing for persons initiating ART in HIV care clinics in South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a microcosting within a randomized controlled",
    "entities": []
  },
  {
    "text": "implementation trial of POC TFV test in government clinics in Durban, South",
    "entities": [
      {
        "text": "Durban",
        "label": "ORG"
      },
      {
        "text": "South",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Africa (STREAM HIV). Time-and-motion observation was conducted between 1st March",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "between 1st March",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 31st December 2022, to assess staff and client time needed for POC TFV",
    "entities": [
      {
        "text": "31st December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "testing and counselling. We estimated both financial and economic costs for",
    "entities": []
  },
  {
    "text": "capital, clinic consumables and personnel using a provider (national government)",
    "entities": []
  },
  {
    "text": "perspective.",
    "entities": []
  },
  {
    "text": "RESULTS: The estimated cost of POC TFV was USD $13 per client, assuming a clinic",
    "entities": [
      {
        "text": "USD $13",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "volume of 20 individuals initiating ART per month. The largest component costs",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of POC TFV testing were the test strip consumables, which accounted for 53% of",
    "entities": [
      {
        "text": "53%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the test cost. The median total time of a clinic visit with a POC TFV test,",
    "entities": []
  },
  {
    "text": "starting from client registration, was 49:19 (minutes: seconds) (IQR:",
    "entities": [
      {
        "text": "49:19 (minutes: seconds",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "29:19-89:35). TFV testing took 9:22 (IQR: 7:35-14:11), taking up 19% of the",
    "entities": [
      {
        "text": "29:19-89:35",
        "label": "TIME"
      },
      {
        "text": "9:22",
        "label": "TIME"
      },
      {
        "text": "7:35-14:11",
        "label": "DATE"
      },
      {
        "text": "19%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "total clinic visit time, including sample collection, sample loading, TFV test",
    "entities": []
  },
  {
    "text": "processing and counselling provision based on test results. Overall, 29% of the",
    "entities": [
      {
        "text": "29%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "clinic visit time included direct clinical care and assessment with a provider,",
    "entities": []
  },
  {
    "text": "with clients spending a median 14:09 (IQR: 10:35-21:22) getting vitals checked,",
    "entities": [
      {
        "text": "14:09",
        "label": "TIME"
      },
      {
        "text": "10:35-21:22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "receiving adherence monitoring via POC TFV testing, and collecting their ART",
    "entities": []
  },
  {
    "text": "refill. Waiting in line for ART took most (48%) of the clinic visit time.",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      },
      {
        "text": "48%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: POC TFV testing can be administered at reasonable costs, requires",
    "entities": []
  },
  {
    "text": "less than 10 minutes of healthcare provider time, and, therefore, may be",
    "entities": [
      {
        "text": "less than 10 minutes",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "feasible to implement in South African clinics. Findings can inform policy and",
    "entities": [
      {
        "text": "South African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "budgetary planning for ART monitoring in South Africa and future",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "cost-effectiveness analyses of POC TFV testing.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Journal of the International AIDS Society published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "the International AIDS Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "John Wiley & Sons Ltd on behalf of the International AIDS Society.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd",
        "label": "PERSON"
      },
      {
        "text": "the International AIDS Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40660747 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660747",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "63. Vox Sang. 2025 Jul 14. doi: 10.1111/vox.70071. Online ahead of print.",
    "entities": [
      {
        "text": "63",
        "label": "CARDINAL"
      },
      {
        "text": "Vox Sang",
        "label": "PERSON"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Risk factors for incident human immunodeficiency virus infection in South",
    "entities": [
      {
        "text": "South",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "African blood donors.",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Swanevelder R(1), Hemingway-Foday JJ(3), Murphy EL(4)(5), Custer B(4)(5).",
    "entities": [
      {
        "text": "Swanevelder R(1",
        "label": "ORG"
      },
      {
        "text": "Hemingway-Foday",
        "label": "ORG"
      },
      {
        "text": "Murphy EL(4)(5",
        "label": "PERSON"
      },
      {
        "text": "Custer B(4)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)South African National Blood Service, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "1)South",
        "label": "CARDINAL"
      },
      {
        "text": "African National Blood Service",
        "label": "ORG"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Clinical Medicine, Faculty of Health Sciences, University of the",
    "entities": [
      {
        "text": "Clinical Medicine, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of the\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Free State, Bloemfontein, South Africa.",
    "entities": [
      {
        "text": "Bloemfontein",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)RTI International, Rockville, Maryland, USA.",
    "entities": [
      {
        "text": "3)RTI International",
        "label": "ORG"
      },
      {
        "text": "Rockville",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Epidemiology and Health Policy Science, Vitalant Research Institute, San",
    "entities": [
      {
        "text": "Health Policy Science",
        "label": "ORG"
      },
      {
        "text": "Vitalant Research Institute",
        "label": "ORG"
      },
      {
        "text": "San\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Laboratory Medicine and Epidemiology/Biostatistics, University",
    "entities": [
      {
        "text": "Laboratory Medicine and Epidemiology/Biostatistics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of California San Francisco, San Francisco, California, USA.",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND AND OBJECTIVES: Recruiting blood donors among a population with a",
    "entities": []
  },
  {
    "text": "high human immunodeficiency virus (HIV) burden requires detailed information on",
    "entities": []
  },
  {
    "text": "HIV risks. We studied demographic and behavioural risk factors for incident HIV",
    "entities": []
  },
  {
    "text": "infection among blood donors in South Africa.",
    "entities": [
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: We conducted a case-control study. Incident HIV was",
    "entities": []
  },
  {
    "text": "defined as HIV antibody negative and RNA positive, or concordant serology and",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RNA positive with a limiting antigen avidity assay optical density of <1.5.",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cases were matched to infection-negative controls (ratio 1:3) on race, age and",
    "entities": [
      {
        "text": "1:3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "geography. Risk factors in the 6 months before donation were ascertained by",
    "entities": [
      {
        "text": "the 6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "audio computer-assisted self-interview. Data were fitted using separate",
    "entities": []
  },
  {
    "text": "RESULTS: From April 2014 to March 2017, we enrolled 323 people with incident HIV",
    "entities": [
      {
        "text": "April 2014 to March 2017",
        "label": "DATE"
      },
      {
        "text": "323",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 877 controls. Among women, incident HIV was associated with sex with a",
    "entities": [
      {
        "text": "877",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "person living with HIV (PLWH) or unknown HIV status, multiple male sex partners,",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "never or occasional condom use, anal preparation before sex, first-time donor",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "status and referral to donation by a healthcare worker. Among men, incident HIV",
    "entities": []
  },
  {
    "text": "was associated with being aged 31-40 years, sex with a PLWH or unknown HIV",
    "entities": [
      {
        "text": "31-40 years",
        "label": "DATE"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gay/bisexual identity, marriage or stable partnership, lower education,",
    "entities": []
  },
  {
    "text": "penetrative injury, occasional condom use and first-time or lapsed donor status.",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Some novel or indirect risks for incident HIV were also observed.",
    "entities": []
  },
  {
    "text": "CONCLUSION: We confirmed the known sexual behaviours asked on the donor",
    "entities": []
  },
  {
    "text": "screening questionnaire. The findings highlight ongoing challenges in donor",
    "entities": []
  },
  {
    "text": "disclosure during selection and the importance of donor education.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Vox Sanguinis published by John Wiley & Sons Ltd on behalf",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Vox Sanguinis",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of International Society of Blood Transfusion.",
    "entities": [
      {
        "text": "International Society of Blood Transfusion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "64. HIV Med. 2025 Jul 14. doi: 10.1111/hiv.70078. Online ahead of print.",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Trends in HIV/AIDS cases in Kyrgyzstan between 2012 and 2022: An ecological",
    "entities": [
      {
        "text": "Kyrgyzstan",
        "label": "GPE"
      },
      {
        "text": "between 2012 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Public Health Department, Health Science Institute, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t",
    "entities": [
      {
        "text": "Health Department",
        "label": "ORG"
      },
      {
        "text": "Health Science Institute",
        "label": "ORG"
      },
      {
        "text": "Y\u0131ld\u0131r\u0131m Beyaz\u0131t",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: HIV/AIDS continues to exert a significant toll on health care",
    "entities": []
  },
  {
    "text": "systems and governments worldwide, including in Kyrgyzstan, impacting the health",
    "entities": [
      {
        "text": "Kyrgyzstan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and well-being of millions. The aim of this study was to examine how the",
    "entities": [
      {
        "text": "millions",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patterns of HIV transmission in Kyrgyzstan evolved between 2012 and 2022.",
    "entities": [
      {
        "text": "Kyrgyzstan",
        "label": "GPE"
      },
      {
        "text": "between 2012 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: This ecological study employed retrospective data collection.",
    "entities": []
  },
  {
    "text": "Quantitative methods were employed to assess and analyse changes in patterns of",
    "entities": []
  },
  {
    "text": "HIV transmission, as well as co-infections such as HIV + hepatitis B virus (HBV)",
    "entities": []
  },
  {
    "text": "and HIV + hepatitis C virus (HCV), across individuals with varying modes of HIV",
    "entities": []
  },
  {
    "text": "RESULTS: HIV incidence increased from 8.36 to 14.56 per 100 000 populations",
    "entities": [
      {
        "text": "8.36",
        "label": "CARDINAL"
      },
      {
        "text": "14.56",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "between 2013 and 2022, with the most significant rise among females, from 8.42",
    "entities": [
      {
        "text": "between 2013 and 2022",
        "label": "DATE"
      },
      {
        "text": "8.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "per 100 000 in 2020 to 11.72 per 100 000 in 2022. The study also highlighted an",
    "entities": [
      {
        "text": "100 000",
        "label": "CARDINAL"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "11.72",
        "label": "CARDINAL"
      },
      {
        "text": "100 000",
        "label": "CARDINAL"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "increase in new HIV cases via heterosexual transmission (from 71.7% in 2020 to",
    "entities": [
      {
        "text": "71.7%",
        "label": "PERCENT"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "81.9% in 2022), and men who have sex with men (MSM)transmission (from 40 cases",
    "entities": [
      {
        "text": "81.9%",
        "label": "PERCENT"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in 2020 to 75 cases in 2022), while transmission among people who inject drugs",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "dropped significantly (from 201 cases in 2017 to 21 cases in 2022). Notably,",
    "entities": [
      {
        "text": "201",
        "label": "CARDINAL"
      },
      {
        "text": "2017",
        "label": "DATE"
      },
      {
        "text": "21",
        "label": "CARDINAL"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "there were reductions in new HIV infections through vertical transmission,",
    "entities": []
  },
  {
    "text": "medical procedures and co-infections with HIV + HBV and HIV + HCV.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Between 2012 and 2022, HIV incidence saw a significant rise,",
    "entities": [
      {
        "text": "Between 2012 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "especially among individuals aged 18-29 and 30-39 years, with a marked increase",
    "entities": [
      {
        "text": "18-29",
        "label": "DATE"
      },
      {
        "text": "30-39 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "among females. The study revealed a shift in transmission modes over this",
    "entities": []
  },
  {
    "text": "period. While new infections among people who inject drugs declined, there was",
    "entities": []
  },
  {
    "text": "an uptick in cases reported among MSM and the general population in the country.",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co-Occurrence of HIV-Susceptibility and -Protective HLA Alleles Is a Possible",
    "entities": [
      {
        "text": "Co-Occurrence of HIV-Susceptibility",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Contributor to the Development of Primary HIV-Associated Thrombocytopenia",
    "entities": [
      {
        "text": "the Development of Primary HIV-Associated Thrombocytopenia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(PHAT): A Cross-Sectional Study.",
    "entities": [
      {
        "text": "PHAT",
        "label": "ORG"
      },
      {
        "text": "Cross-Sectional Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Human Molecular Biology Unit, School of Biomedical Sciences, Faculty of",
    "entities": [
      {
        "text": "1)Human",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Biology Unit",
        "label": "ORG"
      },
      {
        "text": "School of Biomedical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, University of the Free State, Bloemfontein, South Africa.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of the Free State",
        "label": "ORG"
      },
      {
        "text": "Bloemfontein",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Haematology and Cell Biology, School of Pathology, Faculty of",
    "entities": [
      {
        "text": "Haematology and Cell Biology, School of Pathology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)National Health Laboratory Service, Universitas Academic Hospital,",
    "entities": [
      {
        "text": "3)National Health Laboratory Service",
        "label": "ORG"
      },
      {
        "text": "Universitas Academic Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bloemfontein, South Africa.",
    "entities": [
      {
        "text": "Bloemfontein",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Primary HIV-associated thrombocytopenia (PHAT) is an isolated thrombocytopenia",
    "entities": [
      {
        "text": "PHAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in HIV-positive individuals in the absence of secondary causes. The presence of",
    "entities": []
  },
  {
    "text": "certain Human Leukocyte Antigens (HLA) has been linked to individuals' immune",
    "entities": [
      {
        "text": "Leukocyte Antigens",
        "label": "PERSON"
      },
      {
        "text": "HLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "response to HIV and the development of immune-mediated thrombocytopenic",
    "entities": []
  },
  {
    "text": "disorders. Considering the established associations between HLA and HIV",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection and HLA and immune-mediated thrombocytopenias, we hypothesise that",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "specific HLA alleles may also increase the risk of developing PHAT, a condition",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      },
      {
        "text": "PHAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that links both HIV and immune-mediated thrombocytopenia. Therefore, the study",
    "entities": []
  },
  {
    "text": "aimed to determine the frequency of high-resolution HLA alleles in patients",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presenting with possible PHAT. Following a detailed screening process, we",
    "entities": [
      {
        "text": "PHAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "evaluated the HLA profiles of 43 participants with probable PHAT using the Axiom",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      },
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "PHAT",
        "label": "ORG"
      },
      {
        "text": "Axiom",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Precision Medicine Diversity Array (PMDA) Kit on the GeneTitan Multi-Channel",
    "entities": []
  },
  {
    "text": "instrument. No single HLA allele was found to be more prominent in our PHAT",
    "entities": [
      {
        "text": "HLA",
        "label": "ORG"
      },
      {
        "text": "PHAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "population. However, 93.02% of participants had both HIV-protective and",
    "entities": [
      {
        "text": "93.02%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "HIV-susceptible alleles. The potential mechanism causing thrombocytopenia to be",
    "entities": []
  },
  {
    "text": "the only clinically relevant haematological abnormality in these patients",
    "entities": []
  },
  {
    "text": "remains to be explored. We concluded that the presence of both an HIV-protective",
    "entities": []
  },
  {
    "text": "and HIV-susceptibility allele in the same individual may cause antagonistic",
    "entities": []
  },
  {
    "text": "immune reactions, resulting in thrombocytopenia in HIV-positive individuals. We",
    "entities": []
  },
  {
    "text": "propose future long-term follow-up studies to determine the progression and",
    "entities": []
  },
  {
    "text": "outcome in patients with PHAT.",
    "entities": [
      {
        "text": "PHAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). International Journal of Immunogenetics published by John",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "International Journal of Immunogenetics",
        "label": "ORG"
      },
      {
        "text": "John\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Genetic diversity of HIV in Yunnan, China: the role of second-generation",
    "entities": [
      {
        "text": "Yunnan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "recombination involving circulating and unique recombinant forms.",
    "entities": []
  },
  {
    "text": "(1)Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan",
    "entities": [
      {
        "text": "Pathogenic Biology, School of Basic Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Gannan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Ganzhou, 341000, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Ganzhou",
        "label": "GPE"
      },
      {
        "text": "341000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of HIV/AIDS and STD Prevention and Control, Baoshan Center for",
    "entities": [
      {
        "text": "STD Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention, Baoshan, 678000, China.",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Baoshan",
        "label": "GPE"
      },
      {
        "text": "678000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Baoshan People's Hospital, Baoshan, 678000, China.",
    "entities": [
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Baoshan",
        "label": "GPE"
      },
      {
        "text": "678000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)School of Basic Medical Sciences, Baoshan College of Traditional Chinese",
    "entities": [
      {
        "text": "Basic Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Baoshan College of Traditional Chinese",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Baoshan, 678000, China.",
    "entities": [
      {
        "text": "Baoshan",
        "label": "GPE"
      },
      {
        "text": "678000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan",
    "entities": [
      {
        "text": "Pathogenic Biology, School of Basic Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Gannan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Ganzhou, 341000, China. baiyjqqq@126.com.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Ganzhou",
        "label": "GPE"
      },
      {
        "text": "341000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The genetic diversity of HIV is significantly influenced by",
    "entities": []
  },
  {
    "text": "second-generation recombination events involving circulating recombinant forms",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(CRFs) and unique recombinant forms (URFs), which are crucial for the virus's",
    "entities": []
  },
  {
    "text": "evolution and dissemination. The China-Myanmar border region is recognized as a",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Myanmar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "focal point for inter-subtype recombination of HIV, with recombinant strains",
    "entities": []
  },
  {
    "text": "predominating in this area.",
    "entities": []
  },
  {
    "text": "METHODS: Near full-length HIV genomes were amplified from plasma samples of",
    "entities": []
  },
  {
    "text": "eight Burmese individuals newly diagnosed with HIV in Baoshan, China, from 2006",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "Burmese",
        "label": "NORP"
      },
      {
        "text": "Baoshan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "2006",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to 2020. Phylogenetic trees were constructed using maximum likelihood methods,",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and Bootscan analysis was conducted to identify recombination structures.",
    "entities": [
      {
        "text": "Bootscan",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "RESULTS: Among the eight sequences, one (YN33F28) clustered with subtype C, and",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "one (YN9M24) with CRF08_BC. The remaining six sequences did not cluster with any",
    "entities": [
      {
        "text": "YN9M24",
        "label": "GPE"
      },
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "known HIV subtypes, indicating they might represent novel recombinant strains.",
    "entities": []
  },
  {
    "text": "Bootscan analysis revealed that three sequences (YN36F38, YN35F22, and YN32M22)",
    "entities": [
      {
        "text": "Bootscan",
        "label": "NORP"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were likely formed through second-generation recombination involving known CRFs",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(CRF82_cpx and CRF86_BC) and a URF (KY406739). Additionally, three sequences",
    "entities": [
      {
        "text": "KY406739",
        "label": "FAC"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(YN34F21, YN7F27, and YN8F28) were identified as newly formed URFs, resulting",
    "entities": [
      {
        "text": "YN8F28",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "from complex recombination events between HIV subtypes B, C, and CRF01_AE.",
    "entities": [
      {
        "text": "CRF01_AE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSION: These results underscore the continuous evolution of HIV via",
    "entities": []
  },
  {
    "text": "recombination in the China-Myanmar border region. The identification of",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Myanmar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "second-generation recombinants and newly formed URFs highlights the importance",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "of continuous molecular surveillance to better understand HIV diversity and to",
    "entities": []
  },
  {
    "text": "inform strategies for prevention, treatment, and vaccine development.",
    "entities": []
  },
  {
    "text": "PMID: 40660300 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660300",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: This study was conducted in accordance with the Declaration of",
    "entities": [
      {
        "text": "the Declaration of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Helsinki, and the protocol was approved by the Ethics Committee of Gannan",
    "entities": [
      {
        "text": "Helsinki",
        "label": "ORG"
      },
      {
        "text": "the Ethics Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical University (approval number: 2019037; approval date: February 6, 2019).",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "2019037",
        "label": "CARDINAL"
      },
      {
        "text": "February 6, 2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Written informed consent was obtained from all participants prior to the",
    "entities": []
  },
  {
    "text": "collection of whole blood samples. Consent for publication: All the subjects",
    "entities": []
  },
  {
    "text": "provided informed consent for inclusion before they participated in the study.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "67. Int J Equity Health. 2025 Jul 14;24(1):205. doi: 10.1186/s12939-025-02584-2.",
    "entities": [
      {
        "text": "67",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Equity Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "14;24(1):205",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bridging the gap: telemedicine as a solution for HIV care inequities in rural",
    "entities": []
  },
  {
    "text": "(1)Department of Sociology and Anthropology, University of Nigeria Nsukka,",
    "entities": [
      {
        "text": "University of Nigeria Nsukka",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Research and Publications, Kampala International University, P.",
    "entities": [
      {
        "text": "Research and Publications",
        "label": "ORG"
      },
      {
        "text": "Kampala International University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Biochemistry, Faculty of Science, Ebonyi State University,",
    "entities": [
      {
        "text": "Biochemistry, Faculty of Science, Ebonyi State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Research and Publications, Kampala International University, P.",
    "entities": [
      {
        "text": "Research and Publications",
        "label": "ORG"
      },
      {
        "text": "Kampala International University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "continue to exist, especially in rural and populations vulnerable to HIV, where",
    "entities": []
  },
  {
    "text": "factors such as distance, low income, prejudice, and a shortage of healthcare",
    "entities": []
  },
  {
    "text": "workers contribute to delayed diagnosis and inadequate care.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This commentary explores how telemedicine can close the healthcare",
    "entities": []
  },
  {
    "text": "disparity gap for HIV patients in rural and vulnerable settings by bringing care",
    "entities": []
  },
  {
    "text": "closer and decreasing stigma.",
    "entities": []
  },
  {
    "text": "METHODS: The study analyzed primary sources, such as articles from PubMed,",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science Direct, the Web of Science, and WHO reports from 2020 to 2024, including",
    "entities": [
      {
        "text": "Science Direct",
        "label": "ORG"
      },
      {
        "text": "WHO",
        "label": "ORG"
      },
      {
        "text": "2020 to 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "case studies, to examine the role of telemedicine in global HIV care. It",
    "entities": []
  },
  {
    "text": "assessed challenges, effectiveness, and infrastructural barriers, as well as",
    "entities": []
  },
  {
    "text": "policy implications.",
    "entities": []
  },
  {
    "text": "RESULTS: Telemedicine in HIV care for rural and vulnerable groups includes",
    "entities": []
  },
  {
    "text": "virtual consultation, monitoring, telehealth, digital health education,",
    "entities": []
  },
  {
    "text": "diagnostic services, telecounselling, telemental health, telepreventive care,",
    "entities": []
  },
  {
    "text": "and emergency services. It improves treatment involvement, reduces travel,",
    "entities": []
  },
  {
    "text": "ensures confidentiality, and reduces social disapproval. However, internet",
    "entities": []
  },
  {
    "text": "inefficiency and infrastructure issues in isolated regions hinder its use.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Telemedicine effectively addresses HIV care gaps in rural and",
    "entities": []
  },
  {
    "text": "high-risk populations by increasing service utilization, reducing stigma, and",
    "entities": []
  },
  {
    "text": "improving patient care quality; however, long-term sustainability requires",
    "entities": []
  },
  {
    "text": "infrastructure improvements and internet connectivity issues.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12939-025-02584-2",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40660269 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660269",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Consent for publication: All",
    "entities": []
  },
  {
    "text": "Authors read and approved the manuscript for publication. Competing interests:",
    "entities": []
  },
  {
    "text": "The authors declare no competing interests. Ethics approval: Not applicable.",
    "entities": []
  },
  {
    "text": "68. Acad Psychiatry. 2025 Jul 14. doi: 10.1007/s40596-025-02183-x. Online ahead",
    "entities": [
      {
        "text": "68",
        "label": "CARDINAL"
      },
      {
        "text": "Acad Psychiatry",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Towards Ending the HIV Epidemic: The Case for Incorporating PrEP Prescribing",
    "entities": []
  },
  {
    "text": "into Psychiatric Training.",
    "entities": [
      {
        "text": "Psychiatric Training",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, PA,",
    "entities": [
      {
        "text": "Jefferson University Sidney Kimmel Medical College",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, PA,",
    "entities": [
      {
        "text": "Jefferson University Sidney Kimmel Medical College",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The University of California, Irvine School of Medicine, Irvine, CA, USA.",
    "entities": [
      {
        "text": "3)The University of California, Irvine School of Medicine, Irvine",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Disclosures: On behalf of all",
    "entities": []
  },
  {
    "text": "authors, the corresponding author states that there is no conflict of interest.",
    "entities": []
  },
  {
    "text": "Reprint Permission for CDC Materials: Please note, usage of materials from the",
    "entities": [
      {
        "text": "Reprint Permission",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CDC does not imply endorsement by the CDC, ATSDR, Department of Health and Human",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "ATSDR",
        "label": "ORG"
      },
      {
        "text": "Department of Health and Human",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Services, or the United States Government of the authors or the authors\u2019",
    "entities": [
      {
        "text": "the United States Government",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "institution. References to specific commercial products do not constitute its",
    "entities": []
  },
  {
    "text": "endorsement or recommendation by the US Government, ATSDR, Department of Health",
    "entities": [
      {
        "text": "the US Government",
        "label": "ORG"
      },
      {
        "text": "ATSDR",
        "label": "ORG"
      },
      {
        "text": "Department of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Human Services, or Centers for Disease Control and Prevention. All",
    "entities": [
      {
        "text": "Centers for Disease Control and Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "charts/tables that were attributed to the CDC are available on the agency\u2019s",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "website for no charge.",
    "entities": []
  },
  {
    "text": "Follow-up of phenotype and metabolic changes in adult males living with HIV on",
    "entities": []
  },
  {
    "text": "combination antiretroviral therapy (CART) for a decade.",
    "entities": [
      {
        "text": "a decade",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Endocrinology, Diabetes and Metabolism, Christian Medical",
    "entities": [
      {
        "text": "Christian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Infectious Diseases, Christian Medical College Vellore,",
    "entities": [
      {
        "text": "Christian Medical College Vellore",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Biostatistics, Christian Medical College Vellore, Vellore,",
    "entities": [
      {
        "text": "Biostatistics,",
        "label": "ORG"
      },
      {
        "text": "Christian Medical College Vellore",
        "label": "ORG"
      },
      {
        "text": "Vellore",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Endocrinology, Diabetes and Metabolism, Christian Medical",
    "entities": [
      {
        "text": "Christian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Centre for Stem Cell Research (CSCR), Christian Medical College Vellore, (A",
    "entities": [
      {
        "text": "5)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Stem Cell Research",
        "label": "ORG"
      },
      {
        "text": "Christian Medical College Vellore",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Combination Antiretroviral Therapy (CART) is the mainstay in the treatment of",
    "entities": []
  },
  {
    "text": "HIV infection. However, long-term CART causes fat redistribution, insulin",
    "entities": []
  },
  {
    "text": "resistance, and dyslipidaemia in patients living with HIV (PLWH). There is",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "limited data from India that have studied these features exclusively in males.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "In this cross- sectional, observational study, male PLWH (n = 29; mean age: 45.5",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "45.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years) treated on CART for a decade and above were recruited by purposive",
    "entities": [
      {
        "text": "a decade",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "sampling method. Anthropometry and skinfold thickness were measured. Body",
    "entities": []
  },
  {
    "text": "composition analysis was done by DXA. Surrogate indices of insulin resistance",
    "entities": [
      {
        "text": "DXA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(HOMA-IR, HOMA-Beta, and FG-IR) and insulin sensitivity (Mcauley index and",
    "entities": [
      {
        "text": "FG-IR",
        "label": "ORG"
      },
      {
        "text": "Mcauley",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "QUICKI) were calculated. At end of the study period, Zidovudine-based ART",
    "entities": [
      {
        "text": "QUICKI",
        "label": "ORG"
      },
      {
        "text": "Zidovudine",
        "label": "NORP"
      },
      {
        "text": "ART\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "accounted for 54.57% while Stavudine and Tenofovir based ART accounted for",
    "entities": [
      {
        "text": "54.57%",
        "label": "PERCENT"
      },
      {
        "text": "Stavudine",
        "label": "PERSON"
      },
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "28.37% and 17.05% respectively. Male PLWH on CART for more than a decade",
    "entities": [
      {
        "text": "28.37%",
        "label": "PERCENT"
      },
      {
        "text": "17.05%",
        "label": "PERCENT"
      },
      {
        "text": "more than a decade",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "featured increased body weight, higher body fat percentage, total body fat mass",
    "entities": []
  },
  {
    "text": "higher abdominal adiposity and increased fat mass in upper limbs alongside,",
    "entities": []
  },
  {
    "text": "Furthemore, reduced beta cell function, impaired glucose tolerance, insulin",
    "entities": []
  },
  {
    "text": "resistance and lower testosterone levels were observed. The proportion of PLWH",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with diabetes, prediabetes and non-diabetic individuals were (20.6% n = 6),",
    "entities": [
      {
        "text": "20.6%",
        "label": "PERCENT"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(34.5%; n = 10) and (44.8%: n = 13) respectively.",
    "entities": [
      {
        "text": "34.5%",
        "label": "PERCENT"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "44.8%",
        "label": "PERCENT"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41598-025-08083-2",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40659679 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659679",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: The authors",
    "entities": []
  },
  {
    "text": "declare no conflict of interest in this study. Financial disclosure: This study",
    "entities": []
  },
  {
    "text": "was supported by the Fluid Research Grant from CMC Vellore, India.",
    "entities": [
      {
        "text": "the Fluid Research Grant",
        "label": "ORG"
      },
      {
        "text": "CMC Vellore",
        "label": "ORG"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Print 2025 Oct.",
    "entities": []
  },
  {
    "text": "A lyophilized open-source RT-LAMP assay for molecular diagnostics in",
    "entities": [
      {
        "text": "RT-LAMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resource-limited settings.",
    "entities": []
  },
  {
    "text": "Prieto-Godino LL(8)(9), Penninger JM(2)(4)(10); Vienna Covid-19 Detection",
    "entities": [
      {
        "text": "Penninger JM(2)(4)(10",
        "label": "PERSON"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Initiative (VCDI); Awandare GA(11), Brennecke J(12), Pauli A(13).",
    "entities": [
      {
        "text": "VCDI",
        "label": "ORG"
      },
      {
        "text": "Brennecke J(12",
        "label": "PERSON"
      },
      {
        "text": "Pauli",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC),",
    "entities": [
      {
        "text": "Institute of Molecular Pathology",
        "label": "ORG"
      },
      {
        "text": "IMP",
        "label": "ORG"
      },
      {
        "text": "Vienna BioCenter",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Institute of Molecular Biotechnology of the Austrian Academy of Sciences",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Biotechnology",
        "label": "ORG"
      },
      {
        "text": "the Austrian Academy of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and",
    "entities": [
      {
        "text": "3)Vienna",
        "label": "CARDINAL"
      },
      {
        "text": "BioCenter PhD Program",
        "label": "ORG"
      },
      {
        "text": "Doctoral School",
        "label": "ORG"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University of Vienna, Vienna, Austria.",
    "entities": [
      {
        "text": "Medical University of Vienna",
        "label": "ORG"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, Medical University of Vienna, Vienna,",
    "entities": [
      {
        "text": "Laboratory Medicine, Medical University of Vienna",
        "label": "ORG"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)West African Center for Cell Biology of Infectious Pathogens (WACCBIP),",
    "entities": [
      {
        "text": "African Center for Cell Biology of Infectious Pathogens",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Basic and Applied Sciences, University of Ghana, Legon, Ghana.",
    "entities": [
      {
        "text": "Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Ghana",
        "label": "ORG"
      },
      {
        "text": "Legon",
        "label": "GPE"
      },
      {
        "text": "Ghana",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Biology, University of Fribourg, Fribourg, Switzerland.",
    "entities": [
      {
        "text": "Biology, University of Fribourg",
        "label": "ORG"
      },
      {
        "text": "Fribourg",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)TReND in Africa, Brighton, UK.",
    "entities": [
      {
        "text": "8)TReND",
        "label": "CARDINAL"
      },
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "Brighton",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)The Francis Crick Research Institute, London, UK.",
    "entities": [
      {
        "text": "Francis Crick Research Institute",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)West African Center for Cell Biology of Infectious Pathogens (WACCBIP),",
    "entities": [
      {
        "text": "African Center for Cell Biology of Infectious Pathogens",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Basic and Applied Sciences, University of Ghana, Legon, Ghana",
    "entities": [
      {
        "text": "Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Ghana",
        "label": "ORG"
      },
      {
        "text": "Legon",
        "label": "GPE"
      },
      {
        "text": "Ghana",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Institute of Molecular Biotechnology of the Austrian Academy of Sciences",
    "entities": [
      {
        "text": "12)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "the Austrian Academy of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC),",
    "entities": [
      {
        "text": "13)Research Institute of Molecular Pathology",
        "label": "ORG"
      },
      {
        "text": "IMP",
        "label": "ORG"
      },
      {
        "text": "Vienna BioCenter",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "A critical bottleneck for equitable access to population-scale molecular",
    "entities": []
  },
  {
    "text": "diagnostics is the limited availability of rapid, inexpensive point-of-care",
    "entities": []
  },
  {
    "text": "tests, especially in low- and middle-income countries. Here, we developed an",
    "entities": []
  },
  {
    "text": "open-source reverse transcription loop-mediated isothermal amplification",
    "entities": [
      {
        "text": "transcription",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(RT-LAMP) molecular assay for pathogen detection. It is based on nonproprietary",
    "entities": [
      {
        "text": "RT-LAMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enzymes, namely, HIV-1 reverse transcriptase, Bst LF DNA polymerase, and UDG",
    "entities": [
      {
        "text": "Bst LF",
        "label": "PERSON"
      },
      {
        "text": "UDG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BMTU thermolabile uracil-DNA glycosylase. Formulated as liquid or lyophilized",
    "entities": [
      {
        "text": "BMTU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reaction mixtures, these reagents enable sensitive colorimetric detection of",
    "entities": []
  },
  {
    "text": "respiratory samples without the need for prior nucleic acid isolation. We",
    "entities": []
  },
  {
    "text": "evaluated our lyophilized RT-LAMP assay on clinical samples with suspected",
    "entities": [
      {
        "text": "RT-LAMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 infection, demonstrating high sensitivity and 100% specificity compared",
    "entities": [
      {
        "text": "100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with the gold-standard RT-qPCR. Reaction performance was unaffected by prolonged",
    "entities": [
      {
        "text": "RT-qPCR",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "storage of lyophilized reagents at ambient or elevated temperatures. As a proof",
    "entities": []
  },
  {
    "text": "of concept, we evaluated the robustness and ease of use of lyophilized RT-LAMP",
    "entities": [
      {
        "text": "RT-LAMP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reaction mixes through independent laboratory testing of COVID-19 samples in",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ghana. Overall, our open-source RT-LAMP assay provides a flexible and scalable",
    "entities": [
      {
        "text": "Ghana",
        "label": "GPE"
      },
      {
        "text": "RT-LAMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "point-of-care test that can be adapted for rapid detection of various pathogens",
    "entities": []
  },
  {
    "text": "in resource-limited settings.",
    "entities": []
  },
  {
    "text": "PMID: 40659489 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659489",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no conflict",
    "entities": []
  },
  {
    "text": "of interest.",
    "entities": []
  },
  {
    "text": "Print 2025 Sep.",
    "entities": []
  },
  {
    "text": "In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Capoferri AA(1), Sklutuis R(2), Famuyiwa TO(2), Pathak S(2), Li R(3), Rausch",
    "entities": [
      {
        "text": "Capoferri AA(1",
        "label": "PERSON"
      },
      {
        "text": "Sklutuis R(2",
        "label": "PERSON"
      },
      {
        "text": "Famuyiwa TO(2",
        "label": "ORG"
      },
      {
        "text": "Pathak S(2",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Rausch\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "JL(2), Romerio F(3), Kearney MF(8).",
    "entities": [
      {
        "text": "Kearney MF(8",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)HIV Dynamics and Replication Program, National Cancer Institute, Frederick,",
    "entities": [
      {
        "text": "1)HIV Dynamics and Replication Program",
        "label": "ORG"
      },
      {
        "text": "National Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Frederick",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)HIV Dynamics and Replication Program, National Cancer Institute, Frederick,",
    "entities": [
      {
        "text": "2)HIV Dynamics and Replication Program",
        "label": "ORG"
      },
      {
        "text": "National Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Frederick",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Molecular and Comparative Pathobiology, Johns Hopkins",
    "entities": [
      {
        "text": "Molecular and Comparative Pathobiology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University School of Medicine, Baltimore, MD, USA.",
    "entities": [
      {
        "text": "University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Advanced Biomedical Computational Science, Frederick National Laboratories",
    "entities": [
      {
        "text": "Biomedical Computational Science",
        "label": "ORG"
      },
      {
        "text": "Frederick National Laboratories",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Cancer Research, Frederick, MD, USA.",
    "entities": [
      {
        "text": "Cancer Research",
        "label": "ORG"
      },
      {
        "text": "Frederick",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine, University of California, San Francisco, CA, USA.",
    "entities": [
      {
        "text": "Medicine, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Infectious Diseases, Department of Medicine, University of",
    "entities": [
      {
        "text": "Department of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pittsburgh School of Medicine, Pittsburgh, PA, USA.",
    "entities": [
      {
        "text": "Pittsburgh School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Molecular Biology and Microbiology, Tufts University, Boston,",
    "entities": [
      {
        "text": "Molecular Biology and Microbiology",
        "label": "ORG"
      },
      {
        "text": "Tufts University",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)HIV Dynamics and Replication Program, National Cancer Institute, Frederick,",
    "entities": [
      {
        "text": "Dynamics and Replication Program",
        "label": "ORG"
      },
      {
        "text": "National Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Frederick",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Natural antisense transcripts (AST) are expressed in eukaryotes, prokaryotes,",
    "entities": []
  },
  {
    "text": "and viruses and can possess regulatory functions at the transcriptional and/or",
    "entities": []
  },
  {
    "text": "post-transcriptional levels. In vitro studies have shown that HIV-1 AST promote",
    "entities": []
  },
  {
    "text": "viral latency through epigenetic silencing of the proviral 5' long terminal",
    "entities": []
  },
  {
    "text": "repeat. However, expression of AST in vivo has not been convincingly",
    "entities": [
      {
        "text": "AST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "demonstrated. Here, we used single RNA template amplification and sequencing to",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "demonstrate expression of AST in unstimulated PBMC collected from people with",
    "entities": [
      {
        "text": "AST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HIV-1 (PWH). Our results show that expression levels of AST could be higher",
    "entities": [
      {
        "text": "AST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "during ART compared with untreated individuals and that clones of infected cells",
    "entities": []
  },
  {
    "text": "persisting under ART continue to express HIV AST. This study is the first to",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "verify HIV-1 AST expression in vivo with sequencing, documenting AST presence",
    "entities": [
      {
        "text": "HIV-1 AST",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "without cellular activation and suggest its natural occurrence in PWH. These",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "findings advance our understanding of HIV-1 persistence and underscore the need",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for larger studies to determine if targeting AST in viral reservoirs could lead",
    "entities": []
  },
  {
    "text": "to new approaches for the design of strategies towards achieving HIV remission",
    "entities": []
  },
  {
    "text": "without ART.",
    "entities": []
  },
  {
    "text": "PMID: 40659484 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659484",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: JW Mellors is a consultant to Gilead Sciences,",
    "entities": [
      {
        "text": "JW Mellors",
        "label": "ORG"
      },
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "has received research grants from Gilead Sciences to the University of",
    "entities": [
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      },
      {
        "text": "the University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pittsburgh, and owns share options in Infectious Disease Connect (co-founder)",
    "entities": [
      {
        "text": "Pittsburgh",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and Galapagos, NV, unrelated to the current work on HIV. JM Coffin is a member",
    "entities": [
      {
        "text": "Galapagos",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "of the Scientific Advisory Board and a Shareholder of ROME Therapeutics, Inc.",
    "entities": [
      {
        "text": "the Scientific Advisory Board",
        "label": "ORG"
      },
      {
        "text": "a Shareholder of ROME Therapeutics, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Generate Biomedicine, Inc. The remaining authors have no potential",
    "entities": [
      {
        "text": "Generate Biomedicine",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "conflicts.",
    "entities": []
  },
  {
    "text": "A 43-year-old man with an indeterminate HIV test.",
    "entities": [
      {
        "text": "43-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Temerty Faculty of Medicine (Huang, Bunce); Department of Medicine (Huang,",
    "entities": [
      {
        "text": "1)Temerty",
        "label": "CARDINAL"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Huang",
        "label": "PERSON"
      },
      {
        "text": "Bunce",
        "label": "GPE"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Huang",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Dhaliwal, Bunce), University of Toronto; Division of Infectious Diseases",
    "entities": [
      {
        "text": "Bunce",
        "label": "PERSON"
      },
      {
        "text": "University of Toronto",
        "label": "ORG"
      },
      {
        "text": "Division of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(Bunce), University Health Network and Sinai Health System, Toronto, Ont.",
    "entities": [
      {
        "text": "Bunce",
        "label": "PERSON"
      },
      {
        "text": "University Health Network",
        "label": "ORG"
      },
      {
        "text": "Sinai Health System",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Temerty Faculty of Medicine (Huang, Bunce); Department of Medicine (Huang,",
    "entities": [
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Huang",
        "label": "PERSON"
      },
      {
        "text": "Bunce",
        "label": "GPE"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Huang",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests:: Paul Bunce reports payment",
    "entities": [
      {
        "text": "Paul Bunce",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "for legal consultations and expert testimony, and travel support from the",
    "entities": []
  },
  {
    "text": "Canadian Society of Internal Medicine. No other competing interests were",
    "entities": [
      {
        "text": "Canadian Society of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Respiratory health of street and working children: challenges and opportunities.",
    "entities": []
  },
  {
    "text": "(1)Madras Medical College, Chennai, Tamil Nadu, India.",
    "entities": [
      {
        "text": "1)Madras",
        "label": "CARDINAL"
      },
      {
        "text": "Medical College",
        "label": "ORG"
      },
      {
        "text": "Tamil Nadu",
        "label": "PERSON"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Paediatrics, Royal Preston Hospital, Preston, England, UK.",
    "entities": [
      {
        "text": "Paediatrics",
        "label": "ORG"
      },
      {
        "text": "Royal Preston Hospital",
        "label": "ORG"
      },
      {
        "text": "Preston",
        "label": "GPE"
      },
      {
        "text": "England",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Health Data Science, Institute of Population Health, University of Liverpool,",
    "entities": [
      {
        "text": "3)Health",
        "label": "CARDINAL"
      },
      {
        "text": "Data Science, Institute of Population Health, University of Liverpool",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Liverpool, England, UK.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "England",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Respiratory Medicine, Alder Hey Children's NHS Foundation",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "NHS Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trust, Liverpool, England, UK.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "England",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Women's and Children's Health, University of Liverpool,",
    "entities": [
      {
        "text": "Women's and Children's Health, University of Liverpool",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)NIHR Alder Hey Clinical Research Facility, Liverpool, England, UK.",
    "entities": [
      {
        "text": "6)NIHR",
        "label": "CARDINAL"
      },
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "England",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Respiratory Medicine, Alder Hey Children's NHS Foundation",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "NHS Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trust, Liverpool, England, UK iansinha@liv.ac.uk.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "England",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: DH is part funded by the",
    "entities": []
  },
  {
    "text": "NIHR Alder Hey Clinical Research Facility; the funder had no involvement in this",
    "entities": [
      {
        "text": "Hey Clinical Research Facility",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "article. The views expressed are those of the author(s) and not necessarily",
    "entities": []
  },
  {
    "text": "those of the NIHR or the Department of Health and Social Care or Health Data",
    "entities": [
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "the Department of Health and Social Care or Health Data",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research UK.",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Comparative analysis of HIV data completeness in Haiti's iSant\u00e9 Plus Electronic",
    "entities": [
      {
        "text": "Haiti",
        "label": "GPE"
      },
      {
        "text": "iSant\u00e9 Plus Electronic",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Medical Record system across children, adolescents and adults: a cross-sectional",
    "entities": []
  },
  {
    "text": "evaluation of 2016-2022 data.",
    "entities": [
      {
        "text": "2016-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Odeny B(1), Honor\u00e9 JG(2), Balan JG(2), Hughes JP(3), Wagenaar B(3), Gloyd S(4),",
    "entities": [
      {
        "text": "Odeny B(1",
        "label": "PERSON"
      },
      {
        "text": "Honor\u00e9 JG(2",
        "label": "PERSON"
      },
      {
        "text": "Balan JG(2",
        "label": "PERSON"
      },
      {
        "text": "Hughes JP(3",
        "label": "PERSON"
      },
      {
        "text": "Wagenaar B(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Surgery, Washington University in St Louis, St Louis, Missouri,",
    "entities": [
      {
        "text": "Surgery",
        "label": "GPE"
      },
      {
        "text": "Washington University",
        "label": "ORG"
      },
      {
        "text": "St Louis",
        "label": "GPE"
      },
      {
        "text": "St Louis",
        "label": "GPE"
      },
      {
        "text": "Missouri",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)University of Washington, Seattle, Washington, USA.",
    "entities": [
      {
        "text": "Washington",
        "label": "GPE"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Global Health, University of Washington, Seattle, Washington,",
    "entities": [
      {
        "text": "Global Health, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)I-TECH, Department of Global HEalth, University of Washington School of",
    "entities": [
      {
        "text": "6)I",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Global HEalth, University of Washington School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health, Seattle, Washington, USA.",
    "entities": [
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To evaluate and compare documentation completeness of HIV-related",
    "entities": []
  },
  {
    "text": "data by age group (children, adolescents and adults) in Haiti's Electronic",
    "entities": [
      {
        "text": "Haiti",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical Record (EMR) system.",
    "entities": []
  },
  {
    "text": "DESIGN: Cross-sectional evaluation.",
    "entities": []
  },
  {
    "text": "SETTING: EMR data for 36 965 enrolment visits, and 123 608 return visits from 58",
    "entities": [
      {
        "text": "EMR",
        "label": "PERSON"
      },
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "965",
        "label": "CARDINAL"
      },
      {
        "text": "123",
        "label": "CARDINAL"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "facilities in Haiti (from 2016 to 2022).",
    "entities": [
      {
        "text": "Haiti",
        "label": "GPE"
      },
      {
        "text": "2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: Children, adolescents and adults accessing HIV care and treatment",
    "entities": []
  },
  {
    "text": "services in Haiti.",
    "entities": [
      {
        "text": "Haiti",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MAIN EXPOSURE MEASURE: Health facility attendance for HIV-related healthcare.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOME MEASURE: Level of data completeness, as a measure of data quality.",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We developed Composite Completeness Scores (CCS scores) to measure data",
    "entities": [
      {
        "text": "CCS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "completeness. Lower scores meant lower completeness. Generalised linear models",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were used to investigate factors associated with completeness.",
    "entities": []
  },
  {
    "text": "RESULTS: At the enrolment visit, most patients were adults (81.6%) and female",
    "entities": [
      {
        "text": "81.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(56.7%). Most facilities were health centres (75.9%). The overall average",
    "entities": [
      {
        "text": "56.7%",
        "label": "PERCENT"
      },
      {
        "text": "75.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "enrolment visit CCS score was 54.0%. At enrolment, being a child (CCS score",
    "entities": [
      {
        "text": "CCS",
        "label": "ORG"
      },
      {
        "text": "54.0%",
        "label": "PERCENT"
      },
      {
        "text": "CCS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "difference=-7.08, 95% CI: -11.31 to -2.86) and a more recent year of enrolment",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(-6.01, 95% CI: -11.69 to -0.33) were significantly associated with lower",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "completeness scores than being an adult and having an earlier year of enrolment,",
    "entities": [
      {
        "text": "an earlier year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "respectively. The overall average return visit CCS score was 49.6%. At the",
    "entities": [
      {
        "text": "CCS",
        "label": "ORG"
      },
      {
        "text": "49.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "return visit, children (-6.76, 95% CI: -10.07 to -3.45) had significantly lower",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "average completeness scores than adults. For first viral load documentation,",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "children had lower odds of completeness compared with adults (adjusted OR=0.21,",
    "entities": []
  },
  {
    "text": "95% CI: 0.16 to 0.28). Sex, year of enrolment, facility ownership (public,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.16 to 0.28",
        "label": "CARDINAL"
      },
      {
        "text": "Sex, year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "private, mixed), total patient volume and duration of EMR use were not",
    "entities": [
      {
        "text": "EMR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "significantly associated with completeness of documentation at the enrolment and",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: We observed disparities in electronic data completeness by age",
    "entities": []
  },
  {
    "text": "group, which may be indicative of digital health disparities. Documentation was",
    "entities": []
  },
  {
    "text": "particularly poor among children and declined over time for enrolment visits.",
    "entities": []
  },
  {
    "text": "Further research is needed to understand and address these documentation gaps.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY-NC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "commercial re-use. See rights and permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40659393 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Competing interests: JGH, JGB, KC and ME are",
    "entities": [
      {
        "text": "JGH",
        "label": "ORG"
      },
      {
        "text": "JGB",
        "label": "ORG"
      },
      {
        "text": "KC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "affiliated with the CDC. However, the CDC had no role in the study design, data",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "collection, data analysis, data interpretation, the writing of the report or the",
    "entities": []
  },
  {
    "text": "decision to submit the article for publication. All other authors declare that",
    "entities": []
  },
  {
    "text": "they have no competing interests.",
    "entities": []
  },
  {
    "text": "Barriers and facilitators of HIV pre-exposure prophylaxis (PrEP) uptake and use",
    "entities": []
  },
  {
    "text": "in Canada: a scoping review protocol.",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ifeanacho E(6), Ajiboye O(1), Lo Hog Tian J(2), Odhiambo J(2), Nelson LE(7)(8),",
    "entities": [
      {
        "text": "Ifeanacho E(6",
        "label": "PERSON"
      },
      {
        "text": "Ajiboye",
        "label": "PERSON"
      },
      {
        "text": "Lo Hog Tian J(2",
        "label": "PERSON"
      },
      {
        "text": "Nelson LE(7)(8",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)University of Toronto - St George Campus, Toronto, Ontario, Canada.",
    "entities": [
      {
        "text": "1)University",
        "label": "CARDINAL"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)MAP Center for Urban Health Solution, Unity Health Toronto, Toronto, Ontario,",
    "entities": [
      {
        "text": "2)MAP Center for Urban Health Solution, Unity Health Toronto",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Library Services, Unity Health Toronto, Toronto, Ontario, Canada.",
    "entities": [
      {
        "text": "Unity Health Toronto",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Health Research Methods Evidence and Impact, McMaster",
    "entities": [
      {
        "text": "Health Research Methods Evidence",
        "label": "ORG"
      },
      {
        "text": "McMaster",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Hamilton, Ontario, Canada.",
    "entities": [
      {
        "text": "Hamilton",
        "label": "PERSON"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)University of Waterloo, Waterloo, Ontario, Canada.",
    "entities": [
      {
        "text": "Waterloo",
        "label": "PERSON"
      },
      {
        "text": "Waterloo, Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)McMaster University, Hamilton, Ontario, Canada.",
    "entities": [
      {
        "text": "6)McMaster",
        "label": "CARDINAL"
      },
      {
        "text": "Hamilton",
        "label": "PERSON"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Yale University School of Nursing, New Haven, Connecticut, USA.",
    "entities": [
      {
        "text": "7)Yale University School of Nursing",
        "label": "ORG"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "Connecticut",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)St Michael's Hospital Centre for Urban Health Solutions, Toronto, Ontario,",
    "entities": [
      {
        "text": "8)St",
        "label": "CARDINAL"
      },
      {
        "text": "Hospital Centre for Urban Health Solutions",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)University of Toronto, Toronto, Ontario, Canada.",
    "entities": [
      {
        "text": "9)University",
        "label": "CARDINAL"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)MAP Center for Urban Health Solution, Unity Health Toronto, Toronto,",
    "entities": [
      {
        "text": "10)MAP",
        "label": "CARDINAL"
      },
      {
        "text": "Center for Urban Health Solution, Unity Health Toronto",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Despite extensive efforts in HIV prevention, significant barriers",
    "entities": []
  },
  {
    "text": "to accessing interventions such as HIV pre-exposure prophylaxis (PrEP) persist",
    "entities": []
  },
  {
    "text": "in Canada. Although PrEP has demonstrated efficacy in preventing HIV",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transmission, various structural, social and systemic factors continue to impede",
    "entities": []
  },
  {
    "text": "its widespread adoption and use. These factors influence the uptake (acceptance",
    "entities": []
  },
  {
    "text": "and access) and use (adherence and retention) of PrEP. The purpose of this",
    "entities": [
      {
        "text": "PrEP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scoping review is to examine the existing body of evidence regarding the",
    "entities": []
  },
  {
    "text": "barriers and facilitators to uptake and use of PrEP in Canada. By identifying",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "these factors, the review aims to inform future research, policy development and",
    "entities": []
  },
  {
    "text": "interventions to improve PrEP access and its integration into HIV prevention",
    "entities": [
      {
        "text": "PrEP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "strategies in Canada.",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS AND ANALYSIS: This scoping review will focus on studies involving",
    "entities": []
  },
  {
    "text": "HIV-seronegative individuals in Canada who are either eligible for or currently",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "using PrEP as an HIV prevention option. The review will consider barriers and",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "facilitators within services, programmes, policies or practices related to HIV",
    "entities": []
  },
  {
    "text": "prevention in Canada. Eligible studies will include experimental,",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "address PrEP or HIV prevention, or that involve populations not aligned with the",
    "entities": [
      {
        "text": "PrEP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "inclusion criteria, will be excluded. The review will involve searching a range",
    "entities": []
  },
  {
    "text": "of key databases, including MEDLINE, Embase, PsycINFO, Cochrane Library, CINAHL,",
    "entities": [
      {
        "text": "MEDLINE",
        "label": "ORG"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      },
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Scopus, Web of Science and TRIP, with no language restrictions, and focusing on",
    "entities": []
  },
  {
    "text": "publications from 2016 onward. Two independent reviewers will screen titles and",
    "entities": [
      {
        "text": "2016",
        "label": "DATE"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "abstracts, followed by full-text assessment and data extraction, using",
    "entities": []
  },
  {
    "text": "Covidence. Data will be analysed narratively, with a specific focus on subgroup",
    "entities": []
  },
  {
    "text": "analyses of key populations. The findings will be synthesised to provide an",
    "entities": []
  },
  {
    "text": "overview of the key themes, trends, and evidence gaps identified within the",
    "entities": []
  },
  {
    "text": "existing literature.",
    "entities": []
  },
  {
    "text": "ETHICS AND DISSEMINATION: This piece of research will not involve human",
    "entities": [
      {
        "text": "ETHICS",
        "label": "ORG"
      },
      {
        "text": "DISSEMINATION",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "participants and will solely use already published data. Consequently, ethics",
    "entities": []
  },
  {
    "text": "approval is not necessary. The findings will be disseminated through",
    "entities": []
  },
  {
    "text": "peer-reviewed journal articles and conference presentations and may be of",
    "entities": []
  },
  {
    "text": "relevance to governmental health agencies and local HIV/AIDS service",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: The protocol has been registered on Open Science Framework",
    "entities": [
      {
        "text": "Open Science Framework",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40659390 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659390",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1016/S2352-3018(25)00161-4. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Lessons for long-acting lenacapavir: catalysing equitable PrEP access in",
    "entities": [
      {
        "text": "PrEP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "low-income and middle-income countries.",
    "entities": []
  },
  {
    "text": "Lynch S(1), Cohen RM(2), Kavanagh M(2), Sharma A(2), Raphael Y(3), Pillay Y(4),",
    "entities": [
      {
        "text": "Cohen RM(2",
        "label": "PERSON"
      },
      {
        "text": "Kavanagh",
        "label": "PERSON"
      },
      {
        "text": "Sharma A(2",
        "label": "PERSON"
      },
      {
        "text": "Raphael Y(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Center for Global Health Policy and Politics, School of Law and School of",
    "entities": [
      {
        "text": "Global Health Policy and Politics, School of Law and School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, Georgetown University, Washington, DC, USA. Electronic address:",
    "entities": [
      {
        "text": "Georgetown University",
        "label": "ORG"
      },
      {
        "text": "Washington, DC,",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center for Global Health Policy and Politics, School of Law and School of",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Global Health Policy and Politics, School of Law and School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, Georgetown University, Washington, DC, USA.",
    "entities": [
      {
        "text": "Georgetown University",
        "label": "ORG"
      },
      {
        "text": "Washington, DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Advocacy for Prevention of HIV and AIDS, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Public Health Medicine, University of Pretoria, Pretoria, South",
    "entities": [
      {
        "text": "Public Health Medicine, University of Pretoria",
        "label": "ORG"
      },
      {
        "text": "Pretoria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Desmond Tutu HIV Centre, Cape Town, South Africa.",
    "entities": [
      {
        "text": "Tutu HIV Centre",
        "label": "ORG"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Despite substantial advances in biomedical HIV prevention, including long-acting",
    "entities": []
  },
  {
    "text": "injectable pre-exposure prophylaxis (PrEP) options such as cabotegravir,",
    "entities": []
  },
  {
    "text": "barriers to widespread adoption and scale-up persist in low-income and",
    "entities": []
  },
  {
    "text": "middle-income countries. Long-acting injectable lenacapavir is a potentially",
    "entities": []
  },
  {
    "text": "transformative HIV prevention tool, providing an unprecedented opportunity to",
    "entities": []
  },
  {
    "text": "accelerate progress. However, the global HIV response is under threat like never",
    "entities": []
  },
  {
    "text": "before, with drastic funding cuts undermining the gains of the past 25 years.",
    "entities": [
      {
        "text": "the past 25 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The challenges of introducing and scaling up long-acting lenacapavir and other",
    "entities": []
  },
  {
    "text": "PrEP innovations are numerous. Without deliberate policy, programmatic, and",
    "entities": []
  },
  {
    "text": "financing interventions, new prevention technologies risk following slow",
    "entities": []
  },
  {
    "text": "adoption patterns of previous innovations, weakening a needed transformation of",
    "entities": []
  },
  {
    "text": "the HIV response. Drawing on lessons from the scale-up of antiretroviral",
    "entities": []
  },
  {
    "text": "therapy, and experience with previous biomedical prevention tools, a new",
    "entities": []
  },
  {
    "text": "ten-point framework should be adopted to accelerate individual and",
    "entities": [
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "epidemiological impact-even at this time of extraordinary uncertainty.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Ltd. All rights reserved, including those for text and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of interests L-GB received honoraria",
    "entities": [
      {
        "text": "honoraria\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "from Gilead Sciences, Merck, and ViiV Healthcare. All other authors declare no",
    "entities": [
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      },
      {
        "text": "Merck",
        "label": "ORG"
      },
      {
        "text": "ViiV Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1016/S2352-3018(25)00194-8. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Daring to dream of long-acting HIV prevention.",
    "entities": []
  },
  {
    "text": "The Lancet Hiv.",
    "entities": [
      {
        "text": "The Lancet Hiv",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "78. J Homosex. 2025 Jul 14:1-20. doi: 10.1080/00918369.2025.2525162. Online ahead",
    "entities": [
      {
        "text": "78",
        "label": "CARDINAL"
      },
      {
        "text": "J Homosex",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jul 14:1-20",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Multiple Discrimination, Substance-Related Coping, and Depression Among Sexual",
    "entities": [
      {
        "text": "Substance-Related Coping",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Minority Men with HIV.",
    "entities": []
  },
  {
    "text": "Chiu C(1)(2)(3), Shin HJ(3), Baldwin HT(4), O'Cleirigh C(3)(5), Mayer KH(3),",
    "entities": [
      {
        "text": "Chiu",
        "label": "PERSON"
      },
      {
        "text": "Shin",
        "label": "PERSON"
      },
      {
        "text": "Baldwin HT(4",
        "label": "PERSON"
      },
      {
        "text": "O'Cleirigh C(3)(5",
        "label": "PERSON"
      },
      {
        "text": "Mayer KH(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Psychiatry, Boston Medical Center, Boston, MA, USA.",
    "entities": [
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Boston Medical Center",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Psychology, Boston University Chobanian & Avedisian School of Medicine,",
    "entities": [
      {
        "text": "Boston University Chobanian & Avedisian School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)The Fenway Institute, Fenway Health, Boston, MA, USA.",
    "entities": [
      {
        "text": "Fenway Institute",
        "label": "ORG"
      },
      {
        "text": "Fenway Health",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Social & Behavioral Sciences, Yale School of Public Health, New",
    "entities": [
      {
        "text": "Social & Behavioral Sciences",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "York, NY, USA.",
    "entities": [
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Massachusetts General Hospital",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Sexual minority men (SMM) with HIV who use substances experience multiple forms",
    "entities": []
  },
  {
    "text": "of stigma (e.g., experienced discrimination) related to aspects of themselves",
    "entities": []
  },
  {
    "text": "and their behaviors and are disproportionately affected by depression. More",
    "entities": []
  },
  {
    "text": "research is needed to examine the interrelations between multiple",
    "entities": []
  },
  {
    "text": "discrimination, including substance-related discrimination, and depression, and",
    "entities": []
  },
  {
    "text": "the intervening role of substance-related coping among SMM with HIV who use",
    "entities": []
  },
  {
    "text": "drugs. Self-report data (N = 195) collected between 2017-2018 included",
    "entities": [
      {
        "text": "195",
        "label": "CARDINAL"
      },
      {
        "text": "2017-2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "experienced discrimination (categories included HIV, sexual orientation,",
    "entities": []
  },
  {
    "text": "race/ethnicity, substance use), substance-related coping, and depressive",
    "entities": []
  },
  {
    "text": "symptoms. ANCOVA results revealed significant differences in depressive symptoms",
    "entities": []
  },
  {
    "text": "based on the number of discrimination categories endorsed, F(6,188) = 11.71,",
    "entities": [
      {
        "text": "F(6,188",
        "label": "PRODUCT"
      },
      {
        "text": "11.71",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p < .001, with groups that endorsed discrimination across more stigmatized",
    "entities": []
  },
  {
    "text": "categories reporting higher depressive symptoms. Supplemental ANCOVA results",
    "entities": []
  },
  {
    "text": "also indicated differences in depressive symptoms based on endorsement of",
    "entities": []
  },
  {
    "text": "substance use discrimination, F(4,190) = 19.16, p < .001. Analysis of indirect",
    "entities": [
      {
        "text": "F(4,190",
        "label": "ORG"
      },
      {
        "text": "19.16",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations revealed substance-related coping partially accounted for the",
    "entities": []
  },
  {
    "text": "relation between multiple discrimination and depressive symptoms, b = 1.19,",
    "entities": [
      {
        "text": "1.19",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95%CI [0.58, 1.91]. Results suggest that there is a cumulative association",
    "entities": [
      {
        "text": "0.58",
        "label": "CARDINAL"
      },
      {
        "text": "1.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "between multiple discrimination and depressive symptoms, and substance-related",
    "entities": []
  },
  {
    "text": "discrimination and substance-related coping may be particularly important",
    "entities": []
  },
  {
    "text": "influencers on this association. Multi-level intervention efforts that target",
    "entities": []
  },
  {
    "text": "multiple discrimination could help ameliorate the high rates of depression in",
    "entities": []
  },
  {
    "text": "this community.",
    "entities": []
  },
  {
    "text": "Effect of climate change on the health and nutritional status of children and",
    "entities": []
  },
  {
    "text": "their families in Africa: Scoping review.",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Division of Public Health, Faculty of Health Sciences, University of the Free",
    "entities": [
      {
        "text": "Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of the Free\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "State, Bloemfontein South Africa.",
    "entities": [
      {
        "text": "Bloemfontein South Africa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Public Health & Exercise Sciences, College of Health Sciences,",
    "entities": [
      {
        "text": "Public Health & Exercise Sciences",
        "label": "ORG"
      },
      {
        "text": "College of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Appalachian State University, Boone, North Carolina, United States of America.",
    "entities": [
      {
        "text": "Appalachian State University",
        "label": "ORG"
      },
      {
        "text": "Boone",
        "label": "ORG"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      },
      {
        "text": "United States of America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The Joint United Nations Programme on HIV/AIDS (UNAIDS), Pretoria, South",
    "entities": [
      {
        "text": "Joint United Nations Programme on HIV/AIDS",
        "label": "ORG"
      },
      {
        "text": "Pretoria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The health and nutritional status of children and their families is essential",
    "entities": []
  },
  {
    "text": "particularly during climate change. Most of the Sustainable Development Goals",
    "entities": [
      {
        "text": "the Sustainable Development Goals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(SDGs) affect children in some way, namely, poverty (SDG 1), hunger (SDG 2),",
    "entities": [
      {
        "text": "SDG 2",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "health (SDG 3), climate change (SDG 13). Evidence suggests that most countries",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "are behind in achieving the SDGs, with only 17% of the SDGs currently achieved.",
    "entities": [
      {
        "text": "only 17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "The reason is because the SDGs are interconnected such that failure in one SDG,",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "SDG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "may affect the others negatively. For example, evidence from the global north",
    "entities": []
  },
  {
    "text": "provides many examples of the effects of climate change on other SDGs,",
    "entities": []
  },
  {
    "text": "particularly health. Within the global south, evidence of the effects of climate",
    "entities": []
  },
  {
    "text": "change on health is limited. This scoping review aims to document the effects of",
    "entities": []
  },
  {
    "text": "climate change on the health and nutritional status of children and their",
    "entities": []
  },
  {
    "text": "families in Africa. The review was conducted according to the Preferred",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "the Preferred\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping",
    "entities": [
      {
        "text": "Meta-Analyses",
        "label": "ORG"
      },
      {
        "text": "Scoping",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Reviews (PRISMA-ScR). Three electronic databases were searched by a librarian.",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "One reviewer screened the articles to be included in the synthesis and a second",
    "entities": [
      {
        "text": "One",
        "label": "CARDINAL"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "author went through the selected articles to confirm their inclusion. Data was",
    "entities": []
  },
  {
    "text": "extracted and mapped according to four categories: i) climate change events or",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "phenomena, ii) effect of climate change on nutritional and health status, iii)",
    "entities": [
      {
        "text": "phenomena",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "factors influencing vulnerabilities of population to climate change, iv)",
    "entities": []
  },
  {
    "text": "interventions and innovations used to mitigate impact of climate change on",
    "entities": []
  },
  {
    "text": "health.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Mulondo et al. This is an open access article distributed",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Mulondo",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "Tobacco smoking and smokeless tobacco use among people living with HIV in",
    "entities": []
  },
  {
    "text": "Zambia: Findings from a 2023 National NCD/HIV Survey.",
    "entities": [
      {
        "text": "Zambia",
        "label": "GPE"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Community and Family Medicine, School of Public Health,",
    "entities": [
      {
        "text": "Community and Family Medicine, School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Zambia.",
    "entities": [
      {
        "text": "University of Zambia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Centre for Infectious Disease Research in Zambia.",
    "entities": [
      {
        "text": "2)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Infectious Disease Research",
        "label": "ORG"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Epidemiology and Biostatistics, School of Public Health,",
    "entities": [
      {
        "text": "Epidemiology and Biostatistics, School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)|Ministry of Health in Zambia, Lusaka, Zambia.",
    "entities": [
      {
        "text": "4)|Ministry",
        "label": "CARDINAL"
      },
      {
        "text": "Health",
        "label": "ORG"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      },
      {
        "text": "Lusaka",
        "label": "GPE"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Health Policy, School of Public Health, University of Zambia.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Health Policy, School of Public Health",
        "label": "ORG"
      },
      {
        "text": "University of Zambia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: People living with HIV (PLWH) who use tobacco face significant",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "public health risks compared to non-users, including an average loss of 12.3",
    "entities": [
      {
        "text": "12.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years of life expectancy. Tobacco use increases the likelihood of",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "non-communicable diseases (NCDs), such as cardiovascular diseases, hypertension,",
    "entities": []
  },
  {
    "text": "diabetes mellitus, and non-AIDS-related cancers.",
    "entities": []
  },
  {
    "text": "AIM: This study investigated factors associated with tobacco smoking and",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "smokeless tobacco (SLT) use among PLWH in Zambia.",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: Data were obtained from a national cross-sectional survey involving",
    "entities": []
  },
  {
    "text": "5,204 PLWH from 193 clinics across Zambia's 10 provinces. Tobacco smoking, SLT",
    "entities": [
      {
        "text": "5,204",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "193",
        "label": "CARDINAL"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "SLT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "use, behavioral patterns, and clinical characteristics were assessed. Logistic",
    "entities": []
  },
  {
    "text": "regression was used to determine unadjusted (UOR) and adjusted odds ratios (AOR)",
    "entities": [
      {
        "text": "UOR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Among the 5,204 PLWH surveyed, 9.7% were current tobacco smokers (21.9%",
    "entities": [
      {
        "text": "5,204",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "9.7%",
        "label": "PERCENT"
      },
      {
        "text": "21.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "men, 3.7% women), while 1.4% used smokeless tobacco (1.81% men, 1.26% women). In",
    "entities": [
      {
        "text": "3.7%",
        "label": "PERCENT"
      },
      {
        "text": "1.4%",
        "label": "PERCENT"
      },
      {
        "text": "1.81%",
        "label": "PERCENT"
      },
      {
        "text": "1.26%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the multivariable analysis, several factors were identified as predictors of",
    "entities": []
  },
  {
    "text": "tobacco smoking. Male individuals had significantly higher odds of smoking (AOR:",
    "entities": []
  },
  {
    "text": "4.81, 95% CI: 3.36-6.90). In contrast, higher educational attainment was",
    "entities": [
      {
        "text": "4.81",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.36-6.90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associated with lower odds of smoking (AOR: 0.29, 95% CI: 0.16-0.52). Alcohol",
    "entities": [
      {
        "text": "0.29",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "consumption was associated with an increased likelihood of smoking (AOR: 4.97,",
    "entities": [
      {
        "text": "4.97",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI: 2.93-8.44). Additionally, overweight or obese individuals were less",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.93-8.44",
        "label": "CARDINAL"
      },
      {
        "text": "obese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "likely to smoke, with adjusted odds ratios of 0.55 (95% CI: 0.35-0.85) and 0.36",
    "entities": [
      {
        "text": "0.55",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.35-0.85",
        "label": "CARDINAL"
      },
      {
        "text": "0.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(95% CI: 0.17-0.79), respectively. Non-adherence to antiretroviral therapy (ART)",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.17-0.79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was also associated with higher smoking rates (AOR: 1.75, 95% CI: 1.14-2.67).",
    "entities": [
      {
        "text": "1.75",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14-2.67",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Similarly, several factors were identified as predictors of smokeless tobacco",
    "entities": []
  },
  {
    "text": "(SLT) use. Individuals with an annual income exceeding 4,000 ZMW had lower odds",
    "entities": [
      {
        "text": "annual",
        "label": "DATE"
      },
      {
        "text": "4,000",
        "label": "CARDINAL"
      },
      {
        "text": "ZMW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of using SLT (AOR: 0.31, 95% CI: 0.14-0.73). In contrast, alcohol users",
    "entities": [
      {
        "text": "SLT",
        "label": "ORG"
      },
      {
        "text": "0.31",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.14-0.73",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "exhibited significantly higher odds of SLT use (AOR: 14.74, 95% CI:",
    "entities": [
      {
        "text": "SLT",
        "label": "ORG"
      },
      {
        "text": "14.74",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.99-109.02). Furthermore, non-adherence to ART was associated with an increased",
    "entities": [
      {
        "text": "1.99-109.02",
        "label": "DATE"
      },
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our findings highlight the urgent need for targeted interventions",
    "entities": []
  },
  {
    "text": "to reduce tobacco use among PLWH in Zambia. Integrating these measures within",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the existing healthcare framework can maximize impact. Gender-specific programs",
    "entities": []
  },
  {
    "text": "addressing unique risk factors, alongside economic empowerment initiatives for",
    "entities": []
  },
  {
    "text": "low-income females, could help curb SLT use. Additionally, reinforcing ART",
    "entities": []
  },
  {
    "text": "adherence through tobacco cessation counseling within HIV care settings may",
    "entities": []
  },
  {
    "text": "lower smoking rates. Given the strong association between alcohol consumption",
    "entities": []
  },
  {
    "text": "and tobacco use, structured behavioral interventions and support programs should",
    "entities": []
  },
  {
    "text": "also be prioritized. Strengthening collaborations between health authorities and",
    "entities": []
  },
  {
    "text": "community organizations can further enhance accessibility and outreach. By",
    "entities": []
  },
  {
    "text": "embedding these strategies within primary care and ART clinics, Zambia can",
    "entities": [
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "effectively reduce tobacco use among PLWH, ultimately improving overall health",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outcomes and strengthening HIV management efforts.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Zyambo et al. This is an open access article distributed under",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the terms of the Creative Commons Attribution License, which permits",
    "entities": [
      {
        "text": "the Creative Commons Attribution License",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40658694 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40658694",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prevalence and correlates of microalbuminuria in high-risk persons with",
    "entities": []
  },
  {
    "text": "hypertension, diabetes, or HIV at a tertiary hospital in Zambia.",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "SK(1)(2)(3).",
    "entities": []
  },
  {
    "text": "(1)Department of Pathology and Microbiology, Mulungushi University, School of",
    "entities": [
      {
        "text": "Pathology and Microbiology, Mulungushi University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine and Health Sciences, Livingstone, Zambia.",
    "entities": [
      {
        "text": "Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Livingstone",
        "label": "GPE"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiovascular Science and Metabolic diseases, Livingstone",
    "entities": [
      {
        "text": "Cardiovascular Science and Metabolic",
        "label": "ORG"
      },
      {
        "text": "Livingstone\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center for Prevention and Translational Science, Livingstone, Zambia.",
    "entities": [
      {
        "text": "Center for Prevention and Translational Science",
        "label": "ORG"
      },
      {
        "text": "Livingstone",
        "label": "GPE"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Physiological Sciences, Mulungushi University, School of",
    "entities": [
      {
        "text": "Physiological Sciences",
        "label": "ORG"
      },
      {
        "text": "Mulungushi University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Public Health, Mulungushi University, School of Medicine and",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Mulungushi University",
        "label": "ORG"
      },
      {
        "text": "School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, Livingstone, Zambia.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Livingstone",
        "label": "GPE"
      },
      {
        "text": "Zambia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Microalbuminuria is a critical marker for early kidney damage and a",
    "entities": [
      {
        "text": "Microalbuminuria",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "predictor for proteinuria, a defining feature of renal disease. Its detection in",
    "entities": []
  },
  {
    "text": "high-risk individuals is vital for reducing the risk of adverse renal outcomes,",
    "entities": []
  },
  {
    "text": "particularly among persons living with diabetes, hypertension, and HIV. The",
    "entities": []
  },
  {
    "text": "evaluation of microalbuminuria in high-risk individuals allows for the early",
    "entities": []
  },
  {
    "text": "detection of renal impairment and the assessment of cardiovascular risk",
    "entities": []
  },
  {
    "text": "profiles. Additionally, it informs targeted therapeutic interventions and",
    "entities": []
  },
  {
    "text": "provides critical prognostic information, thereby enhancing overall clinical",
    "entities": []
  },
  {
    "text": "outcomes. The goal of the study was to determine the prevalence and correlates",
    "entities": []
  },
  {
    "text": "of microalbuminuria in high risk patients.",
    "entities": []
  },
  {
    "text": "METHODS: A cross-sectional study was conducted at Livingstone University",
    "entities": [
      {
        "text": "Livingstone University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Teaching Hospital (LUTH) from September 2023 to July 2024. We employed",
    "entities": [
      {
        "text": "Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "LUTH",
        "label": "ORG"
      },
      {
        "text": "September 2023 to July 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "homogeneous purposive sampling to recruit 306 high-risk adults (\u226518 years) with",
    "entities": [
      {
        "text": "306",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes, hypertension, and/or HIV. Purposive sampling was employed to recruit",
    "entities": []
  },
  {
    "text": "patients attending routine medical clinic at LUTH. Sample size was calculated",
    "entities": [
      {
        "text": "LUTH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "using the formula for a single proportion (expected prevalence: 30%, margin of",
    "entities": [
      {
        "text": "30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "error: 5%, 95% CI), yielding 323; we recruited 306 due to logistical",
    "entities": [
      {
        "text": "5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "323",
        "label": "CARDINAL"
      },
      {
        "text": "306",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "constraints. Data were collected directly from participants as well as using",
    "entities": []
  },
  {
    "text": "hospital records and laboratory analysis of blood/urine samples. Descriptive and",
    "entities": []
  },
  {
    "text": "inferential statistics were analyzed using SPSS v22.",
    "entities": [
      {
        "text": "SPSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 306 high-risk individuals were screened, with a median age",
    "entities": [
      {
        "text": "306",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of 46 years (IQR: 31-58). Of these, 61.8% (n = 189) were females and 38.2%",
    "entities": [
      {
        "text": "46 years",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "31-58",
        "label": "CARDINAL"
      },
      {
        "text": "61.8%",
        "label": "PERCENT"
      },
      {
        "text": "189",
        "label": "CARDINAL"
      },
      {
        "text": "38.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(n = 117) were males. The prevalence of microalbuminuria was 28.8% (95%CI",
    "entities": [
      {
        "text": "117",
        "label": "CARDINAL"
      },
      {
        "text": "microalbuminuria",
        "label": "ORG"
      },
      {
        "text": "28.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "23.7-33.8), while its prevalence among individuals with diabetes, hypertension,",
    "entities": [
      {
        "text": "23.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and HIV was 45.4%, 33.3%, and 39.1%, respectively. Microalbuminuria was",
    "entities": [
      {
        "text": "45.4%",
        "label": "PERCENT"
      },
      {
        "text": "33.3%",
        "label": "PERCENT"
      },
      {
        "text": "39.1%",
        "label": "PERCENT"
      },
      {
        "text": "Microalbuminuria",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "significantly associated with diabetes (p = 0.033), individuals living with HIV",
    "entities": [
      {
        "text": "0.033",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(p = 0.035), and high-sensitivity C-reactive protein (Hs-CRP) (p = 0.007) in",
    "entities": [
      {
        "text": "0.035",
        "label": "CARDINAL"
      },
      {
        "text": "Hs-CRP",
        "label": "ORG"
      },
      {
        "text": "0.007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "univariate analysis. On multivariable analysis, microalbuminuria was associated",
    "entities": [
      {
        "text": "microalbuminuria",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with diabetes (AOR 2.90; 95% CI 1.02-8.19 p = 0.044), Living with HIV (AOR 1.96;",
    "entities": [
      {
        "text": "2.90",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "0.044",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95%CI 1.02-3.78; p = 0.042) and Hs-CRP (AOR 1.16; 95%CI 1.02-1.30 p = 0.015).",
    "entities": [
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "0.042",
        "label": "CARDINAL"
      },
      {
        "text": "Hs-CRP",
        "label": "ORG"
      },
      {
        "text": "1.16",
        "label": "CARDINAL"
      },
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "0.015",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: The findings underscore the importance of routine screening for",
    "entities": []
  },
  {
    "text": "microalbuminuria in high-risk populations. Early detection and intervention",
    "entities": [
      {
        "text": "microalbuminuria",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "could prevent the progression of microalbuminuria to overt renal disease,",
    "entities": []
  },
  {
    "text": "particularly in individuals with diabetes, HIV, and systemic inflammation.",
    "entities": []
  },
  {
    "text": "Integrating microalbuminuria screening into chronic disease management programs",
    "entities": []
  },
  {
    "text": "is essential to mitigate renal complications in these vulnerable groups.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Mutelo et al. This is an open access article distributed under",
    "entities": [
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "Mutelo et al",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PMID: 40658688 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40658688",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Sequence Notes: Genomic Characterization of Two Novel HIV-1 Recombinant Forms",
    "entities": []
  },
  {
    "text": "(B/C) Among Men Who Have Sex with Men in Hebei, China.",
    "entities": [
      {
        "text": "Hebei",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Clinical Laboratory, Baoding Central Blood Station, Baoding, China.",
    "entities": [
      {
        "text": "1)Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "Baoding Central Blood Station",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Clinical Laboratory, Baoding People's Hospital, Baoding, China.",
    "entities": [
      {
        "text": "Baoding People's Hospital",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The genetic diversity of HIV-1, driven by mutation and recombination, poses",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant challenges to prevention and control efforts, particularly in",
    "entities": []
  },
  {
    "text": "regions like China where multiple subtypes and circulating recombinant forms",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "co-circulate. Men who have sex with men (MSM) represent a key population for the",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "emergence of novel recombinants. This study characterizes two novel unique",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recombinant forms (URFs) identified within the MSM population in Hebei, China.",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      },
      {
        "text": "Hebei",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Viral RNA extraction, amplification, and near full-length genome (NFLG)",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "NFLG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sequencing were performed. Phylogenetic analysis based on NFLG alignments was",
    "entities": [
      {
        "text": "NFLG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conducted in MEGA 6 under the Kimura 2-parameter model with 1,000 bootstrap",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "1,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "replicates. Recombination was assessed using the Recombinant Identification",
    "entities": []
  },
  {
    "text": "Program and SimPlot v3.5.1. Breakpoint-defined regions were phylogenetically",
    "entities": [
      {
        "text": "SimPlot",
        "label": "ORG"
      },
      {
        "text": "Breakpoint",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analyzed, and recombination maps were generated. Phylogenetic and recombinant",
    "entities": []
  },
  {
    "text": "analysis based on NFLG sequences (designated BDL061 and BDL071) revealed that",
    "entities": [
      {
        "text": "NFLG",
        "label": "ORG"
      },
      {
        "text": "BDL061",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "they originated from subtypes B and C. BDL061 exhibited a predominantly subtype",
    "entities": [
      {
        "text": "C. BDL061",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "B backbone with interspersed subtype C segments, while BDL071 displayed a",
    "entities": []
  },
  {
    "text": "predominantly subtype C backbone with subtype B segments. Phylogenetic analysis",
    "entities": []
  },
  {
    "text": "of recombinant segments strongly supported (bootstrap >90%) subtype B and C",
    "entities": [
      {
        "text": "90%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "parental origins for the respective fragments. We report the identification and",
    "entities": []
  },
  {
    "text": "characterization of two phylogenetically distinct, novel HIV-1B/C URFs (BDL061",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "BDL061",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and BDL071) among MSM in Hebei, China. Their unique mosaic structures, differing",
    "entities": [
      {
        "text": "MSM",
        "label": "ORG"
      },
      {
        "text": "Hebei",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "mosaic structures",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "predominant backbones, and confirmation as novel recombinants underscore the",
    "entities": []
  },
  {
    "text": "ongoing evolution and increasing complexity of the HIV-1 epidemic within this",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "high-risk population in China. These findings highlight the critical need for",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "NFLG-based surveillance to accurately track viral diversity and inform public",
    "entities": [
      {
        "text": "NFLG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "health strategies.",
    "entities": []
  },
  {
    "text": "Adults Aged \u226550 Years Reached by the CDC's HIV Programs Including HIV Testing,",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "HIV Programs Including HIV Testing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PrEP Referrals, and Linkage to Care in the U.S., Puerto Rico, and the U.S.",
    "entities": [
      {
        "text": "PrEP Referrals",
        "label": "ORG"
      },
      {
        "text": "Linkage to Care",
        "label": "ORG"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      },
      {
        "text": "Puerto Rico",
        "label": "GPE"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Virgin Islands, 2019-2022.",
    "entities": [
      {
        "text": "Virgin Islands",
        "label": "GPE"
      },
      {
        "text": "2019-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Marano-Lee M(1), Williams W(2), Xu S(1), Uhl G(1).",
    "entities": [
      {
        "text": "Marano-Lee M(1",
        "label": "PERSON"
      },
      {
        "text": "Williams",
        "label": "PERSON"
      },
      {
        "text": "Xu S(1",
        "label": "PERSON"
      },
      {
        "text": "Uhl",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Translation and Evaluation Branch, Division of HIV Prevention, National",
    "entities": [
      {
        "text": "Evaluation Branch",
        "label": "ORG"
      },
      {
        "text": "Division of HIV Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for",
    "entities": [
      {
        "text": "Viral Hepatitis",
        "label": "ORG"
      },
      {
        "text": "STD",
        "label": "ORG"
      },
      {
        "text": "TB Prevention, Centers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Public Health Analytic Consulting Services, Inc, Hillsborough, NC, USA.",
    "entities": [
      {
        "text": "Health Analytic Consulting Services",
        "label": "ORG"
      },
      {
        "text": "Inc, Hillsborough",
        "label": "ORG"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Older adults (defined as adults who are 50 and over) accounted for",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1 in 6 persons newly diagnosed with HIV in 2022. The objectives of this analysis",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "were to present the most currently available data about older adults reached by",
    "entities": []
  },
  {
    "text": "the Centers for Disease Control and Prevention's (CDC) HIV programs.",
    "entities": [
      {
        "text": "the Centers for Disease Control and Prevention's",
        "label": "ORG"
      },
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: From 2019 through 2022, CDC funded 61 health departments and 160",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "61",
        "label": "CARDINAL"
      },
      {
        "text": "160",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "community-based organizations in the United States and Puerto Rico and the U.S.",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      },
      {
        "text": "Puerto Rico",
        "label": "GPE"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Virgin Islands to provide HIV testing, pre-exposure prophylaxis (PrEP)",
    "entities": []
  },
  {
    "text": "referrals, and linkage to HIV medical care and report on their program outcomes",
    "entities": []
  },
  {
    "text": "to CDC. We conducted descriptive analysis as well as multivariable robust",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Poisson regression analysis to assess the association between demographic",
    "entities": []
  },
  {
    "text": "characteristics and outcomes of HIV tests among older adults.",
    "entities": []
  },
  {
    "text": "RESULTS: Between 2019 and 2022, the percentage of CDC-funded HIV tests provided",
    "entities": [
      {
        "text": "Between 2019 and 2022",
        "label": "DATE"
      },
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to older adults increased, (16.9% in 2019, 17.3% in 2020, 18.3% in 2021, and",
    "entities": [
      {
        "text": "16.9%",
        "label": "PERCENT"
      },
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "17.3%",
        "label": "PERCENT"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "18.3%",
        "label": "PERCENT"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "18.4% in 2022). In 2022, older adults accounted for 11% of new diagnoses. Among",
    "entities": [
      {
        "text": "18.4%",
        "label": "PERCENT"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "11%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "those, (876), 779 people had linkage data, and of those, 579 (74.1%) were linked",
    "entities": [
      {
        "text": "876",
        "label": "CARDINAL"
      },
      {
        "text": "779",
        "label": "CARDINAL"
      },
      {
        "text": "579",
        "label": "CARDINAL"
      },
      {
        "text": "74.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "to HIV medical care within 30 days after diagnosis. Of those older adults with a",
    "entities": [
      {
        "text": "30 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "negative test result and available data, 90,422 (41.3%) were eligible for a PrEP",
    "entities": [
      {
        "text": "90,422",
        "label": "CARDINAL"
      },
      {
        "text": "41.3%",
        "label": "PERCENT"
      },
      {
        "text": "PrEP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "referral and 39,382 (44.3%) were referred to a PrEP provider.",
    "entities": [
      {
        "text": "39,382",
        "label": "CARDINAL"
      },
      {
        "text": "44.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "DISCUSSION: Continued efforts are needed to provide focused HIV prevention",
    "entities": []
  },
  {
    "text": "messaging specifically for older adults and to make available relevant",
    "entities": []
  },
  {
    "text": "information about HIV to health care providers.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Conflicting Interests: The authors declared no",
    "entities": []
  },
  {
    "text": "potential conflicts of interest with respect to the research, authorship, and/or",
    "entities": []
  },
  {
    "text": "publication of this article.",
    "entities": []
  },
  {
    "text": "Abstract Supplement Abstracts from IAS 2025, the 13th IAS Conference on HIV",
    "entities": [
      {
        "text": "Abstract Supplement Abstracts",
        "label": "ORG"
      },
      {
        "text": "IAS",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "13th",
        "label": "ORDINAL"
      },
      {
        "text": "IAS Conference",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "Science, 13 - 17 July, Kigali, Rwanda & Virtual.",
    "entities": [
      {
        "text": "13 - 17 July",
        "label": "DATE"
      },
      {
        "text": "Kigali",
        "label": "GPE"
      },
      {
        "text": "Rwanda & Virtual",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "85. Res Nurs Health. 2025 Jul 14. doi: 10.1002/nur.70009. Online ahead of print.",
    "entities": [
      {
        "text": "85",
        "label": "CARDINAL"
      },
      {
        "text": "Res Nurs Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Integrating a Human-Centered Design Tool, dScout, to Design a Web-Based",
    "entities": [
      {
        "text": "dScout",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Intervention for Parent-Adolescent Sexual Health Communication.",
    "entities": []
  },
  {
    "text": "Randolph SD(1), Jeter E(1), Zuber CD(2), Johnson R(1), Emerson M(1), Jemmott",
    "entities": [
      {
        "text": "Randolph SD(1",
        "label": "PERSON"
      },
      {
        "text": "Zuber CD(2",
        "label": "PERSON"
      },
      {
        "text": "Johnson R(1",
        "label": "PERSON"
      },
      {
        "text": "Emerson",
        "label": "ORG"
      },
      {
        "text": "Jemmott",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "JS(1), Johnson A(1).",
    "entities": [
      {
        "text": "Johnson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Duke University School of Nursing, Durham, North Carolina, USA.",
    "entities": [
      {
        "text": "University School of Nursing",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "North Carolina",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Stanford School of Medicine, Palo Alto, California, USA.",
    "entities": [
      {
        "text": "2)Stanford",
        "label": "CARDINAL"
      },
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Palo Alto",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Black male adolescents and young adults (BMAYA) experience pronounced and",
    "entities": [
      {
        "text": "BMAYA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "persistent sexual health disparities compared to other groups in the US. This",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "original research focuses on the early-stage development of The TALK, a",
    "entities": []
  },
  {
    "text": "nurse-led multi-pronged web-based eHealth intervention to improve shared",
    "entities": [
      {
        "text": "eHealth",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "parent-adolescent sexual health knowledge and communication. A community-engaged",
    "entities": []
  },
  {
    "text": "approach was used to codesign the intervention with a community advisory council",
    "entities": []
  },
  {
    "text": "and two Black-owned barbershop owners. Researchers leveraged human-centered",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "design process using dscout, a virtual ethnographic research tool, to examine",
    "entities": []
  },
  {
    "text": "the usability, feasibility and acceptability of The TALK with parents of BMAYA",
    "entities": [
      {
        "text": "BMAYA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(n = 13). Open- and close-ended questions captured qualitative data of",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "end-users' experiences of and preferences for intervention technology and",
    "entities": []
  },
  {
    "text": "content within the three primary intervention components: videos, website, and",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "an interactive activity. Feedback from participants on digital design,",
    "entities": []
  },
  {
    "text": "functionality, and overall ease of use and navigation of The TALK was beneficial",
    "entities": []
  },
  {
    "text": "for the initial intervention codesign process. Feedback was positive and",
    "entities": []
  },
  {
    "text": "constructive, highlighting where the intervention was culturally relevant and",
    "entities": []
  },
  {
    "text": "satisfying for users with recommendations for changes in areas of design",
    "entities": []
  },
  {
    "text": "friction and content accessibility before efficacy and effectiveness testing.",
    "entities": []
  },
  {
    "text": "This study helps understand how The TALK engaged participants and assisted in",
    "entities": []
  },
  {
    "text": "parent-adolescent communication through beta testing the technological design",
    "entities": []
  },
  {
    "text": "and content. Considering the potential for eHealth technologies in sexual health",
    "entities": [
      {
        "text": "eHealth",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "promotion and prevention for BMAYA, thoughtful design and quality experience",
    "entities": [
      {
        "text": "BMAYA",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "should be developed early in the intervention design through human-centered",
    "entities": []
  },
  {
    "text": "processes and community-engaged approaches.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Otolaryngological Manifestations and Associated Biochemical, Hematological, and",
    "entities": [
      {
        "text": "Associated Biochemical, Hematological",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Immunological Profiles in HIV-Positive Patients in Vietnam.",
    "entities": [
      {
        "text": "Immunological Profiles",
        "label": "ORG"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Ear, Nose and Throat, Haiphong Children's Hospital, Haiphong,",
    "entities": [
      {
        "text": "Throat",
        "label": "PERSON"
      },
      {
        "text": "Haiphong Children's Hospital",
        "label": "ORG"
      },
      {
        "text": "Haiphong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Ear, Nose and Throat, Viet-Tiep Friendship Hospital, Haiphong,",
    "entities": [
      {
        "text": "Throat",
        "label": "PERSON"
      },
      {
        "text": "Viet-Tiep Friendship Hospital",
        "label": "ORG"
      },
      {
        "text": "Haiphong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The global HIV/AIDS epidemic, with its significant presence in",
    "entities": []
  },
  {
    "text": "Vietnam by the early 2000s, often linked to injecting drug use, prompted concern",
    "entities": [
      {
        "text": "Vietnam",
        "label": "GPE"
      },
      {
        "text": "the early 2000s",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "at the National Otorhinolaryngology Hospital due to a rising prevalence of HIV",
    "entities": [
      {
        "text": "the National Otorhinolaryngology Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "among ENT patients. This highlighted a need to understand their specific",
    "entities": []
  },
  {
    "text": "clinical and laboratory profiles.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study aimed to systematically evaluate selected biochemical,",
    "entities": []
  },
  {
    "text": "hematological, and immunological parameters in these HIV-positive ENT patients",
    "entities": [
      {
        "text": "ENT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to characterize their infection and identify significant laboratory alterations.",
    "entities": []
  },
  {
    "text": "METHODS: This retrospective-prospective cohort study included 104 HIV-positive",
    "entities": [
      {
        "text": "104",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ENT patients from January 2010 to August 2014. HIV diagnoses were confirmed via",
    "entities": [
      {
        "text": "January 2010 to August 2014",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a multi-test approach. Demographic, risk behavior, and ENT diagnosis data were",
    "entities": [
      {
        "text": "Demographic",
        "label": "PERSON"
      },
      {
        "text": "ENT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "collected from medical records. Biochemical, hematological, and immunological",
    "entities": []
  },
  {
    "text": "(CD4, CD8, CD4/CD8 ratio) parameters were analyzed.",
    "entities": [
      {
        "text": "CD8",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The cohort was predominantly young adult males (85.55%), with injecting",
    "entities": [
      {
        "text": "85.55%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "drug use as the main risk factor (79.04%). Over half (53.60%) had HIV-related",
    "entities": [
      {
        "text": "79.04%",
        "label": "PERCENT"
      },
      {
        "text": "Over half",
        "label": "CARDINAL"
      },
      {
        "text": "53.60%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "ENT conditions; 46.40% were incidentally diagnosed. Biochemical analysis showed",
    "entities": [
      {
        "text": "46.40%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "significantly elevated total protein/globulin and reduced albumin/A/G ratio (p <",
    "entities": []
  },
  {
    "text": "0.05). Hematologically, leukopenia (7.4% males) and mild/moderate anemia (20.4%",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "7.4%",
        "label": "PERCENT"
      },
      {
        "text": "20.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "males, 33.3% females) were observed. Immunological profiling revealed",
    "entities": [
      {
        "text": "33.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "significantly decreased CD4 counts (264\u00b189.57 cells/mm\u00b3) and CD4/CD8 ratios,",
    "entities": []
  },
  {
    "text": "alongside increased CD8 counts (all p < 0.05).",
    "entities": []
  },
  {
    "text": "CONCLUSION: HIV-positive ENT patients in Vietnam exhibit typical",
    "entities": [
      {
        "text": "ENT",
        "label": "ORG"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "demographic/risk profiles and frequent HIV-related ENT manifestations.",
    "entities": [
      {
        "text": "demographic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Significant biochemical, hematological, and profound immunological abnormalities",
    "entities": []
  },
  {
    "text": "underscore HIV's systemic impact. ENT clinics are crucial for early HIV",
    "entities": []
  },
  {
    "text": "detection, necessitating comprehensive laboratory monitoring for effective",
    "entities": []
  },
  {
    "text": "PMID: 40657334 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest",
    "entities": []
  },
  {
    "text": "regarding the research or publication of this article.",
    "entities": []
  },
  {
    "text": "Rapid Initiation of Antiretroviral Therapy Suppresses T Cell Pathological",
    "entities": []
  },
  {
    "text": "Proliferation and Improves Immune Recovery in People Living with HIV.",
    "entities": []
  },
  {
    "text": "(1)Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical",
    "entities": [
      {
        "text": "Beijing Youan Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Beijing, 100069, People's Republic of China.",
    "entities": [
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100069",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Beijing Institute of Sexually Transmitted Disease Prevention and Control,",
    "entities": [
      {
        "text": "Institute of Sexually Transmitted Disease Prevention and Control",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Beijing, 100069, People's Republic of China.",
    "entities": [
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100069",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Beijing Key Laboratory of HIV/AIDS Research, Beijing, 100069, People's",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100069",
        "label": "DATE"
      },
      {
        "text": "People's\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Republic of China.",
    "entities": []
  },
  {
    "text": "(4)Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital,",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Capital Medical University, Beijing, 100069, People's Republic of China.",
    "entities": [
      {
        "text": "Capital Medical University",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100069",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Initiating antiretroviral therapy promptly (rapid ART) is linked to",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "better immune recovery in people with HIV (PWH), although its specific effects",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "on immune dysregulation remain partially understood. We have discovered a",
    "entities": []
  },
  {
    "text": "\"pathological proliferation\" phenomenon, marked by T cell over-proliferation and",
    "entities": []
  },
  {
    "text": "exhaustion in PWH, potentially hindering full immune recovery. The objective of",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "this research is to examine how rapid ART affects T-cell pathological",
    "entities": []
  },
  {
    "text": "proliferation, immune recovery, and systemic inflammation in PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PATIENTS AND METHODS: In this cross-sectional study (conducted at Beijing Youan",
    "entities": [
      {
        "text": "Beijing Youan",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hospital, Capital Medical University, China, from April 1 to September 18,",
    "entities": [
      {
        "text": "Capital Medical University",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "April 1 to September 18",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2022), we recruited 39 PWH, including 23 in the rapid ART group (within 30 days)",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "39",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "23",
        "label": "CARDINAL"
      },
      {
        "text": "30 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 16 in the non-rapid ART group (after 180 days). Fasting venous blood samples",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "180 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "were collected in the morning. Immune phenotypes of T cells were analyzed using",
    "entities": [
      {
        "text": "the morning",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "mass cytometry and Luminex.",
    "entities": [
      {
        "text": "Luminex",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: The rapid ART group demonstrated a significant decline in Ki67\u207a CD4\u207a",
    "entities": [
      {
        "text": "Ki67\u207a CD4\u207a",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "and CD8\u207a T cells. Within this group, a higher percentage of naive T (TN) cells",
    "entities": [
      {
        "text": "TN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was observed in CD4\u207a T cells, along with a remarkable reduction in Ki67",
    "entities": []
  },
  {
    "text": "expression. Additionally, CD8\u207a T cells in the rapid ART group exhibited an",
    "entities": []
  },
  {
    "text": "increased presence of TN cells while showing a decreased proportion of",
    "entities": [
      {
        "text": "TN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PD-1/HLA-DR/CD38 high-expressing cells. In addition, the rapid ART group",
    "entities": []
  },
  {
    "text": "exhibited significantly lower IL-18 levels. TN cells (CD31+ HLA-DR- CD38- CD57-",
    "entities": [
      {
        "text": "TN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PD-1-) and central memory T (TCM) cells (HLA-DR+ CD38- PD-1- CD57-) that were",
    "entities": [
      {
        "text": "PD-1-",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "not suppressed by rapid ART showed significant correlations with baseline CD4",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "counts, HIV loads, and recent CD4/CD8 ratio.",
    "entities": []
  },
  {
    "text": "CONCLUSION: These findings suggest rapid ART may curb pathological T cell",
    "entities": []
  },
  {
    "text": "proliferation and improved immune recovery in PWH. Despite these benefits,",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "persistent immune activation in some individuals highlights the need for",
    "entities": []
  },
  {
    "text": "targeted immune monitoring and potential adjunctive interventions to optimize",
    "entities": []
  },
  {
    "text": "long-term immune health in PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflation of prediction and causality in the TB literature.",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Global Health and Social Medicine, Harvard Medical School,",
    "entities": [
      {
        "text": "Global Health and Social Medicine",
        "label": "ORG"
      },
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, Massachusetts, USA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics, \"V. Buzzi\" Children's Hospital, ASST FBF Sacco,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Children's Hospital",
        "label": "WORK_OF_ART"
      },
      {
        "text": "ASST",
        "label": "GPE"
      },
      {
        "text": "FBF Sacco",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Clinical Research Department, Faculty of Infectious and Tropical Diseases,",
    "entities": [
      {
        "text": "3)Clinical Research Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Infectious and Tropical Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London School of Hygiene & Tropical Medicine, London, UK.",
    "entities": [
      {
        "text": "London School of Hygiene & Tropical Medicine",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Interactive Research & Development (IRD) Global, Singapore, Singapore.",
    "entities": [
      {
        "text": "Research & Development",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Observational data can answer both predictive and etiologic research",
    "entities": []
  },
  {
    "text": "questions; however, the model-building approach and interpretation of results",
    "entities": []
  },
  {
    "text": "differ based on the research goal (i.e., prediction versus causal inference).",
    "entities": []
  },
  {
    "text": "Conflation occurs when aspects of the methodology and/or interpretation that are",
    "entities": []
  },
  {
    "text": "unique to prediction or etiology are combined or confused, potentially leading",
    "entities": []
  },
  {
    "text": "to biased results and erroneous conclusions.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a rapid review using MEDLINE (2018-2023) of a subset of",
    "entities": [
      {
        "text": "MEDLINE",
        "label": "ORG"
      },
      {
        "text": "2018-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the observational TB literature: cohort studies among people with drug-resistant",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TB that considered HIV status an exposure of interest and reported on TB",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment outcomes. For each article, we assessed the research question,",
    "entities": []
  },
  {
    "text": "statistical approach, presentation of results, and discussion and interpretation",
    "entities": []
  },
  {
    "text": "of results.",
    "entities": []
  },
  {
    "text": "RESULTS: Among the 40 articles included, 32 (80%) had evidence of conflation.",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "32",
        "label": "DATE"
      },
      {
        "text": "80%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "The most common specific types of conflation were recommending or proposing",
    "entities": []
  },
  {
    "text": "interventions to modify exposures in a predictive study and having a causal",
    "entities": []
  },
  {
    "text": "interpretation of predictors, with both types frequently co-occurring.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Conflation between prediction and etiology was common, highlighting",
    "entities": []
  },
  {
    "text": "the importance of increasing awareness about it and its potential consequences.",
    "entities": []
  },
  {
    "text": "We propose simple steps on how TB and lung health researchers can avoid",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conflation, beginning with clearly defining the research question.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Authors.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of interest: none declared.",
    "entities": []
  },
  {
    "text": "Non-tuberculous mycobacterial disease in a high TB/HIV burden setting.",
    "entities": []
  },
  {
    "text": "Janssen S(1)(2), Ismail Z(3), Lovelock T(3), Hugo S(3), van Schalkwyk M(3),",
    "entities": [
      {
        "text": "Ismail Z(3",
        "label": "PERSON"
      },
      {
        "text": "Hugo",
        "label": "EVENT"
      },
      {
        "text": "van Schalkwyk M(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)TASK, Cape Town, South Africa.",
    "entities": [
      {
        "text": "1)TASK",
        "label": "DATE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Radboud University Medical Center, Nijmegen, The Netherlands.",
    "entities": [
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Nijmegen",
        "label": "PERSON"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape",
    "entities": [
      {
        "text": "Medicine, Stellenbosch University",
        "label": "ORG"
      },
      {
        "text": "Tygerberg Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Town, South Africa.",
    "entities": [
      {
        "text": "Town",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "TB-related stigma is widely prevalent among people with TB and carers in",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Australia.",
    "entities": [
      {
        "text": "2)Victorian",
        "label": "CARDINAL"
      },
      {
        "text": "Tuberculosis Program",
        "label": "ORG"
      },
      {
        "text": "Melbourne Health",
        "label": "ORG"
      },
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "VIC",
        "label": "ORG"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Infectious Diseases, University of Melbourne, Parkville, VIC,",
    "entities": [
      {
        "text": "Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "University of Melbourne",
        "label": "ORG"
      },
      {
        "text": "Parkville",
        "label": "GPE"
      },
      {
        "text": "VIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)National Center for Communicable Diseases of the Ministry of Health,",
    "entities": [
      {
        "text": "Center for Communicable Diseases",
        "label": "ORG"
      },
      {
        "text": "the Ministry of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)National Center for Public Health of the Ministry of Health of Mongolia,",
    "entities": [
      {
        "text": "Center for Public Health",
        "label": "ORG"
      },
      {
        "text": "the Ministry of Health of Mongolia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)National Human Rights Commission of Mongolia, Ulaanbaatar, Mongolia.",
    "entities": [
      {
        "text": "Human Rights Commission",
        "label": "ORG"
      },
      {
        "text": "Ulaanbaatar",
        "label": "GPE"
      },
      {
        "text": "Mongolia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)The Global Fund Project Coordinating Unit, Ministry of Health of Mongolia,",
    "entities": [
      {
        "text": "Global Fund Project Coordinating Unit",
        "label": "ORG"
      },
      {
        "text": "Ministry of Health of Mongolia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Country Coordinating Mechanism of the Global Fund supported TB and HIV",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Melbourne Children's Global Health, University of Melbourne Department of",
    "entities": [
      {
        "text": "Children's Global Health, University of Melbourne Department",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Paediatrics and Murdoch Children's Research Institute, Royal Children's",
    "entities": [
      {
        "text": "Murdoch Children's",
        "label": "ORG"
      },
      {
        "text": "Research Institute",
        "label": "ORG"
      },
      {
        "text": "Royal Children's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: In Mongolia, estimated TB incidence is high, but treatment coverage",
    "entities": [
      {
        "text": "Mongolia",
        "label": "GPE"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "is low. Stigma is a likely barrier to access but has not previously been",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a national TB stigma assessment in Mongolia in 2021-2022",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "Mongolia",
        "label": "GPE"
      },
      {
        "text": "2021-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to evaluate prevalence and impact of TB-related stigma. All survey participants",
    "entities": []
  },
  {
    "text": "had face-to-face interviews conducted by trained community staff members using",
    "entities": []
  },
  {
    "text": "RESULTS: Study participants included 460 people with TB, 90 family members, 83",
    "entities": [
      {
        "text": "460",
        "label": "CARDINAL"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "90",
        "label": "CARDINAL"
      },
      {
        "text": "83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "community members and 115 healthcare workers (HCWs). Overall, 53% of",
    "entities": [
      {
        "text": "115",
        "label": "CARDINAL"
      },
      {
        "text": "53%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "participants reported experiencing stigma with HCWs reporting highest prevalence",
    "entities": []
  },
  {
    "text": "(72%). Stigma was most commonly experienced in healthcare settings, particularly",
    "entities": [
      {
        "text": "72%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "during initial diagnosis and treatment initiation. Urban slum residence was",
    "entities": []
  },
  {
    "text": "associated with higher stigma among patients while older age was associated with",
    "entities": []
  },
  {
    "text": "lower scores. Female respondents reported stigma significantly more commonly",
    "entities": []
  },
  {
    "text": "overall. Family members and community members commonly reported secondary stigma",
    "entities": []
  },
  {
    "text": "with concerns about infection and social isolation being prevalent.",
    "entities": []
  },
  {
    "text": "CONCLUSION: TB-related stigma is highly prevalent across Mongolia. There is an",
    "entities": [
      {
        "text": "Mongolia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "urgent need for comprehensive stigma-reduction strategies that extend beyond",
    "entities": []
  },
  {
    "text": "PWTB and their families to also include HCWs and broader community.",
    "entities": []
  },
  {
    "text": "91. Open Forum Infect Dis. 2025 Jun 17;12(7):ofaf353. doi: 10.1093/ofid/ofaf353.",
    "entities": [
      {
        "text": "91",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HIV Care Continuum Outcomes Among Adolescents and Young Adults Living With HIV",
    "entities": [
      {
        "text": "Young Adults Living With HIV\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in Latin America and the Caribbean: Association With Depression and Substance",
    "entities": [
      {
        "text": "Latin America",
        "label": "LOC"
      },
      {
        "text": "the Caribbean: Association With Depression and Substance\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pinto J(10), Wagner Cardoso S(11), Maruri F(12), Shepherd BE(3), McGowan CC(12),",
    "entities": [
      {
        "text": "Wagner Cardoso S(11",
        "label": "ORG"
      },
      {
        "text": "Maruri",
        "label": "GPE"
      },
      {
        "text": "Shepherd BE(3",
        "label": "PERSON"
      },
      {
        "text": "McGowan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Person AK(12).",
    "entities": []
  },
  {
    "text": "(2)Department of Biomedical Informatics, Vanderbilt University Medical Center,",
    "entities": [
      {
        "text": "Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "Vanderbilt University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Biostatistics, Vanderbilt University School of Medicine,",
    "entities": [
      {
        "text": "Biostatistics, Vanderbilt University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections",
    "entities": [
      {
        "text": "Group for the Study of Kaposi's",
        "label": "ORG"
      },
      {
        "text": "Sarcoma and Opportunistic Infections",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Weill Cornell Medicine, New York, New York, USA.",
    "entities": [
      {
        "text": "Cornell Medicine",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Pediatrics, Instituto Hondure\u00f1o de Seguridad Social and",
    "entities": [
      {
        "text": "Instituto Hondure\u00f1o de Seguridad Social",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)School of Medicine, Federal University of Minas Gerais, Belo Horizonte,",
    "entities": [
      {
        "text": "Medicine, Federal University of Minas Gerais",
        "label": "ORG"
      },
      {
        "text": "Belo Horizonte",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)Division of Infectious Diseases, Vanderbilt University School of Medicine,",
    "entities": [
      {
        "text": "12)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Vanderbilt University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Adolescents and young adults with HIV (AYAWH) represent vulnerable",
    "entities": []
  },
  {
    "text": "populations, with increased risk of virologic failure, loss to follow-up, and",
    "entities": []
  },
  {
    "text": "death. Depression and substance use in AYAWH can lead to worse outcomes, yet",
    "entities": []
  },
  {
    "text": "this overlap is not well understood.",
    "entities": []
  },
  {
    "text": "METHODS: This cross-sectional study included adolescents (10-17 years) and young",
    "entities": [
      {
        "text": "10-17 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "adults (18-24 years) with HIV in the Caribbean, Central and South America",
    "entities": [
      {
        "text": "18-24 years",
        "label": "DATE"
      },
      {
        "text": "Caribbean",
        "label": "LOC"
      },
      {
        "text": "Central and South America",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "network for HIV epidemiology (CCASAnet). Participants were administered surveys",
    "entities": []
  },
  {
    "text": "to assess for depression, substance use, and antiretroviral therapy (ART)",
    "entities": []
  },
  {
    "text": "adherence. Risk factors for depression; alcohol, tobacco, and substance use;",
    "entities": []
  },
  {
    "text": "missing ART doses; viral suppression; and 1-year retention were assessed.",
    "entities": [
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: Six hundred twenty-five AYAWH were included. Depression prevelance was",
    "entities": [
      {
        "text": "Six hundred twenty-five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "16%. Males (adjusted odds ratio [aOR], 0.26; 95% CI, 0.16-0.44) and younger",
    "entities": [
      {
        "text": "16%",
        "label": "PERCENT"
      },
      {
        "text": "0.26",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "youth (15-year-olds vs 18-year-olds: aOR, 0.61; 95% CI, 0.40-0.95) were less",
    "entities": [
      {
        "text": "15-year-olds",
        "label": "DATE"
      },
      {
        "text": "18-year-olds",
        "label": "DATE"
      },
      {
        "text": "aOR",
        "label": "GPE"
      },
      {
        "text": "0.61",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "0.40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "likely to have depression. Fifty-eight percent reported using alcohol, 28%",
    "entities": [
      {
        "text": "Fifty-eight percent",
        "label": "PERCENT"
      },
      {
        "text": "28%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "reported tobacco use, 17% reported cannabis use, and 4% reported cocaine use.",
    "entities": [
      {
        "text": "17%",
        "label": "PERCENT"
      },
      {
        "text": "4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Forty-one percent missed 1 or more doses of ART in the past week. Forty percent",
    "entities": [
      {
        "text": "Forty-one percent",
        "label": "PERCENT"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "the past week",
        "label": "DATE"
      },
      {
        "text": "Forty percent",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "had detectable viral loads at the time of survey completion. Those who acquired",
    "entities": []
  },
  {
    "text": "HIV perinatally were more likely to have an unsuppressed viral load (aOR, 2.4;",
    "entities": [
      {
        "text": "2.4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI, 1.24-4.62; P = .009). Only 73% of participants were retained in care",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.24",
        "label": "CARDINAL"
      },
      {
        "text": ".009",
        "label": "CARDINAL"
      },
      {
        "text": "Only 73%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "following the survey; there was no statistical association between retention and",
    "entities": []
  },
  {
    "text": "age, sex, education, probable route of HIV acquisition, depression, and needing",
    "entities": []
  },
  {
    "text": "intervention for substance use.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Substance use and depression were prevalent in AYAWH, as were",
    "entities": [
      {
        "text": "AYAWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "missed doses of ART and detectable viral loads.",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1093/ofid/ofaf353",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Potential conflicts of interest. All authors",
    "entities": []
  },
  {
    "text": "declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "10.36519/idcm.2025.503. eCollection 2025 Jun.",
    "entities": [
      {
        "text": "10.36519",
        "label": "CARDINAL"
      },
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "Jun.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Characteristics and Distribution of Fungal Meningitis: A Systematic Review.",
    "entities": []
  },
  {
    "text": "(1)Student Research Committee, Ahvaz Jundishapur University of Medical Sciences,",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Ahvaz Jundishapur University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Health Information Technology, School of Allied Medical",
    "entities": [
      {
        "text": "Health Information Technology",
        "label": "ORG"
      },
      {
        "text": "School of Allied Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",
    "entities": [
      {
        "text": "Ahvaz Jundishapur University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Ahvaz",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz",
    "entities": [
      {
        "text": "Laboratory Sciences",
        "label": "ORG"
      },
      {
        "text": "School of Allied Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Ahvaz",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Jundishapur University of Medical Sciences, Ahvaz, Iran.",
    "entities": [
      {
        "text": "Jundishapur University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Ahvaz",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Nutrition and Metabolic Disease Research Center, Clinical Sciences Research",
    "entities": [
      {
        "text": "Metabolic Disease Research Center, Clinical Sciences Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",
    "entities": [
      {
        "text": "Ahvaz Jundishapur University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Ahvaz",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Meningitis is one of the most severe manifestations of fungal",
    "entities": [
      {
        "text": "Meningitis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "infections in the central nervous system. Various microorganisms, including",
    "entities": []
  },
  {
    "text": "fungi, can cause the disease. Understanding the prevalence of fungal meningitis",
    "entities": []
  },
  {
    "text": "is crucial for identifying geographical areas with higher incidence rates and",
    "entities": []
  },
  {
    "text": "improving prevention, control, and treatment strategies. This study aimed to",
    "entities": []
  },
  {
    "text": "highlight gaps in understanding disease-causing factors and vulnerable",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: This study followed the Preferred Reporting Items for",
    "entities": [
      {
        "text": "the Preferred Reporting Items for\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Systematic Reviews and Meta-Analyses (PRISMA) guidelines to systematically",
    "entities": [
      {
        "text": "Meta-Analyses",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "review articles on fungal meningitis from 2014 to 2023. Relevant articles were",
    "entities": [
      {
        "text": "2014",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "screened for eligibility and quality-checked using the Joanna Briggs Institute",
    "entities": [
      {
        "text": "the Joanna Briggs Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(JBI) tools before inclusion in the final analysis.",
    "entities": [
      {
        "text": "JBI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 33 articles were included in the review. Most of the",
    "entities": [
      {
        "text": "33",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "articles on the prevalence of fungal meningitis were published in 2015. The",
    "entities": [
      {
        "text": "2015",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "highest number of studies were conducted in the United States, southern African",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      },
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "countries, and Brazil. Cryptococcus spp. was identified as the primary cause of",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "Cryptococcus",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "fungal meningitis in 84.8% of the articles. Additionally, HIV was the most",
    "entities": [
      {
        "text": "84.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "commonly associated medical condition.",
    "entities": []
  },
  {
    "text": "CONCLUSION: This systematic review provides an overview of the global",
    "entities": []
  },
  {
    "text": "epidemiology of fungal meningitis and underscores its significant burden. While",
    "entities": []
  },
  {
    "text": "progress has been made in understanding the epidemiology of the disease, major",
    "entities": []
  },
  {
    "text": "challenges remain in early diagnosis, access to effective treatment, and",
    "entities": []
  },
  {
    "text": "management of complications. Continued research and improved access to",
    "entities": []
  },
  {
    "text": "healthcare resources are critical to mitigating the impact of this",
    "entities": []
  },
  {
    "text": "life-threatening condition worldwide.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Infectious Diseases and Clinical Microbiology.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflict of interest.",
    "entities": []
  },
  {
    "text": "Concurrent Mpox and HSV-1 Proctitis in a Young Male With AIDS: A Case Report of",
    "entities": [
      {
        "text": "HSV-1 Proctitis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "S(1), Peachey M(1).",
    "entities": []
  },
  {
    "text": "(1)Department of Medicine, BronxCare Health System, Bronx, New York, USA.",
    "entities": [
      {
        "text": "BronxCare Health System",
        "label": "ORG"
      },
      {
        "text": "Bronx",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Managing the mpox in patients with advanced HIV infection and coinfections poses",
    "entities": []
  },
  {
    "text": "significant challenges. This report discusses a young male with advanced HIV",
    "entities": []
  },
  {
    "text": "(CD4 count 28) and severe concurrent mpox and HSV-1 proctitis. Despite initial",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "HSV-1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "treatment with oral tecovirimat, acyclovir, and antiretrovirals, the patient's",
    "entities": []
  },
  {
    "text": "condition worsened, requiring readmission. The patient received intravenous",
    "entities": []
  },
  {
    "text": "extensive rectal and sigmoid lesions that necessitated prolonged hospitalization",
    "entities": []
  },
  {
    "text": "and pain management. This case emphasizes the complexity of treating severe",
    "entities": []
  },
  {
    "text": "coinfections in immunocompromised patients, highlighting the need for a",
    "entities": []
  },
  {
    "text": "multidisciplinary approach and consideration of alternative therapies when",
    "entities": []
  },
  {
    "text": "standard treatment fails.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Mikhail Sukhoroslov et al. Case Reports in Infectious Diseases",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Mikhail Sukhoroslov",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "94. Ther Adv Infect Dis. 2025 Jul 8;12:20499361251351801. doi:",
    "entities": [
      {
        "text": "94",
        "label": "CARDINAL"
      },
      {
        "text": "Ther Adv Infect Dis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "10.1177/20499361251351801. eCollection 2025 Jan-Dec.",
    "entities": [
      {
        "text": "10.1177/20499361251351801",
        "label": "DATE"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jan-Dec.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Global \"expiration\" of abacavir in adults with HIV: a rapid review of safety and",
    "entities": []
  },
  {
    "text": "efficacy concerns challenging its role in modern ART.",
    "entities": []
  },
  {
    "text": "Cluck DB(1), Chastain DB(2), Lines JD(3), Short WR(4), Cecchini D(5)(6),",
    "entities": [
      {
        "text": "Cluck DB(1",
        "label": "PERSON"
      },
      {
        "text": "Chastain DB(2",
        "label": "PERSON"
      },
      {
        "text": "Lines JD(3",
        "label": "PERSON"
      },
      {
        "text": "Short WR(4",
        "label": "PERSON"
      },
      {
        "text": "Cecchini",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Pharmacy Practice, East Tennessee State University Bill Gatton",
    "entities": [
      {
        "text": "Pharmacy Practice",
        "label": "ORG"
      },
      {
        "text": "East Tennessee",
        "label": "ORG"
      },
      {
        "text": "State",
        "label": "ORG"
      },
      {
        "text": "Bill Gatton",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "College of Pharmacy, P. O. Box 70657, Johnson City, TN 37614, USA.",
    "entities": [
      {
        "text": "College of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Johnson City",
        "label": "GPE"
      },
      {
        "text": "TN 37614",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)University of Georgia College of Pharmacy, 1000 Jefferson Street, Albany, GA",
    "entities": [
      {
        "text": "2)University",
        "label": "CARDINAL"
      },
      {
        "text": "Georgia College of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "1000",
        "label": "CARDINAL"
      },
      {
        "text": "Jefferson Street",
        "label": "FAC"
      },
      {
        "text": "Albany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)East Tennessee State University Center of Excellence for HIV/AIDS, Johnson",
    "entities": [
      {
        "text": "Tennessee State University Center of Excellence for HIV/AIDS",
        "label": "ORG"
      },
      {
        "text": "Johnson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "City, TN, USA.",
    "entities": [
      {
        "text": "TN",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Infectious Diseases, Department of Medicine, Perelman School of",
    "entities": [
      {
        "text": "Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Perelman School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine at the University of Pennsylvania, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "the University of Pennsylvania",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)HIV Unit and Infectious Disease Service, Hospital Clinic and Fundaci\u00f3 de",
    "entities": [
      {
        "text": "Infectious Disease Service",
        "label": "ORG"
      },
      {
        "text": "Hospital Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)University of Barcelona, Barcelona, Spain.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Division of Infectious Diseases, University of Colorado, Aurora, CO, USA.",
    "entities": [
      {
        "text": "University of Colorado",
        "label": "ORG"
      },
      {
        "text": "Aurora",
        "label": "GPE"
      },
      {
        "text": "CO, USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Barry and Judy Silverman College of Pharmacy, Nova Southeastern University,",
    "entities": [
      {
        "text": "11)Barry",
        "label": "CARDINAL"
      },
      {
        "text": "Judy Silverman",
        "label": "PERSON"
      },
      {
        "text": "Nova Southeastern University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Division of Infectious Disease, Memorial Healthcare System, Hollywood, FL,",
    "entities": [
      {
        "text": "12)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Hollywood",
        "label": "GPE"
      },
      {
        "text": "FL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Emerging evidence from the REPRIEVE study cohort has further clarified the",
    "entities": []
  },
  {
    "text": "association between abacavir use and cardiovascular risk. This analysis, along",
    "entities": []
  },
  {
    "text": "with previous findings, demonstrates a significant elevation in time to first",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "major adverse cardiovascular events (MACE) among adults living with HIV with",
    "entities": []
  },
  {
    "text": "current or past abacavir exposure. Given the availability of safer, equally",
    "entities": []
  },
  {
    "text": "effective alternative ART regimens with fewer cardiovascular risks, the",
    "entities": [
      {
        "text": "ART",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "continued clinical relevance of abacavir in adults living with HIV should be",
    "entities": []
  },
  {
    "text": "critically reassessed. Considering these findings, abacavir should be considered",
    "entities": []
  },
  {
    "text": "an obsolete option for most, if not all, adults living with HIV. This",
    "entities": []
  },
  {
    "text": "perspective shift emphasizes the importance of selecting ART regimens that",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "optimize long-term cardiovascular health while achieving durable virologic",
    "entities": []
  },
  {
    "text": "suppression in the modern era of HIV treatment.",
    "entities": []
  },
  {
    "text": "95. Blood Lymphat Cancer. 2025 Jul 7;15:85-101. doi: 10.2147/BLCTT.S529249.",
    "entities": [
      {
        "text": "95",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.2147",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for",
    "entities": [
      {
        "text": "Clinical Characteristics",
        "label": "ORG"
      },
      {
        "text": "Prognostic Risk Factors",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Elderly Patients with Primary Central Nervous System Lymphoma: A Seer",
    "entities": []
  },
  {
    "text": "Database-Based Research.",
    "entities": [
      {
        "text": "Database-Based Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong",
    "entities": [
      {
        "text": "Hematology",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Xi'an, China, Xi'an, Shaanxi, 710061, People's Republic of China.",
    "entities": [
      {
        "text": "Xi'an",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Xi'an",
        "label": "GPE"
      },
      {
        "text": "Shaanxi",
        "label": "GPE"
      },
      {
        "text": "710061",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a highly",
    "entities": [
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "aggressive extranodal non-Hodgkin's lymphoma. Moreover, there is currently no",
    "entities": [
      {
        "text": "non-Hodgkin's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This study retrospectively selected patients diagnosed with PCNSL",
    "entities": [
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "between 1975 and 2016 from the National Cancer Institute Surveillance,",
    "entities": [
      {
        "text": "between 1975 and 2016",
        "label": "DATE"
      },
      {
        "text": "the National Cancer Institute Surveillance",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Epidemiology, and End Results Database (SEER NCI). The COX model was used to",
    "entities": [
      {
        "text": "Results Database",
        "label": "GPE"
      },
      {
        "text": "COX",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "determine the risk factors for overall survival (OS) and disease-specific",
    "entities": []
  },
  {
    "text": "survival (DSS). The prognostic prediction models for DSS and OS were developed",
    "entities": [
      {
        "text": "DSS",
        "label": "ORG"
      },
      {
        "text": "DSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by integrating significant covariates identified through multivariate analysis.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 3,554 patients with PCNSL were included in this",
    "entities": [
      {
        "text": "3,554",
        "label": "CARDINAL"
      },
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "retrospective study based on inclusion and exclusion criteria. Significant",
    "entities": []
  },
  {
    "text": "differences exist in clinical profiles between elderly (\u226560 years) and younger",
    "entities": []
  },
  {
    "text": "(<60 years) patients with PCNSL. The results showed that the age at diagnosis,",
    "entities": [
      {
        "text": "60 years",
        "label": "DATE"
      },
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathological subtype, whether or not they have undergone surgical treatment, and",
    "entities": []
  },
  {
    "text": "whether or not they have received chemotherapy are independent risk factors for",
    "entities": []
  },
  {
    "text": "DSS, among elderly PCNSL patients. In addition to the risk factors, etc for DSS,",
    "entities": [
      {
        "text": "DSS",
        "label": "ORG"
      },
      {
        "text": "PCNSL",
        "label": "ORG"
      },
      {
        "text": "DSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "human immunodeficiency virus (HIV) infection was also an independent risk factor",
    "entities": []
  },
  {
    "text": "for OS. Based on this, we developed nomograms to estimate OS and DSS for 1, 2,",
    "entities": [
      {
        "text": "DSS",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 3 years.",
    "entities": [
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: This study found differences in baseline data between elderly PCNSL",
    "entities": [
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients and younger PCNSL patients. Surgery and chemotherapy are associated",
    "entities": [
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with better OS and DSS. However, in the long run, radiotherapy is not beneficial",
    "entities": [
      {
        "text": "DSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to OS and DSS of elderly PCNSL patients.",
    "entities": [
      {
        "text": "DSS",
        "label": "ORG"
      },
      {
        "text": "PCNSL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A Study to Improve the Safety of Transplantation: Is Control Necessary for",
    "entities": []
  },
  {
    "text": "Detecting Human Adenovirus in Umbilical Cord Blood Units?",
    "entities": [
      {
        "text": "Detecting Human Adenovirus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)First Propaedeutic Department of Internal Medicine, University General",
    "entities": [
      {
        "text": "1)First",
        "label": "CARDINAL"
      },
      {
        "text": "Propaedeutic Department of Internal Medicine, University General",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Haematology and Public Cord Blood Bank, General Hospital of",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Haematology",
        "label": "ORG"
      },
      {
        "text": "General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Molecular Biology and Genetics, Democritus University of",
    "entities": [
      {
        "text": "Molecular Biology and Genetics",
        "label": "ORG"
      },
      {
        "text": "Democritus University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Thrace, Alexandroupolis, GRC.",
    "entities": [
      {
        "text": "Alexandroupolis",
        "label": "PRODUCT"
      },
      {
        "text": "GRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Medical Biology and Genetics, Aristotle University of",
    "entities": [
      {
        "text": "Medical Biology and Genetics",
        "label": "ORG"
      },
      {
        "text": "Aristotle University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Umbilical cord blood (UCB) units are an alternative valuable",
    "entities": [
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "source for allogeneic hematopoietic stem cells (allo-HSCT). Patients undergoing",
    "entities": []
  },
  {
    "text": "allo-HSCT remain at high risk for complications and mortality due to viral",
    "entities": []
  },
  {
    "text": "infections such as human adenovirus (HAdV). HAdV, a double-stranded DNA virus,",
    "entities": []
  },
  {
    "text": "has been detected in the full-term placenta, raising concerns about vertical",
    "entities": []
  },
  {
    "text": "transmission. This study aims to examine the presence of HAdV in UCB samples to",
    "entities": [
      {
        "text": "HAdV",
        "label": "GPE"
      },
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improve the safety of transplantation procedures. Methods: A total of 98 UCB",
    "entities": [
      {
        "text": "98",
        "label": "CARDINAL"
      },
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "plasma samples were assayed to detect the presence of HAdV DNA using real-time",
    "entities": [
      {
        "text": "HAdV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "polymerase chain reaction (PCR) technology Results: Of the 98 UCB plasma samples",
    "entities": [
      {
        "text": "PCR",
        "label": "ORG"
      },
      {
        "text": "98",
        "label": "CARDINAL"
      },
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analyzed for HAdV, three tested positive (3.06%). In control testing for",
    "entities": [
      {
        "text": "HAdV",
        "label": "GPE"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "3.06%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "prevalent pathogens, 67.3% of the samples were Cytomegalovirus (CMV)",
    "entities": [
      {
        "text": "67.3%",
        "label": "PERCENT"
      },
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IgG-positive (indicating past infection) and 4.2% were CMV IgM-positive (recent",
    "entities": [
      {
        "text": "IgG",
        "label": "ORG"
      },
      {
        "text": "4.2%",
        "label": "PERCENT"
      },
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "or active infection). All the samples were negative for human T-lymphotropic",
    "entities": []
  },
  {
    "text": "virus I-II (HTLV_I-II), hepatitis C virus (HCV), hepatitis B surface antigen",
    "entities": []
  },
  {
    "text": "(HBsAg), and human immunodeficiency virus I-II (HIV_I-II).",
    "entities": [
      {
        "text": "I-II",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: The detection of HAdV in a subset of UCB samples highlights the",
    "entities": [
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "need to consider molecular screening for HAdV as part of routine safety",
    "entities": [
      {
        "text": "HAdV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "evaluations in allogeneic UCB transplantation.",
    "entities": [
      {
        "text": "UCB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Consent for treatment and open",
    "entities": []
  },
  {
    "text": "access publication was obtained or waived by all participants in this study. The",
    "entities": []
  },
  {
    "text": "Bioethics and Ethics Committee of the Medical Department at Aristotle University",
    "entities": [
      {
        "text": "Bioethics and Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "the Medical Department",
        "label": "ORG"
      },
      {
        "text": "Aristotle University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Thessaloniki issued approval 2.693 (07-12-2021). Animal subjects: All authors",
    "entities": [
      {
        "text": "Thessaloniki",
        "label": "ORG"
      },
      {
        "text": "2.693",
        "label": "CARDINAL"
      },
      {
        "text": "07-12-2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "have confirmed that this study did not involve animal subjects or tissue.",
    "entities": []
  },
  {
    "text": "Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors declare the following: Payment/services info: All authors have declared",
    "entities": []
  },
  {
    "text": "that no financial support was received from any organization for the submitted",
    "entities": []
  },
  {
    "text": "work. Financial relationships: All authors have declared that they have no",
    "entities": []
  },
  {
    "text": "financial relationships at present or within the previous three years with any",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "97. Front Health Serv. 2025 Jun 27;5:1562651. doi: 10.3389/frhs.2025.1562651.",
    "entities": [
      {
        "text": "97",
        "label": "CARDINAL"
      },
      {
        "text": "Front Health Serv",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jun",
        "label": "PERSON"
      },
      {
        "text": "27;5:1562651",
        "label": "CARDINAL"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Assessing the influence of lived-experience experts on healthcare providers in a",
    "entities": []
  },
  {
    "text": "virtual community of practice: a qualitative study.",
    "entities": []
  },
  {
    "text": "D(6), Scott JD(7), Sharp SP(4), Samaniego J(4), Bean DR(8), Issa A(1), Lin",
    "entities": [
      {
        "text": "D(6",
        "label": "PERSON"
      },
      {
        "text": "Scott JD(7",
        "label": "PERSON"
      },
      {
        "text": "Sharp SP(4",
        "label": "ORG"
      },
      {
        "text": "Bean DR(8",
        "label": "PERSON"
      },
      {
        "text": "Issa",
        "label": "PERSON"
      },
      {
        "text": "Lin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Centers for Disease Control and Prevention, National Center for Emerging and",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Zoonotic Infectious Diseases, Chronic Viral Diseases Branch, Atlanta, GA, United",
    "entities": [
      {
        "text": "Zoonotic Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "States.",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Centers for Disease Control and Prevention, Global Health Center, HIV",
    "entities": [
      {
        "text": "2)Centers",
        "label": "CARDINAL"
      },
      {
        "text": "Disease Control and Prevention, Global Health Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention Branch, Atlanta, GA, United States.",
    "entities": [
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Herbert Wertheim School of Public Health and Human Longevity Science,",
    "entities": [
      {
        "text": "Wertheim School of Public Health and Human Longevity Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of California, San Diego, La Jolla, CA, United States.",
    "entities": [
      {
        "text": "University of California,",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Laura Rodriguez Research Institute, Family Health Centers of San Diego, San",
    "entities": [
      {
        "text": "Rodriguez Research Institute",
        "label": "ORG"
      },
      {
        "text": "Family Health Centers of San Diego",
        "label": "ORG"
      },
      {
        "text": "San\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diego, CA, United States.",
    "entities": [
      {
        "text": "Diego",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Internal Medicine, University of New Mexico, Albuquerque, NM,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine, University of New Mexico",
        "label": "ORG"
      },
      {
        "text": "Albuquerque",
        "label": "GPE"
      },
      {
        "text": "NM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Pediatrics, Nutrition Section, University of Colorado School of",
    "entities": [
      {
        "text": "Pediatrics, Nutrition Section, University of Colorado School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Aurora, CO, United States.",
    "entities": [
      {
        "text": "Aurora",
        "label": "ORG"
      },
      {
        "text": "CO",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Allergy and Infectious Diseases, University of Washington, Seattle, WA,",
    "entities": [
      {
        "text": "Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)PHI/CDC Global Health Fellowship Program, Public Health Institute, Oakland,",
    "entities": [
      {
        "text": "Public Health Institute",
        "label": "ORG"
      },
      {
        "text": "Oakland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CA, United States.",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and",
    "entities": []
  },
  {
    "text": "other poorly understood post-acute infection syndromes (PAIS) can present with",
    "entities": []
  },
  {
    "text": "unexplained symptoms or conditions that may be misunderstood by healthcare",
    "entities": []
  },
  {
    "text": "providers, causing delays in diagnosis and care. To address these issues, the",
    "entities": []
  },
  {
    "text": "Centers for Disease Control and Prevention (CDC) funded the Long COVID and",
    "entities": [
      {
        "text": "Centers for Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "CDC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fatiguing Illness Recovery Program (LC&FIRP), initiated as a pilot project to",
    "entities": [
      {
        "text": "Fatiguing Illness Recovery Program",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assess whether providing tele-mentoring and other online education for primary",
    "entities": []
  },
  {
    "text": "care providers could help them improve the quality of life and support the",
    "entities": []
  },
  {
    "text": "recovery of their patients with these conditions. The LC&FIRP multi-disciplinary",
    "entities": []
  },
  {
    "text": "team-based care approach is built on the Extension for Community Healthcare",
    "entities": [
      {
        "text": "the Extension for Community Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Outcomes (ECHO) learning model, which is an evidence-based virtual learning",
    "entities": [
      {
        "text": "Outcomes (ECHO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "framework developed by the University of New Mexico and designed to disseminate",
    "entities": [
      {
        "text": "the University of New Mexico",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and implement best practices, especially in under-resourced areas. A distinctive",
    "entities": []
  },
  {
    "text": "feature of LC&FIRP was the inclusion of lived-experience experts. To explore the",
    "entities": []
  },
  {
    "text": "influence of lived-experience experts on the care patients received, we",
    "entities": []
  },
  {
    "text": "collected the educational recommendations provided by the lived-experience",
    "entities": []
  },
  {
    "text": "experts during webinar sessions (January 2022-March 2024) and grouped these by",
    "entities": [
      {
        "text": "January 2022-March 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "themes. The major themes that emerged included validation of patients' illness",
    "entities": []
  },
  {
    "text": "experience; attitudes and beliefs about Long COVID, ME/CFS, and PAIS;",
    "entities": [
      {
        "text": "PAIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "understanding patients' challenges and communicating with empathy; navigating",
    "entities": []
  },
  {
    "text": "referrals; recognizing and supporting disability; and supporting self-care.",
    "entities": []
  },
  {
    "text": "Investigators also interviewed patients of the Family Health Centers of San",
    "entities": [
      {
        "text": "the Family Health Centers of San\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diego (FHCSD) about their experiences receiving care from participating primary",
    "entities": [
      {
        "text": "FHCSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "care providers and employed content analysis methods to code interview",
    "entities": []
  },
  {
    "text": "transcripts to identify themes among patients' perspectives. Positive comments",
    "entities": []
  },
  {
    "text": "from the patients about topics emphasized by the lived-experience experts",
    "entities": []
  },
  {
    "text": "provided evidence of providers' uptake and application of the experts'",
    "entities": []
  },
  {
    "text": "recommendations and support the value of involving lived-experience experts in",
    "entities": []
  },
  {
    "text": "medical education to improve health services.",
    "entities": []
  },
  {
    "text": "At least a portion of this work is authored by Stephanie Sargent Weaver, Monique",
    "entities": [
      {
        "text": "Stephanie Sargent Weaver",
        "label": "ORG"
      },
      {
        "text": "Monique",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Carry, Jeanne Bertolli, Anindita Issa, Jin-Mann S. Lin, Elizabeth R. Unger on",
    "entities": [
      {
        "text": "Jeanne Bertolli",
        "label": "PERSON"
      },
      {
        "text": "Anindita Issa",
        "label": "PERSON"
      },
      {
        "text": "Jin-Mann S. Lin",
        "label": "PERSON"
      },
      {
        "text": "Elizabeth R. Unger",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "behalf of the U.S. Government and as regards Dr. Weaver, Dr. Carry, Dr.",
    "entities": [
      {
        "text": "the U.S. Government",
        "label": "ORG"
      },
      {
        "text": "Weaver",
        "label": "PERSON"
      },
      {
        "text": "Carry",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Bertolli, Dr. Issa, Dr. Lin, Dr. Unger and the U.S. Government, is not subject",
    "entities": [
      {
        "text": "Bertolli",
        "label": "PERSON"
      },
      {
        "text": "Issa",
        "label": "PERSON"
      },
      {
        "text": "Lin",
        "label": "PERSON"
      },
      {
        "text": "Unger",
        "label": "PERSON"
      },
      {
        "text": "the U.S. Government",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to copyright protection in the United States. Foreign and other copyrights may",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "apply.",
    "entities": []
  },
  {
    "text": "Advances in HIV Treatment and Vaccine Development: Emerging Therapies and",
    "entities": []
  },
  {
    "text": "Breakthrough Strategies for Long-Term Control.",
    "entities": []
  },
  {
    "text": "BM(8), Ahmed MM(9), Oso TA(2), Musa SS(10)(11), Lucero-Prisno DE(12)(13)(14).",
    "entities": [
      {
        "text": "BM(8",
        "label": "PERSON"
      },
      {
        "text": "Ahmed MM(9",
        "label": "PERSON"
      },
      {
        "text": "Oso TA(2",
        "label": "ORG"
      },
      {
        "text": "Musa SS(10)(11",
        "label": "PERSON"
      },
      {
        "text": "Lucero-Prisno",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Public Health and Maritime Transport, University of Thessaly,",
    "entities": [
      {
        "text": "Maritime Transport",
        "label": "ORG"
      },
      {
        "text": "University of Thessaly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Laboratory Science, Neuropsychiatric Hospital, Aro,",
    "entities": [
      {
        "text": "Medical Laboratory Science",
        "label": "ORG"
      },
      {
        "text": "Neuropsychiatric Hospital",
        "label": "ORG"
      },
      {
        "text": "Aro",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Laboratory Science, Chrisland University, Abeokuta,",
    "entities": [
      {
        "text": "Medical Laboratory Science",
        "label": "ORG"
      },
      {
        "text": "Chrisland University",
        "label": "ORG"
      },
      {
        "text": "Abeokuta",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Medical Microbiology, Department of Public Health Science,",
    "entities": [
      {
        "text": "Medical Microbiology, Department of Public Health Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University College Hospital Ibadan, Ibadan, Nigeria.",
    "entities": [
      {
        "text": "University College Hospital Ibadan",
        "label": "ORG"
      },
      {
        "text": "Ibadan",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical Laboratory Science, Edo State University Uzairue, Benin",
    "entities": [
      {
        "text": "Medical Laboratory Science",
        "label": "ORG"
      },
      {
        "text": "Edo State University Uzairue",
        "label": "ORG"
      },
      {
        "text": "Benin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "City, Nigeria.",
    "entities": [
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Medical Microbiology and Parasitology, Bayero University Kano,",
    "entities": [
      {
        "text": "Medical Microbiology and Parasitology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Medical Laboratory Science, State Hospital Ede, Ede, Osun,",
    "entities": [
      {
        "text": "Medical Laboratory Science",
        "label": "ORG"
      },
      {
        "text": "State Hospital Ede",
        "label": "ORG"
      },
      {
        "text": "Ede",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Community and Clinical Research Division, First On-Call Initiative, Port",
    "entities": [
      {
        "text": "Clinical Research Division",
        "label": "ORG"
      },
      {
        "text": "First On-Call Initiative, Port",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Harcourt, Nigeria.",
    "entities": [
      {
        "text": "Harcourt",
        "label": "GPE"
      },
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu,",
    "entities": [
      {
        "text": "Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "SIMAD University",
        "label": "ORG"
      },
      {
        "text": "Mogadishu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Faculty of Medicine, School of Global Health, Chulalongkorn University,",
    "entities": [
      {
        "text": "10)Faculty",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine, School of Global Health, Chulalongkorn University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Nursing Science, Ahmadu Bello University, Zaria, Nigeria.",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Ahmadu Bello University",
        "label": "ORG"
      },
      {
        "text": "Zaria, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Global Health and Development, London School of Hygiene and",
    "entities": [
      {
        "text": "Global Health and Development",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Research and Development Office, Biliran Province State University, Naval,",
    "entities": [
      {
        "text": "13)Research",
        "label": "DATE"
      },
      {
        "text": "Development Office",
        "label": "ORG"
      },
      {
        "text": "Biliran Province State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Research and Innovation Office, Southern Leyte State University, Sogod,",
    "entities": [
      {
        "text": "14)Research and Innovation Office",
        "label": "ORG"
      },
      {
        "text": "Southern Leyte State University",
        "label": "ORG"
      },
      {
        "text": "Sogod",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Southern Leyte, Philippines.",
    "entities": [
      {
        "text": "Philippines",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Since its identification in 1981, HIV has posed a global public health",
    "entities": [
      {
        "text": "1981",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "challenge, witnessing transformative advancements in treatment and prevention.",
    "entities": []
  },
  {
    "text": "This review summarizes recent novel therapeutic and preventive approaches for",
    "entities": []
  },
  {
    "text": "long-term HIV control, management, and elimination, and how global collaboration",
    "entities": []
  },
  {
    "text": "and technological innovations may advance HIV control efforts. This study",
    "entities": []
  },
  {
    "text": "highlights the progress and challenges in HIV treatment, emphasizing the",
    "entities": []
  },
  {
    "text": "effectiveness of current antiretroviral therapy (ART) in suppressing viral",
    "entities": []
  },
  {
    "text": "replication, reducing transmission, and preventing end-organ damage. However,",
    "entities": []
  },
  {
    "text": "psychosocial factors affecting patients. ART-related toxicities include",
    "entities": []
  },
  {
    "text": "neuropathy, hepatotoxicity, metabolic disorders, and neuropsychiatric effects.",
    "entities": []
  },
  {
    "text": "Long-acting ART (LA-ART) offers a promising alternative to daily dosing;",
    "entities": [
      {
        "text": "ART",
        "label": "PERSON"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "however, challenges such as injection site reactions persist. Broadly",
    "entities": []
  },
  {
    "text": "neutralizing antibodies (bNAbs) have shown enhanced efficacy in viral",
    "entities": []
  },
  {
    "text": "suppression and immune response activation, offering potential for treatment and",
    "entities": []
  },
  {
    "text": "vaccine design. Innovative gene-editing tools, such as CRISPR-Cas systems, are",
    "entities": [
      {
        "text": "CRISPR-Cas",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "being explored for their ability to excise or silence proviral DNA; however,",
    "entities": []
  },
  {
    "text": "their clinical application is limited by off-target effects and delivery",
    "entities": []
  },
  {
    "text": "challenges. Latency-targeting strategies like \"shock and kill\" and \"block and",
    "entities": []
  },
  {
    "text": "lock\" remain experimental with limited clinical success, and",
    "entities": []
  },
  {
    "text": "nanotechnology-based drug delivery systems offer targeted, sustained, and less",
    "entities": []
  },
  {
    "text": "toxic treatment options. Despite the challenges posed by the virus's rapid",
    "entities": []
  },
  {
    "text": "mutation rate and immune evasion mechanisms, novel vaccine approaches, such as",
    "entities": []
  },
  {
    "text": "mRNA technology, vector-based platforms, and epitope-targeting strategies, are",
    "entities": []
  },
  {
    "text": "being explored. In addition, artificial intelligence and machine learning are",
    "entities": []
  },
  {
    "text": "enhancing the design of vaccines, predictive modeling, and fast-tracking",
    "entities": []
  },
  {
    "text": "progress in this area. Socio-economic bottlenecks in HIV control, such as",
    "entities": []
  },
  {
    "text": "stigma, gender disparities, and inequitable healthcare access, exacerbate the",
    "entities": []
  },
  {
    "text": "epidemic, particularly in sub-Saharan Africa. Enhancing global collaboration,",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "providing sustainable funding, and integrating emerging and innovative",
    "entities": []
  },
  {
    "text": "technologies are critical for advancing HIV prevention and management. Achieving",
    "entities": []
  },
  {
    "text": "an AIDS-free generation and ultimately eliminating the epidemic will depend on",
    "entities": []
  },
  {
    "text": "effectively addressing the social, structural, and scientific barriers that",
    "entities": []
  },
  {
    "text": "hinder progress in this regard. Trial Registration: ClinicalTrials.gov",
    "entities": []
  },
  {
    "text": "identifier: NCT02120352, NCT02938520, NCT03639311, NCT03497676, NCT03635788.",
    "entities": [
      {
        "text": "NCT02120352",
        "label": "PERSON"
      },
      {
        "text": "NCT02938520, NCT03639311",
        "label": "ORG"
      },
      {
        "text": "NCT03497676",
        "label": "ORG"
      },
      {
        "text": "NCT03635788",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Olalekan John Okesanya et al. AIDS Research and Treatment",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Okesanya",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "99. J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S1994-S1997. doi:",
    "entities": [
      {
        "text": "99",
        "label": "CARDINAL"
      },
      {
        "text": "Bioallied Sci",
        "label": "PERSON"
      },
      {
        "text": "2):S1994",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Hemophagocytic Lymphohistiocytosis and Disseminated Histoplasmosis in an HIV",
    "entities": [
      {
        "text": "Hemophagocytic Lymphohistiocytosis",
        "label": "ORG"
      },
      {
        "text": "Disseminated Histoplasmosis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ahmad S(1), Gosavi S(1), Acharya RV(1), Varma M(1).",
    "entities": [
      {
        "text": "Ahmad S(1",
        "label": "PERSON"
      },
      {
        "text": "Gosavi S(1",
        "label": "PERSON"
      },
      {
        "text": "Varma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of General Medicine, Kasturba Medical College, Manipal Manipal",
    "entities": [
      {
        "text": "General Medicine",
        "label": "ORG"
      },
      {
        "text": "Kasturba Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Academy of Higher Education, Manipal, Karnataka, India.",
    "entities": [
      {
        "text": "Academy of Higher Education",
        "label": "ORG"
      },
      {
        "text": "Manipal",
        "label": "GPE"
      },
      {
        "text": "Karnataka",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "We present a case of a 54-year-old male, with newly detected HIV with low CD4",
    "entities": [
      {
        "text": "54-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "counts, diagnosed with hemophagocytic lymphohistiocytosis secondary to",
    "entities": []
  },
  {
    "text": "disseminated histoplasmosis. The history of his high-risk sexual behavior,",
    "entities": []
  },
  {
    "text": "fever, and pancytopenia led to clinical suspicion of HIV which was confirmed on",
    "entities": []
  },
  {
    "text": "serology. Hemophagocytosis was detected on bone marrow aspiration cytology and",
    "entities": [
      {
        "text": "Hemophagocytosis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "histoplasmosis was diagnosed on ultrasound-guided fine needle aspiration",
    "entities": []
  },
  {
    "text": "cytology of cervical lymph nodes. Timely interference of antiretroviral therapy",
    "entities": []
  },
  {
    "text": "(ART), antifungals, and identification of HLH lead to recovery of the patient.",
    "entities": [
      {
        "text": "HLH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright: \u00a9 2025 Journal of Pharmacy and Bioallied Sciences.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Journal of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Bioallied Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There are no conflicts of interest.",
    "entities": []
  },
  {
    "text": "100. Int J Integr Care. 2025 Jul 9;25(2):8. doi: 10.5334/ijic.8944. eCollection",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Integr Care",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.5334",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A Framework for Implementing Integrated HIV and Non-Communicable Disease Care at",
    "entities": [
      {
        "text": "Non-Communicable Disease Care",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Primary Health Care Facilities in Southern Africa.",
    "entities": [
      {
        "text": "Southern Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)School of Health Systems and Public Health, Faculty of Health Sciences,",
    "entities": [
      {
        "text": "1)School of Health Systems and Public Health, Faculty of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Pretoria, Pretoria, South Africa.",
    "entities": [
      {
        "text": "University of Pretoria",
        "label": "ORG"
      },
      {
        "text": "Pretoria",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)University of South Africa, College of Graduate Studies, Pretoria, South",
    "entities": [
      {
        "text": "2)University",
        "label": "CARDINAL"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      },
      {
        "text": "College of Graduate Studies",
        "label": "ORG"
      },
      {
        "text": "Pretoria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Human Sciences Research Council, Pretoria, South Africa.",
    "entities": [
      {
        "text": "3)Human Sciences Research Council",
        "label": "ORG"
      },
      {
        "text": "Pretoria",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Comorbidities of HIV/AIDS and non-communicable diseases (NCDs) are",
    "entities": []
  },
  {
    "text": "increasingly prevalent, affecting up to 30% of individuals living with HIV/AIDS,",
    "entities": [
      {
        "text": "up to 30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "particularly in Sub-Saharan Africa. Conventional approaches that treat NCDs",
    "entities": [
      {
        "text": "Sub-Saharan Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "separately from HIV/AIDS care have been deemed inefficient, highlighting the",
    "entities": []
  },
  {
    "text": "need for integrated models. This study aims to develop a framework for",
    "entities": []
  },
  {
    "text": "integrating NCD care into HIV programs at primary healthcare facilities in",
    "entities": [
      {
        "text": "NCD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Southern Africa.",
    "entities": [
      {
        "text": "Southern Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "METHODS: As part of a broader study examining the burden, extent and cost of",
    "entities": []
  },
  {
    "text": "HIV/NCD integration we employed a modified 'Best fit' framework synthesis",
    "entities": []
  },
  {
    "text": "method. Thematic analysis was the primary method of analysis used to inform the",
    "entities": []
  },
  {
    "text": "framework.",
    "entities": []
  },
  {
    "text": "RESULTS: The study expanded on existing framework themes related to effective",
    "entities": []
  },
  {
    "text": "team-working, organizational leadership, patient-centered care,",
    "entities": []
  },
  {
    "text": "community/patient/provider partnerships. It introduced seven additional themes:",
    "entities": [
      {
        "text": "community/patient/provider partnerships",
        "label": "ORG"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "country specific NCD prioritization, multi stakeholder partnerships, healthcare",
    "entities": [
      {
        "text": "NCD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "worker mental wellbeing, unified health information systems, with enhanced",
    "entities": []
  },
  {
    "text": "privacy, establishing costing databases for HIV/NCD integrated care, robust",
    "entities": []
  },
  {
    "text": "monitoring and evaluation mechanisms, and opportunities for regional",
    "entities": []
  },
  {
    "text": "coordination.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Improving existing frameworks for integrating HIV/NCD care is",
    "entities": []
  },
  {
    "text": "feasible by leveraging established HIV care platforms. These enhancements can",
    "entities": []
  },
  {
    "text": "support more efficient holistic healthcare delivery across primary healthcare",
    "entities": []
  },
  {
    "text": "facilities in Southern Africa.",
    "entities": [
      {
        "text": "Southern Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Copyright: \u00a9 2025 The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors have no competing interests to",
    "entities": []
  }
]